Yaya tsawon lokacin da waɗannan alamun ke faruwa?
Kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ma a shekarunka.
Kuma da zazzabi.
Kuma za ku gwada yawan cholesterol da jini.
Kuma yanzu kana da zazzabi?
Kuma yanzu kana da wannan ciwon kirji?
Kuma kana da wahalar numfashi?
Kuma ka gaya mini, waɗanne alamun cutar ne kake da su?
Kuma yawan zafin jikinka.
Kuma ina da tari.
Kuma ina da ɗan sanyi da tari.
Kuma ina da ciwon kirji sosai a yau.
Kuma a wannan lokacin ne ciyawa ke da zazzabi.
Kuma zai iya sa ka ciwon kirji.
Kuma ina ganin ina da zazzabi kadan.
Kuma ina so ku bayyana inda zuciyarku ke ciwo.
Kuma suna da zazzabi.
Kuma da tarihin ciwon sukari.
Kuma, ka sani, kamar kirji zai fashe.
Kuma ka san mutane suna yawan yin tari a gabana.
Kuma kuna da ciwon kirji.
Kuma kuna cewa yana jin matsin lamba a kirjin ku.
Wani a cikin iyalinku yana da ciwon zuciya, ciwon zuciya, bugun zuciya, babban cholesterol, hawan jini.
Shin kun lura da wasu alamomi ko matsaloli tare da ciwon tsoka?
Shin akwai wasu marasa lafiya a gidanku da ke da alamun cutar kamar ku?
Kana da wasu alamun cutar?
Kana da ciwon numfashi?
Har yanzu kana da ciwon kirji?
Domin wannan shi ne lokacin mura.
Amma ba za mu manta da ciwon zuciya ba.
Amma abin da ya fi muhimmanci yanzu shi ne ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa sun yi kuka a gabana.
Amma dole ne mu dauki duk wani ciwon kirji da muke ji da muhimmanci.
Amma ba ka da matsalar numfashi a yanzu, ko?
Na manta da wannan ciwon kirji.
Kamar wani yana matsa maka a kirji.
Har yanzu ina numfashi.
Shin sun yi rahoton rashin lafiya iri ɗaya?
Kana da wata cuta mai tsanani kamar hawan jini ko wani abu makamancin haka?
Kana da wata cuta ko kuma ciwon sukari?
Kuna da ciwon numfashi tare da ciwon kirji?
Kana da hawan jini?
Shin kana da ciwon numfashi?
Ka san alamun cutar?
Kuna ganin wannan hoton?
Ka sha ruwa da yawa a yau.
Ko da yake na yi gwajin ciwon sukari.
Amma yana da alamun da na ke da su.
Yaya zazzabi yake?
Yaya karfin jini naka yake?
Idan kana da zazzabi mai yawa kuma ba ya sauka
Idan kana da zazzabi mai ɗari biyu ko sama da haka
Idan ka ga cewa kana bukatar ƙarin bincike game da alamun cututtuka ko matsalolin da kake da su
Na yi zazzabi a jiya.
Ni ma ina da zazzabi.
Na yi zazzabi a jiya.
Ina da ciwo mai tsanani a cikin kirji a nan.
Ina da wahalar numfashi.
Zan aiko maka da hoton.
Ina jin ciwon kirji a cikin kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina ganin mura ce.
Ina ganin ba cutar mura ba ce.
Kamar wani mai kiba ne yake zaune a kan kirjinka?
Hakan ya fara ne da ciwon kai da zazzabi a lokaci guda.
Ya buge ni a tsakiyar kirji.
Yana da zafi kamar ciwon kirji.
Yana cikin kirji na.
Yana daidai a tsakiyar kirji na.
Yana daidai a tsakiyar kirji.
Ina jin ciwon kirji.
Na damu sosai game da wannan ciwon kirji.
Ka gaya mini dalla-dalla game da wannan ciwon zuciyar ka.
Kamar cutar hawan jini ko ciwon sukari.
Kamar dai a tsakiyar kirji.
Yanzu za ku iya samun tachypirina don zazzabi.
To, Mary, yaushe ne alamun cutar suka kasance a gare ku?
Kafin nan, ka ce kana da ciwon kirji.
Wani lokaci na kan ji ciwon kirji.
Shin kana da wasu alamun ban da ciwo?
Ko kuwa wani yana zaune a kan kirjinka?
Da yawan zazzabi da tari, ciwon kai da ciwon tsoka.
A tsakiyar kirji na.
Ka nuna mini a wannan hoton inda kake jin zafi.
Tun da kana da zazzabi.
Shin kana ganin wasu daga cikin wadannan alamun na iya zama na ciki?
Shin yaranku ma suna da irin wannan alamun?
Ka gaya mini game da ciwon kirjinka.
Zazzabi yana ƙaruwa da dare.
Na yi zazzabi a cikin kwanaki biyu da suka gabata.
Ta fara zazzabi a daren jiya.
Ni ne Dr. Porter daga sashen gaggawa na Cibiyar Kula da Cutar.
To, ka gaya mini game da ciwon kirjinka?
Na ji ciwo a kirji a gaban jiki.
Duba, ina da ciwo mai tsanani a kirji.
Amma, idan na ji ciwon kirji,
Wane irin ciwo ne ke damun ka a kirji?
Yaushe wannan ciwon kirji ya fara?
Ina ciwon kirjinka?
A ina kake jin wannan ciwon a kirji?
Da alama akwai wani matsin lamba a kirjinka.
Ka san cewa ina da ciwon sukari.
Ka ce kana da ciwon kirji.
Saurin karuwa a cikin tarin cututtukan cutar coronavirus (COVID-19) a cikin EU / EEA da UK daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Abubuwan da ke tattare da cutar coronavirus (COVID-19) suna nuna irin wannan yanayin tsakanin ƙasashen Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya wanda ke tabbatar da cewa cutar COVID-19 tana ci gaba da sauri a duk ƙasashe, kodayake tana cikin matakai daban-daban dangane da ƙasa.
Bisa ga ilimin da aka samu daga Italiya, dole ne ƙasashe, asibitoci da raka'a masu kulawa da hankali su haɓaka shirye-shirye don saurin haɓaka marasa lafiya da ke fama da COVID-19 waɗanda ke buƙatar kiwon lafiya da ke buƙatar kulawa ta musamman.
An bayar da rahoton wani sabon kamuwa da cutar sankarar bargo da ba a san asalinsa ba a birnin Wuhan, lardin Hubei, kasar Sin a ranar 31 ga watan Disamba, 2019.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ce an sanya sunan kwayar cutar coronavirus mai dauke da cutar mai dauke da cutar ta SARS-CoV-2 a matsayin kwayar cutar da ke dauke da cutar.
Saboda haka, cutar da ke haifar da kamuwa da SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Bayanai masu inganci a yau sun nuna cewa kashi 80% na mutanen da suka kamu da COVID-19 suna da rashin lafiya mai laushi, wato, kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba kuma yawancin su sun warke.
A cikin kashi 14% na masu kamuwa da cutar, COVID-19 ya zama mafi muni wanda ke haifar da buƙatar asibiti, yayin da kashi 6% na masu kamuwa da cutar ke fuskantar rashin lafiya mai tsanani wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke kwance a asibiti saboda COVID-19 ya kai kusan 4%.
A cikin wannan binciken muna nazarin yanayin abubuwan da ke tattare da COVID-19 a kowace ƙasa ta Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU/EEA) da Ingila (UK) da kuma kwatanta su da lardin Hubei na China.
Mun kuma kwatanta adadin mutanen da suka kamu da cutar a Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020 da adadin mutanen da ke fama da cutar a EU/EEA da kuma Birtaniya.
Cutar COVID-19 a cikin EU / EEA da UK
Kasar Sin ta biyo bayan COVID-19 da ke yaduwa a duniya, kuma halin da ake ciki a sauran sassan duniya a halin yanzu yana bin kasar.
Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris, 2020.
A cikin fitowar 5 ga Maris na EuroSurveillance 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon lamuran da aka tabbatar na Turai na COVID-19 bisa ga ma'anar WHO.
A cikin EU/EEA, Faransa ta sanar da farko uku daga cikin mutane da suka dawo daga Wuhan, lardin Hubei na kasar Sin a ranar 24 ga Janairu, 2020.
A ranar 15 ga Maris, 2020, an samu kamuwa da COVID-19 a dukkan ƙasashen EU/EEA 30 da Ingila (UK), inda aka ba da rahoton shari'o'i 39,768 da mutuwar 1,727 daga 31 ga Disamba, 2019, tare da 17,750 da mutuwar 1,441 a Italiya kadai.
Ana samun adadi mai yawa na masu cutar COVID-19 da kuma yaduwar su.
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana da bayanai game da ƙididdigar COVID-19 a kowace ƙasa a duniya da aka samo daga ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki, da kuma tushen hukuma kamar WHO, waɗanda aka sabunta kowace rana da ƙarfe 8:00.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU / EEA da Burtaniya da kuma kwatanta shi da abin da ya faru a Italiya.
A matsayin wakili na barkewar cutar COVID-19 mai aiki, mun kirga kwanaki 14 na gajeren lokaci na COVID-19, don haka muna la'akari da yanayin COVID-19 a kowace ƙasa a cikin EU/EEA da Burtaniya a cikin lokacin Janairu 1 - 15 Maris 2020.
Mun kuma gabatar da adadin adadin adadin masu cutar da aka rubuta a kowace ƙasa har zuwa karfe 8:00 na safe ranar 15 ga Maris, 2020 idan aka kwatanta da adadin masu cutar a Italiya a cikin lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU / EEA da UK
Yanayin karuwar kwanaki 14 na COVID-19 a cikin ƙasashen EU/EEA da Burtaniya gabaɗaya ya bi yanayin lardin Hubei (China) (Figure 1).
Ga EU/EEA da kuma Burtaniya gabaɗaya, ƙwayoyin cuta na COVID-19 sun fara ƙaruwa a kusa da 21 ga Fabrairu sannan suka ƙaru sosai a kusa da 28 ga Fabrairu 2020 (ƙarin abu).
Wannan ya kasance ne saboda saurin karuwar adadin masu cutar da aka ruwaito a Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan yanayin karuwa a cikin abubuwan da ke tattare da karuwar COVID-19 (kayan aiki).
Hoto na 2 ya nuna kwatancen lambobin Italiya da adadin adadin COVID-19 a cikin ƙasashen EU/EEA da Ingila don lokacin 31 ga Janairu-15 ga Maris 2020.
Ya kamata a lura cewa, a karfe 8:00 na safe ranar 15 ga Maris, wasu ƙasashe 15 na EU/EEA da Burtaniya sun riga sun ba da rahoton adadin adadin masu kamuwa da cutar kamar Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa adadin sanannun cututtukan COVID-19 suna ƙaruwa cikin sauri a cikin EU / EEA da Burtaniya.
Yanayin da aka lura a cikin tarin abubuwan da suka faru na COVID-19 ya nuna cewa annobar tana ci gaba da saurin tafiya a duk ƙasashe.
Wannan duk da cewa kasashe suna cikin matakai daban-daban, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, da bambance-bambance a cikin ma'anar masu yuwuwar kamuwa da cutar a cikin ƙasashe da kuma ladabi daban-daban don rarrabe marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kama-karya.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke fama da COVID-19 ke buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da raka'a masu kulawa da hankali a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da asibiti da / ko shigar da marasa lafiya na COVID-19 a cikin sashin kulawa mai tsanani a halin yanzu ana samun su ne kawai a cikin kashi 6% da 1% na masu cutar a matakin EU / EEA (ba a nuna bayanan ba).
Koyaya, ya kamata a tattara su ta hanyar tsari don haɓaka bayanan sa ido na yanzu wanda ke mai da hankali kan adadin adadin rahotannin da aka bayar da kuma yawan mutuwar.
Wani bincike da aka gudanar a 2010/11 ya nuna bambanci mai yawa tsakanin wadatar gadaje masu kulawa da hankali da kuma matsakaiciyar kulawa a Turai, a cikin tsarin gadaje 4.2 a kowace 100,000 a Jamus daga 29.2 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙasa ko sama da albarkatu fiye da Italiya (gadoji 12.5 na kulawa mai tsanani da na tsaka-tsaki a cikin 100,000 a 201011).
Tare da yawan adadin COVID-19 da aka kwantar a asibiti a kowace EU/EEA da Burtaniya, yanayin samfurin da ke tattare da daidaitawar iyawar kiwon lafiya ya nuna cewa akwai haɗarin > 90% na wuce gona da iri na gadajen kulawa mai tsanani, kuma an bayar da shi a cikin sabuntawa na shida na ECDC na COVID-19 Rapid Risk Assessment.
Tunda har yanzu akwai lamura a cikin ƙasashen EU/EEA da wasu yankuna na Burtaniya, kuma asibitoci da raka'a na kulawa mai tsanani galibi suna ba da sabis na yanki ga jama'a, yana da kyau a sami bayanai game da masu cutar da gadajen kulawa mai tsanani a cikin tsarin sanya sunan rukunin yanki don ƙididdigar 2 (NUTS-2).
Kwarewar da aka samu daga Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da Burtaniya.
Don haka, ƙasashe, asibitoci da raka'a masu kulawa da hankali su shirya kansu don yanayin ci gaba da yaduwar al'umma na SARS-CoV-2 da kuma yawan adadin marasa lafiya na COVID-19 da ke buƙatar kiwon lafiya da kuma kulawa mai tsanani, kamar yadda ya faru a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin sabon kimantawa na ECDC mai sauri, hanzari, mai saurin aiki da kuma cikakkiyar hanyar da za a iya amfani da ita don jinkirta yaduwar SARS-COV-2 yana da mahimmanci, tare da sauyawa daga hanawa zuwa ragewa, saboda idan ba a aiwatar da shi ba da wuri, saurin karuwar adadin lokuta ba zai ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da kuma daidaita martani ba.
Binciken hadarin gaggawa ya kuma bada jerin sunayen matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai ɗan gajeren lokaci na dama wanda ƙasashe za su iya ƙara haɓaka ƙoƙarin sarrafa su don rage saurin yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan ba a yi hakan ba, akwai yiwuwar tsarin kiwon lafiya a wasu ƙasashen EU/EEA zai fuskanci karuwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki masu zuwa ko makonni.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututut
SARS-CoV yayi kama da kwayar cutar da ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya kamuwa da cutar daga jemage kuma yana haifar da alamun bayyanar cututtuka ta hanyar wannan hanyar.
Koyaya, COVID-19 yana da ƙananan cututtuka da mutuwar fiye da SARS amma yana da saurin yaduwa kuma yana shafar maza fiye da matasa da mata fiye da matasa.
A cikin martani ga yawan wallafe-wallafen da ke tasowa game da cututtuka masu tasowa, wannan labarin ya yi ƙoƙari ya ba da cikakken bayani game da wannan bincike mai tasowa.
Za mu hada da abubuwan farko game da cututtukan cututtuka, ilimin cututtuka, ilimin cututtuka, ganewar asali, magani, alamun cutar da rigakafi.
Ko da yake har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan wannan bita zai taimaka wajen fahimtar da kuma kawar da cutar.
Bikin bazara na ranar 25 ga Janairun 2020 ya zama abin tunawa ga dukkan Sinawa waɗanda ba a taɓa mantawa da su ba, waɗanda aka umarce su da su zauna a gida a duk lokacin hutu da kuma makonni bayan haka saboda barkewar sabuwar cutar kwayar cutar.
Kwayar cutar tana da alaƙa da kwayar cutar coronavirus (CoV) wanda ya haifar da ɓarkewar mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututut
An fara bullar cutar a Wuhan, China, kuma ta bazu cikin sauri a duk faɗin ƙasar da kuma wasu ƙasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, an tabbatar da sama da mutane 80,000 da cutar ta COVID-19 ta haifar, tare da sama da mutane 40,000 da aka warke da sama da mutane 3,000 da suka mutu.
"WHO ta yi gargadin cewa COVID-19 "maƙiyi na 1 na mutane ne"" kuma mai yiwuwa ya fi ta'addanci ƙarfi".
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), an buga sama da labarai 200 game da COVID-19 wanda ya haɗa da cututtuka, ilimin annoba, ilimin lissafi, bincike da magani, wanda ya tsara jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa, ƙasa da watanni biyu tun lokacin da aka fara ba da rahoto a ranar 7 ga Janairu, 2020.
Wannan bita ya yi ƙoƙarin taƙaita ci gaban bincike a cikin sabon abu da ke haɓaka cikin sauri.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da kuma wata cuta da CoV ke haifarwa, Ciwon Numfashi na Gabas ta Tsakiya (MERS, annoba a 2012).
Mun tattauna abin da muka sani game da rigakafin cututtuka da kuma tsinkaya har zuwa yanzu, da kuma wasu tambayoyi masu muhimmanci da suka rage.
CoVs an ɗauka a matsayin ƙwayoyin cuta marasa lahani ga mutane waɗanda ke haifar da kusan kashi 4 cikin 15 na cututtukan sanyi.
Koyaya, a wannan karni, mun sami sau biyu da cutar ta haifar da cutar ta mutum, wato SARS-CoV da MERS-CoV, waɗanda suka fara barkewar annoba a China a 2003 da Saudi Arabiya a 2012 bi da bi, kuma nan da nan suka bazu zuwa wasu ƙasashe da yawa tare da munanan alamomi da mutuwa.
Don haka, COVID-19 na yanzu shine barkewar CoV na uku da aka rubuta a tarihin ɗan adam.
Kamar yadda aka nuna a Figure 1.1, an fara ba da rahoton tarin fuka-fukan cutar sankarar bargo daga Wuhan zuwa Hukumar Kiwon Lafiyar Kasa ta China a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an bayyana jerin CoV.
An bayar da rahoton mutuwar mutum na farko a Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an sanar da masu ba da kiwon lafiya game da kamuwa da cutar, wanda ke nuna yiwuwar kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan kuma an dakatar da duk hanyoyin sufuri.
A ranar 24 ga watan Janairu, binciken farko na cutar ya nuna cewa daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, inda aka fara cutar daga wata dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin wannan rahoton, cutar ta riga ta bazu zuwa China da wasu ƙasashe kusan 50 a duniya (Figure (Figure 2).2).
A halin yanzu, ba a san iyakar girman cutar da kuma tsananin cutar ba, saboda yanayin ya ci gaba da saurin bunkasa.
A ranar 11 ga Fabrairu, 2020, binciken da aka yi a kan marasa lafiya 8,866 da suka hada da 4,021 da suka kamu da cutar COVID-19 ya gabatar da ƙarin bayanan cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma an fi samunsa a tsakanin shekaru 30 zuwa 65.
Kusan rabin wadanda suka kamu da cutar (47.7%) sun haura shekaru 50, kaɗan sun kasance 'yan ƙasa da shekaru 20, kuma mutane 14 ne kawai ke fama da cutar da shekarunsu ba su kai 10 ba.
SARS-CoV-2 ya kamu da maza da yawa (0.27/100,000) fiye da mata (0.31/100,000).
COVID-19 ya bazu cikin sauri, musamman a Hubei da kewayenta.
Matsakaicin lokacin da COVID-19 ke ɗauka daga farawa zuwa ganewar asali shine kwanaki 5 (2-9).
Matsakaicin lokacin incubation na kwayoyin cuta ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin farawa zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Yawan haifuwa na farko (R0) ya kasance 3.77 (95% CI: 3.51-4.05), kuma daidaitaccen R0 ya kasance 2.23-4.82.
Yawan masu kamuwa da cutar ya karu sosai kafin ranar 23 ga Janairu, 2020, daidai da lokacin babban zirga-zirgar jama'a kafin bikin bazara na kasar Sin.
Yawan mutuwar da aka tabbatar da su ya kasance 1.44% (95% CI: 1.10-1.86%) kuma yawan mutuwar da aka daidaita a cikin dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60) da kuma cutar huhu mai tsanani.
CoVs wani ƙaramin rukuni ne na ƙwayoyin cuta masu girma da yawa waɗanda ke ɗauke da ma'anar RNA guda ɗaya.
Ana iya raba su zuwa rukuni huɗu ko jinsi, wato, alpha, beta, gamma, da delta, daga cikinsu an san alpha da beta-CoVs suna cutar da mutane.
A cikin SARS-CoV da MERS-CoV, glycoprotein mai ɗauke da kebul (S) yana ɗaure da ƙwayoyin cuta masu karɓar kwayoyin halitta na angiotensin-converting enzyme 2 (ACE2) da dipeptideal peptidase 4 (DPP4), bi da bi, sannan kuma an haɗa su da membrane.
Kwayar RNA ta kwayar cutar ta saki a cikin kwayar halitta; bayan an kwafi kwayar cutar, envelope tare da glycoproteins da nucleocapsid sunadaran suna samar da kwayar RNA ta genomic tare da vesicles ko vesicles, wanda ya haɗu da membrane na plasma don saki kwayar cutar.
An ba da rahoton farkon yanayin kwayoyin halitta na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 wani sabon nau'in beta-CoV ne wanda ke da asalin asalin asalin cutar tare da ganowar kwayoyin halitta sama da kashi 99.98% a cikin samfuran 10 da aka tattara daga kasuwar abincin teku ta Hunan a Wuhan.
A cikin kwayoyin halitta, SARS-CoV-2 yana da kamanceceniya da SARS-CoV fiye da MES-CoV.
Ta hanyar amfani da na'urar daukar hotan lantarki, an gano kwayoyin SARS-CoV-2 a cikin ƙananan sassan epithelium na numfashi na mutum.
An gano cewa mutum ACE2 ya kasance mai karɓar mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, sunadaran S na SARS-CoV-2 suna ɗaurewa ga ACE2 na ɗan adam da ƙarancin ƙarfi fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 ya samar da ƙaramin ƙaramin furotin wanda aka ɓoye ta hanyar orf3b kuma yana iya samar da furotin wanda aka ɓoye ta hanyar orf8.
SARS-CoV-2 orf3b na iya taka rawa wajen haifar da cututtukan kwayar cuta da hana sakin IFNβ; duk da haka, orf8 ba shi da sanannen filin aiki ko tsari.
A ranar 18 ga Fabrairun 2020, Zhou da sauransu sun ba da rahoton tsarin cryo-EM na cikakken tsayin ɗan adam ACE2 a cikin ma'auni mai ma'ana 2.9 Å a cikin kayan haɗin amino acid transporter B0AT1.
Sun gano cewa an haɗa mahaɗin da ke buɗe da rufewa a matsayin dimer, kuma mahaɗin ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbaci ga ganewa da watsa CoV.
Don rage kamuwa da SARS-CoV-2, B0AT1 na iya zama maƙasudin warkewa don gwajin magunguna.
Mahimman abinci da matsakaitan abinci
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga barbashi kuma sun bazu zuwa ga mutane ta hanyar kuliyoyi da rakuma, bi da bi.
Ta hanyar kwatanta tsarin kwayoyin halitta na SARS-CoV-2 da sauran CoVs, an yi la'akari da cewa jemage ne mai ba da abinci na SARS-CoV-2 saboda sabon kwayar cutar tana da daidaito 96% tare da SARS-kamar CoVs guda biyu da aka samo daga jemage, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, har yanzu ba a san abin da matsakaiciyar mai kula da cutar ta taimaka wa kwayar cutar ta ƙetare shingen jinsin don cutar da mutane ba, kuma har yanzu ba a bayyana cikakken hanyar watsawa ba.
Ji da sauransu sun gabatar da maciji a matsayin mai ɗaukar kwayar cutar daga jemage zuwa ɗan adam wanda ke da alaƙa da sake haɗuwa da homologues a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa kashi 99% na CoVs da aka gano tsakanin long-beaked pangolins, masu shayarwa masu shayarwa-SARS-CoV-2 da pangolins, waɗanda galibi ana amfani da su a cikin maganin gargajiya na kasar Sin, sune masu yuwuwar matsakaiciyar abinci ga SARS-CoV-2 bisa ga tsarin kwayoyin halitta.
Duk da haka, bambancin 1% a cikin kwayoyin halittar biyu ya kasance babban bambanci; saboda haka har yanzu ana jiran sakamakon ƙarshe don tabbatar da tabbacin (Fig. (Fig.33)).
Har yanzu ba a san yawancin halayen ilimin halin dan Adam na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a waje da jikin mutum a cikin yanayin bushewa na tsawon awanni 48 da zafin jiki ƙasa da 20 °C da zafi 40%-50% har zuwa kwanaki 5.
Hakanan SARS-CoV-2 na iya samun halaye iri ɗaya.
An ba da rahoton cewa SARS-CoV-2 yana da ƙarancin haske a cikin UV da zafi na tsawon minti 30 a 56 °C; ether, 75% ethanol, chlorinated disinfectants, paracetic acid, chloroform, da sauran masu narkewar mai ban da chlorhexidine na iya kashe kwayar cutar yadda ya kamata.
Yawancin mutane suna da ƙarancin rigakafin SARS-CoV-2, kuma saboda haka suna cikin haɗarin kamuwa da sabon ƙwayar cuta.
A halin yanzu babu cikakken bincike game da amsar rigakafin SARS-CoV-2.
Don haka, zamu iya ganin binciken da aka yi a baya akan sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig. 4).4).
Yawancin lokaci, bayan cutar ta shiga cikin mai garken, tsarin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigaka
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan ƙonewa, balaga na ƙwayoyin dendritic, da kuma kira na nau'in I Interferons (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta phagocytosis na macrophage na ƙwayoyin cuta.
Amma furotin N na SARS-CoV na iya taimaka wa kwayar cutar ta tsira daga amsawar tsarin garkuwar jiki.
Ba da daɗewa ba, tsarin rigakafi mai dacewa ya shiga cikin yaƙi da kwayar cutar.
T lymphocytes, gami da CD4+ da CD8+ T cells suna taka muhimmiyar rawa wajen rigakafi.
Kwayoyin CD4+ T suna motsa kwayoyin B don samar da ƙwayoyin cuta na musamman, kuma CD8+ T suna kashe kwayoyin cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da proinflammatory cytokines don taimakawa kwayoyin rigakafi.
Koyaya, CoVs na iya hana aikin T-cell ta hanyar haifar da mutuwar T-cell.
Hakanan an ba da damar rigakafin jiki tare da kari kamar C3a da C5a da ƙwayoyin cuta don yaƙar kamuwa da cutar.
Misali, ƙwayoyin cuta da aka ware daga marasa lafiya masu warkewa suna hana MERS-CoV.
A gefe guda, rashin lafiyar jiki yana haifar da yawan adadin radicals kyauta wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin, kuma a cikin mafi munin yanayin, rashin aiki da yawa ko ma mutuwa.
Cutar SARS-CoV-2 wacce ke da alamun farawar cuta ta iya cutar da tsofaffi da ke da cutar da ke da cutar da kuma mata masu juna biyu.
Yana da kyau cewa mutanen da ke fuskantar yawan kwayar cutar ko kuma waɗanda ke da ƙarancin rigakafi suna iya kamuwa da cutar fiye da sauran mutane.
Bisa ga binciken da aka yi kan mutane 425 da suka kamu da cutar a Wuhan, kimanin lokacin kamuwa da cutar SARS-CoV-2 ya kai kwanaki 1-14, mafi yawan lokuta kwanaki 3-7.
Koyaya, binciken da aka yi akan mutane 1,099 ya nuna cewa lokacin incubation na cutar ya kasance kwanaki 3 a matsakaita kuma ya kasance daga kwanaki 0 zuwa 24.
A cikin bayanin da ke sama, binciken da aka yi kwanan nan ya nuna cewa tsawon lokacin haifuwa na kwayar cutar ya kasance kwanaki 4.8 (3.0-7.2) dangane da yawan mutane 8,866.
Yana da mahimmanci ga hukumomin kiwon lafiya su daidaita lokacin keɓewar da ya dace dangane da lokacin da cutar ta fi dacewa, don haka hana yaduwar kwayar cutar daga mutane masu kamuwa da cutar amma ba tare da alamomi ba.
A matsayinka na al'ada, mutanen da suka kamu da cutar ko kuma suka sadu da cutar yawanci suna buƙatar keɓewa na kwanaki 14.
Shin akwai bukatar a kara wa'adin killacewa zuwa kwanaki 24?
A mafi yawan lokuta zazzabi shine babban alamun bayyanar COVID-19 wanda ba zai iya kasancewa ba tare da alamun bayyanar ba ko kuma wasu alamun bayyanar cututtuka kamar bushewar tari, tashin zuciya, ciwon tsoka, rashin barci, ciwon kai, ciwon makogwaro, rhinuria, ciwon kirji, zazzaɓi, amai da gudawa.
Wasu marasa lafiya sun ji dyspnea (ƙuncin numfashi) da / ko hypoxemia mako guda bayan farawar cutar.
A cikin mawuyacin hali, marasa lafiya suna haɓaka cikin hanzari zuwa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Marasa lafiya da ke da alamun zazzabi da / ko rashin numfashi da zazzabi mai tsanani suna buƙatar gwajin kwayar cutar don ganewar asali, koda kuwa ba su da ƙarancin hoto na huhu.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98% na alamun cutar sun kasance zazzabi, kashi 76% na tari mai bushe, kashi 55% suna da dyspnea, kuma kashi 3% suna da zazzabi; 8% na marasa lafiya suna buƙatar taimakon iska.
An ba da rahoton irin wannan binciken a cikin binciken biyu na kwanan nan na wani nau'i na ƙwayar cuta (ƙungiya ta iyali) da kuma ƙungiya ta kamuwa da cuta daga mutum mara alamun.
A kwatankwacin haka, wani binciken ilimin lissafi a cikin 2012 ya nuna cewa yawancin masu cutar MERS-CoV suna da zazzabi (98%), tari mai bushewa (47%) da dyspnea (55%).
Koyaya, sun buƙaci tallafin iska na kashi 80%, wanda ya fi na marasa lafiyar COVID-19 yawa kuma yana da daidaito da mafi girman mutuwar MERS fiye da COVID-19.
An kuma samu gudawa (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiyar SARS, an nuna cewa zazzabi (99% -100%), tari mai bushewa (29% -75%), dyspnea (40% -42%), zawo (20-25%), da ciwon makogwaro (13) -25%) sune manyan alamun, kuma kusan 14% -20% na marasa lafiya suna buƙatar taimakon iska.
A ranar 14 ga watan Fabrairu, yawan mutuwar COVID-19 a duniya ya kai kashi 2%, yayin da adadin tabbatar da cutar ya kai 66,576.
A kwatankwacin, SARS yana da yawan mutuwar mutane har zuwa Nuwamba 2002, kashi 10 cikin dari na 8,096 da aka tabbatar.
Ga MERS, yawan mutuwar ya kasance 37% na mutane 2,494 da aka tabbatar da su a cikin binciken demographic a watan Yunin 2012.
Wani binciken da ya gabata ya ba da rahoton cewa R0 na SARS-CoV-2 tare da 95% Confidence Interval (CI) na 5.71-7.23 ya kasance kamar R0 na 6.47, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4 kawai.
Kwatanta MERS-CoV da SARA-CoV tare da SARS-CoV-2 dangane da bayyanar cututtuka, yawan mace-mace da R0 an gabatar da su a cikin Tebur 1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari kamar sauran biyun.
Saboda haka, ya fi ƙalubale a sarrafa annobar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
A cikin rukuni, cutar ta fara ne a cikin iyali ɗaya ko kuma daga rukuni ɗaya ko kuma daga jirgin ruwa.
Yawancin lokuta marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu wuraren da ke fama da cutar ko kuma sun kasance tare da masu cutar ko marasa lafiya a cikin makonni biyu da suka gabata na bayyanar cututtuka.
Amma an samu rahotanni cewa mutane na iya daukar kwayar cutar ba tare da alamomi ba sama da makonni biyu, kuma marasa lafiya da suka warke daga asibiti na iya sake daukar kwayar cutar, wanda ke aika gargadi don tsawaita lokacin killacewa.
A farkon matakin marasa lafiya suna da ƙarancin ƙwayoyin jini (musamman lymphocytes) ko ƙananan ƙwayoyin jini.
Misali, an sami cutar lymphopenia da matakan aminotransferase na aspartate da haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓ
Wasu marasa lafiya sun sami karuwar matakan hanta da jijiyoyin jiki da kuma myoglobin a cikin jini, kuma yawancin marasa lafiya sun sami karuwar C-reactive protein da red blood cells.
A cikin marasa lafiya masu fama da cutar, matakan D-dimer, wani samfurin lalacewar fibrin a cikin jini, ya karu kuma yawan ƙwayoyin lymphocytes ya ragu.
Ana samun rashin daidaito a cikin radiography na kirji a cikin yawancin marasa lafiya na COVID-19 kuma ana nuna su da inuwa mai launin ruwan kasa ko kuma tabarau mai launin ruwan kasa a cikin huhu.
Sau da yawa marasa lafiya suna da cutar nimoniya mara alamomi, mummunan rauni na huhu da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Lokacin da ARDS ta faru, kumburi mara kyau, ƙwayoyin jini da kuma ci gaba da fibrosis suna haifar da mummunar haɗari ga musayar gas.
Rashin aiki na nau'ikan-I da nau'ikan-II na ƙwayoyin cuta yana haifar da raguwar matakan surfactant da haɓaka ƙarfin farfajiya, wanda ke rage ƙarfin ƙwayar huhu da haɓaka haɗarin rauni na huhu.
Saboda haka, mafi munin nau'in binciken kirji na kirji galibi ana samun su ne a cikin mafi munin yanayin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na cututtukan COVID-19 ya nuna raguwar ƙwayar cuta, samuwar membrane na hyaline, shigarwar lymphocyte na tsakanin mutum da ƙwayoyin cuta masu ƙwayoyin cuta a cikin huhu na mutumin da ya mutu daga cutar, wanda ya dace da kamuwa da cutar ta kwayar cuta da kuma cutar ta ARDS, kuma kamar yadda yake a cikin marasa lafiya na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar juyawa-fassarar polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Koyaya, saboda yawan kuskuren kuskuren kuskuren, wanda zai iya saurin barkewar cutar, daga 13 ga Fabrairu, 2020 a China, an fara amfani da bayyanar asibiti ko bincike don ganewar asali (wanda ba ya dogara da RT-PCR kawai).
A cikin binciken da aka yi a cikin SARS, an sami irin wannan yanayin.
Don haka, haɗuwa da tarihin cutar, nuni na bincike, gwaje-gwajen dakin gwaje-gwaje da binciken radiological yana da mahimmanci kuma dole ne don tabbatar da ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da dabarun CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 na roba daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafin 10-100 na kowane microliter a kowace shigarwa) ta amfani da kayan aiki a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan haɓaka ba.
Ana fatan cewa sabon fasahar zai iya haɓaka ƙwarewa da haɓaka ƙwarewa sosai lokacin da aka gwada samfurin bincike.
Sakamakon rashin kwarewar sabon CoVs, likitoci na iya ba da kulawa ta tallafi ga marasa lafiya na COVID-19 da farko yayin da suke ƙoƙarin amfani da magungunan da aka riga aka yi amfani da su ko shawarar don magance sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table 2).2).
Magungunan sun hada da magungunan rigakafin cutar, hana kamuwa da cuta, steroids, jini na marasa lafiya, magungunan kasar Sin da kuma taimakon tunani don magance halin yanzu da kuma yiwuwar magani.
Har ma an ba da shawarar yin amfani da jini daga marasa lafiya da suka warke don magani.
Kamfanonin harhada magunguna sun shiga gasar samar da rigakafi da alluran rigakafi kan cutar.
SARS-CoV-2 ya fara kai hari ga huhu da kuma yiwuwar wasu gabobin da ke nuna ACE2 kamar su gastrointestinal system da koda.
Duk da haka, rashin aiki da nakasa na numfashi shine babban barazana da kuma babban dalilin mutuwa ga marasa lafiya.
Don haka, taimakon numfashi yana da mahimmanci don rage alamun cututtuka kuma yana ceton rayuka, kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai ƙarfi, iska mai ƙarfi wanda ba ya buƙatar yankewa da iska mai ƙarfi wanda ya dogara da tsananin cutar.
Ya kamata a tallafawa marasa lafiya da ke da mummunan cututtukan numfashi tare da Oxygenation na membrane na ECMO, ingantaccen fasahar karamin zuciya da ake amfani da ita don magance cututtukan zuciya ko na numfashi.
Hakanan yana da mahimmanci a kula da daidaiton lantarki, hanawa da kula da kamuwa da cuta ta hanyar kai tsaye da harin septic da kuma kare ayyukan gabobin da ke da mahimmanci a cikin marasa lafiya tare da SARS-CoV-2.
An gano cewa cutar ta haifar da lalacewar cytokine daga yawan amsawar rigakafi a cikin marasa lafiya na SARS da MERS.
Cytokine disruption wani nau'i ne na halayen ƙwayoyin cuta wanda ya faru ta hanyar sakin nau'ikan cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna wucewa ta hanyar kwayoyin cutar don fitar da yawancin 'yanci masu kyauta, wanda shine babban dalilin ARDS da cututtukan jiki da yawa.
Tsanantawar amsawar rigakafi yana da mahimmanci a cikin maganin cutar cytokine, musamman a cikin marasa lafiya masu tsanani.
Corticosteroids da tosalizumab, wanda shine kwayar cutar IL6 monoclonal, an yi amfani da ita don magance lalacewar cytokine.
Sauran magungunan hanawa na amsawar rigakafi don lalacewar cytokine sun haɗa da gyaran amsawar rigakafin T-cell; hana IFN-γ, IL-1, da TNF; JAK inhibition; blinatumomab; masu hana siginar cytokine 4; da masu hana HDAC.
Don rage tsananin lalacewar kumburi, an yi amfani da steroids sosai azaman masu hana rigakafi don maganin SARS.
Ko da yake, steroids a cikin manyan allurai ba su da amfani ga mummunan rauni na huhu a cikin marasa lafiya na SARS da COVID-19.
A maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman cutar osteoarthritis na avascular, wanda ke shafar yiwuwar warkewa.
Koyaya, an ba da shawarar yin amfani da gajeren hanya na ƙananan zuwa matsakaiciyar maganin corticosteroids tare da hankali ga marasa lafiya masu cutar COVID-19 masu rauni.
A lokacin rubuce-rubuce, babu wani ingantaccen maganin rigakafin cutar da aka tabbatar.
Koyaya, amfani da intravenous tare da remdesivir, analog na nucleotide ya tabbatar da inganci ga wani mai haƙuri na Amurka da ke da COVID-19.
Remdesivir wani magani ne na maganin rigakafin kwayar cuta wanda Gilead ta fara samarwa don magance cututtukan da ke haifar da cutar Ebola da Marlberg.
Daga baya, an nuna yiwuwar maganin Remdesivir don hana sauran ƙwayoyin cuta na RNA guda ɗaya, gami da MERS da SARS.
Bisa ga wannan, Gilead ta samar da fili ga China don gudanar da gwaje-gwaje guda biyu a kan mutanen da ke da cutar SARS-CoV-2, kuma sakamakon yana da matukar tsammanin.
Baricitinb, interferon-α, lopinavir / ritonavir, da ribavirin an ba da shawarar a matsayin hanyoyin magance marasa lafiya da ke da alamun cututtukan numfashi.
Bayan maganin haɗin gwiwa tare da lopinavir/ritonavir, za a iya haifar da zazzabi, tashin zuciya, tashin zuciya, lalacewar hanta da sauran halayen da ba su dace ba.
Dole ne a lura da hulɗar wannan magani tare da sauran magungunan da ake amfani da su a cikin marasa lafiya.
Samar da jini da kuma rigakafi daga marasa lafiya da suka warke.
Akwai dogon tarihi na karɓar jini daga marasa lafiya da suka warke daga cututtukan cututtuka don magance wasu marasa lafiya da ke fama da cutar guda ɗaya ko don hana lafiyayyun mutane kamuwa da cutar.
A zahiri, marasa lafiya da suka warke galibi suna da matakan ƙwayoyin cuta masu yawa a cikin jinin su dangane da cutar.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwan waje kuma suna gano kwayoyin halittar ƙwayoyin cuta kuma suna kawar da su kai tsaye.
Dangane da wannan, an tattara jini daga rukunin marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi a cikin marasa lafiya 10 masu fama da cutar.
Alamun su sun inganta cikin awanni 24, tare da rage kumburi da nauyin kwayar cuta da ingantaccen oxygenation na jini.
Koyaya, har yanzu ba a haɓaka takamaiman magunguna ba kuma ana buƙatar tabbatarwa da bayyanawa don ba da shawarar hanyoyin don amfani da yawa kafin hakan.
Bugu da ƙari, a cikin yanayin tasirin magani, wasu matsaloli da ke tattare da plasma ya kamata a yi la'akari da su a hankali.
Misali, ƙwayoyin cuta na iya haifar da halayen rigakafi da haifar da cutar ƙwayar cuta, wanda shine guba mai guba.
Yawan ƙwayoyin cuta a cikin jini yawanci ƙasa ne, kuma ana buƙatar plasma sosai don kula da marasa lafiya masu rauni.
Yana da wahala a samu saurin bunkasa da samar da kwayoyin cutar a wasu matakai don yakar cutar ta duniya.
Don haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da suka warke kuma gano lambobin kwayoyin halitta don bincika ƙwayoyin cuta masu tasiri akan sunadarai masu mahimmanci na kwayar cutar ko kuma ɓoye ƙwayoyin cuta masu tasiri.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin rigakafi.
An yi amfani da TCM don magance cututtuka daban-daban a China tsawon dubban shekaru.
Koyaya, tasirinsa ya dogara da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da yanayin cutar da aka kafa bisa ka'idar TCM.
Yawancin abubuwan da ke aiki ba a sani ba ko ba a san su ba, saboda irin waɗannan abubuwa ko haɗuwa da su suna da wuya a cire su kuma tabbatar da su.
A halin yanzu, saboda rashin ingantaccen magani da takamaiman maganin COVID-19, TCM ya zama ɗayan mahimman hanyoyin magani na zaɓi don marasa lafiya masu saurin nuna alamun cutar ko waɗanda suka dawo daga mawuyacin hali.
Misali, an gano cewa capsules na Shu Feng Jie Du da Lian Hua Qing Wen sun kasance masu tasiri wajen magance COVID-19.
A cikin jihohin China da yawa, TCM ya kasance mafi girma a cikin yawan masu cutar COVID-19 tare da yawan adadin masu lafiya 87% tare da mafi yawan adadin warkewa, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, inda TCM ya kasance a cikin kusan 30% na masu cutar COVID-19, ya kasance mafi ƙarancin adadin warkewa (13%).
Koyaya, wannan kwatancen ne mai mahimmanci saboda ya kamata a haɗa wasu abubuwan da ke tasiri kamar yawan marasa lafiya da tsananin cutar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga wani bincike da ya kwatanta WM da TCM tare da maganin magungunan Yammacin Turai (WM).
Sun ga cewa lokacin da ake buƙata don dawo da zafin jiki zuwa al'ada, bayyanar cututtuka da asibiti sun kasance ƙasa da ƙasa a cikin rukunin WM + TCM fiye da rukunin WM kawai.
Mafi ban sha'awa, yawan alamun bayyanar cututtuka (mai laushi zuwa mai tsanani) sun kasance ƙasa da ƙasa a cikin ƙungiyar WM+TCM fiye da ƙungiyar WM kawai (7.4% vs 46.2%) kuma yawan mutuwar ya kasance ƙasa da ƙungiyar WM+TCM kawai (8.8% vs 39%).
Duk da haka, inganci da amincin TCM suna jiran ƙarin gwaji a kan sikelin da kuma cibiyoyi da yawa.
Hakanan zai zama mai ban sha'awa don gano aikin aiki da kuma bayyana abubuwan da ke aiki na maganin TCM ko haɗuwa da su idan ya yiwu.
Yawancin marasa lafiya da ake zargi ko tabbatar da cutar COVID-19 suna jin tsoron kamuwa da cuta mai saurin yaduwa da ma cutar da ke sa mutum cikin hatsari, kuma mutanen da ke keɓewa suna jin kaɗaici, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia, tari da kuma mummunan tasirin magani kamar rashin bacci da corticosteroids ke haifar, na iya haifar da ƙarin damuwa da damuwa.
A farkon lokacin barkewar SARS, an ba da rahoton alamun cututtukan ƙwaƙwalwa iri-iri, gami da baƙin ciki na dogon lokaci, damuwa, harin firgici, tashin hankali na psycho motor, alamun psychotic, delirium har ma da son yin kisan kai.
A matsayin wani ɓangare na amsawar kiwon lafiyar jama'a ga ɓarkewar COVID-19, tilasta tuntuɓar tuntuɓar tuntuɓar da ke tattare da keɓewa na iya haifar da ƙarin damuwa da laifi ga mutane game da tasirin kamuwa da cuta, keɓewa da kuma ɓata sunan danginsu da abokansu.
Don haka, ya kamata a samar da kulawar kiwon lafiyar kwakwalwa ga marasa lafiya na COVID-19, mutanen da ake zargi da cutar da kuma mutanen da suka sadu da su, da kuma mutanen da ke cikin buƙata.
Taimako na ilimin halayyar dan adam ya kamata ya hada da kafa ƙungiyoyin kiwon lafiya na kwakwalwa daga fannoni daban-daban na ilimin likitanci, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma ingantaccen bayani game da barkewar SARS-CoV-2 da tsare-tsaren magani da kuma amfani da kayan aikin lantarki na ƙwararru da aikace-aikace don guje wa kusanci da juna.
Ana buƙatar alluran rigakafi masu tasiri don hana sarkar kamuwa da cuta daga dabbobi masu ruwa da mutane masu kamuwa da cuta zuwa dabbobi masu cutarwa, kuma galibi ana amfani da su don haɓaka maganin rigakafin cutar ta hanyar cutar da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don haɓaka alluran rigakafin S-protein don samar da ƙwayoyin cuta masu ƙarfi da ƙarfi da ke hana SARS-CoV da / ko samar da rigakafin kariya.
An gwada allurar rigakafin rayuwa-ta raguwa a cikin samfurin dabbobi na SARS.
Amma kafin a fara binciken asibiti, ba a tabbatar da ingancin waɗannan takarar allurar rigakafin a cikin tsofaffi da kuma a cikin ƙirar ƙalubalen rayuwa ba, da kuma kariya daga kamuwa da cutar da ke yaduwa daga dabbobi zuwa mutane.
Wannan na iya zama saboda an kawar da SARS shekaru 17 da suka gabata kuma ba a sami rahoton sabon kamuwa da cutar ba tun daga lokacin.
A akasin wannan, an ci gaba da samun karuwar cututtuka da kuma barkewar cutar MERS a Gabas ta Tsakiya, kuma ta bazu zuwa wasu yankuna saboda kasancewar tushen cutar a yankin da cutar ta addabi.
An tsara dabarun rigakafin MERS ta amfani da ƙwayoyin cuta marasa aiki, DNA plasmids, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta da ƙwayoyin furotin masu sake haɗawa, kuma an kimanta wasu a cikin samfurin dabba.
Samar da ingantaccen allurar rigakafi mai lafiya da tasiri ga mutanen da ba su da rigakafin SARS-CoV-2 yana da gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Koyaya, shawo kan wannan ƙalubalen yana da ƙalubale saboda tsayi mai tsawo (a matsakaita watanni 18) da ake buƙata don haɓaka allurar rigakafi da kuma canjin canjin CoV.
A matsayin sabon cuta, cikakken tsarin binciken COVID-19 ya fara cikawa ga dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya ba tare da yanayin cutar ba suna samun sauki a hankali.
Amma kamar SARS da MERS, COVID-19 yana da alaƙa da yawan rashin lafiya da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, yana da mahimmanci ga hukumomin kiwon lafiya su samar da samfurin hasashen cutar don ba da fifiko ga ayyukansu, musamman a yankunan da ke da iyakantaccen albarkatu.
Dangane da nazarin bincike da aka ruwaito zuwa yanzu, abubuwan da ke gaba suna iya tasiri ko haɗawa da alamun yanayin cutar a cikin marasa lafiya na COVID-19 (Table (Table 33):
Shekaru: Shekaru sune babban abin da ya haifar da cutar SARS, kamar yadda yake a COVID-19.
A cikin binciken da aka yi na mutane 8,866, da aka ambata a sama, COVID-19 ya faru ne a tsakanin masu shekaru 30-65, tare da kashi 47.7 cikin dari na marasa lafiya da suka haura shekaru 50.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi dacewa da wasu cututtuka da rikitarwa kuma sun fi tsufa fiye da sauran (matsakaicin shekaru 66 da matsakaicin shekaru 51) wanda ke nuna shekaru a matsayin mai nuna yanayin cutar don sakamakon mai haƙuri na COVID-19.
Jima'i: Masu kamuwa da cutar SARS-CoV-2 a cikin maza sun fi yawa fiye da mata (0.31/100,000 vs 0.27/100,000), kamar yadda aka bayyana a sama.
Kasancewar cututtuka da yawa da rikitarwa: Marasa lafiya da ke da COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da mummunan rauni na zuciya da arrhythmias.
Hakanan abubuwan da ke faruwa na zuciya sune babban dalilin mutuwar marasa lafiya na SARS.
An kuma ba da rahoton cewa SARS-CoV-2 na iya ɗaure kansa ga cholangiocytes masu ACE2-positive, wanda zai haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Ya kamata a tuna cewa shekaru da cututtuka masu mahimmanci suna da alaƙa da juna kuma suna iya tsoma baki.
Bayanai na musamman a cikin dakin gwaje-gwaje: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an ba da shawarar a matsayin mai nuna alamar cutarwa ga cutar, amsawar magani da kuma warkarwa ta ƙarshe.
An kuma ba da shawarar alaƙar da ke tsakanin tsananin COVID-19 da tsinkayar CRP.
Bugu da ƙari, haɓaka lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan masu tayar da hankali suna da yawa a cikin gabobin da yawa, musamman a zuciya da hanta, kuma suna fitowa a lokacin lalacewar ƙwayoyin halitta.
Saboda haka, waɗannan alamun alamun alamun cutar zuciya ko cutar hanta ne.
Babban alamun bayyanar cututtuka: Ana buƙatar yin la'akari da ci gaban lokaci na radiography na kirji da bayyanar cututtuka tare da sauran matsaloli don hango tsananin cutar COVID-19 da kuma tsinkayar sakamakon.
Amfani da steroid: Kamar yadda aka bayyana a sama, don rage tsananin lalacewar kumburi, steroids sune magungunan rigakafi da aka saba amfani dasu azaman magani na gaba don cututtukan cututtuka.
Tun da yake ana amfani da magungunan magungunan corticosteroids sosai a cikin marasa lafiya masu tsanani na SARS, yawancin waɗanda suka tsira suna fama da cutar osteoarthritis tare da nakasa mai tsawo da ƙarancin rayuwa.
Don haka, idan ya cancanta, ya kamata a yi amfani da steroids a cikin ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsin lamba: Kamar yadda aka bayyana a sama, yawancin marasa lafiya a lokacin cutar ta COVID-19 galibi suna jimre wa keɓewar lokaci da rashin tabbas mai yawa kuma suna cikin damuwa ta rashin ƙarfi yayin da suke ganin danginsu da abokan aikin su suna mutuwa.
Shawarwarin ilimin halayyar dan adam da tallafi na dogon lokaci suna da mahimmanci don taimakawa waɗannan marasa lafiya su warware damuwa da dawowa cikin rayuwar yau da kullun.
Dangane da nazarin al'umma har zuwa yanzu, yanayin cutar COVID-19 ya bambanta da na SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi a cikin ƙananan hanyoyin numfashi kuma yana haifar da mild ko babu alamun bayyanar cututtuka a farkon lokacin kamuwa da cuta, wanda yayi kama da sauran CoVs da ke da alhakin sanyi.
Don haka, marasa lafiya da ke fama da cutar a farkon lokacin cutar ko lokacin da cutar ta fi ƙarfin cutar na iya samar da ƙwayoyin cuta da yawa a cikin aikin yau da kullun, wanda ke haifar da wahalar sarrafa cutar.
Koyaya, ana ɗaukar kamuwa da SARS-CoV ne lokacin da marasa lafiya suka kamu da rashin lafiya, yayin da yawancin kamuwa da cuta ba sa faruwa a farkon matakan.
Ta haka ne, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wahalar sarrafawa.
A halin yanzu, kasar Sin tana da manyan matakai, ciki har da kulle Wuhan da biranen da ke kewaye da ita da kuma keɓe kusan dukkanin jama'a a cikin fatan dakile yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan matakan sun yi mummunan lahani ga tattalin arziki da sauran sassan kasar, amma yawan sabbin masu cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
Mafi kyawun hasashen shine cewa barkewar cutar za ta ƙare a watan Maris kuma lokacin saukar cutar zai ci gaba da watanni 3-4.
Amma wasu masana ba su da tabbaci.
Paul Hunter da sauransu sun yi hasashen cewa COVID-19, wanda ke nuna cewa yana da saurin kamuwa da cutar fiye da SARS, ba zai ƙare a 2020 ba.
Ira Longini da sauransu sun kafa wani tsari don hango sakamakon cutar, suna nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wani rukunin Kanada ya ba da rahoton cewa an gano SARS-CoV-2 a cikin marasa lafiya da suka warke da waɗanda aka sallama daga asibiti makonni 2 da suka gabata a cikin tsakiyar turbinate da kuma larura da aka ɗauka daga makogwaro, wanda ke nuna cewa sabon kwayar cutar da aka gano za ta kasance cikin yanayi mai kama da mura.
Duk da haka, akwai alamun kyakkyawan fata a China dangane da yawan sabbin cututtukan, wanda ke nuna cewa dabarun da ake da su yanzu na iya ci gaba da aiki.
An fara hasashen cewa cutar Ebola za ta haifar da kamuwa da cutar miliyan daya da mutuwar mutane miliyan daya.
Amma, ta hanyar tsauraran matakan killacewa da keɓewa, cutar ta kasance a ƙarƙashin iko.
Hakanan yana yiwuwa cewa kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni ga kamuwa da cuta kuma daga ƙarshe ya lalace ko ya zama ƙarancin kwayar cuta mai saurin kamuwa da cuta a cikin ɗan adam.
A ƙasa akwai kwatancen SARS da MERS tare da cutar COVID-19 (Figure 55).
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko hancinsa kuma mai yiwuwa ma ta hanyar hulɗa kai tsaye da kayan da cutar ta gurɓata.
An kuma gano kwayar cutar a cikin bargo wanda ya nuna sabon yiwuwar kamuwa da cutar ta hanyar bargo.
Wani binciken da aka yi kwanan nan a kan mutane 138 ya nuna cewa kashi 41 cikin dari na masu cutar sun kasance ne saboda cututtukan nasocomial (wanda aka samo asali a asibiti), wanda ya haɗa da marasa lafiya 17 da ke da wasu cututtuka da kuma masu kula da kiwon lafiya 40.
Don haka, mutane, musamman masu ba da kiwon lafiya, ma'aikatan zamantakewa, dangin su, abokan aiki, har ma da waɗanda ke kusa da marasa lafiya ko mutanen da ke da cutar, dole ne su ɗauki matakan kariya.
Ana iya amfani da sanya abin rufe fuska a matsayin matakin farko na kariya don rage haɗarin kamuwa da cuta; amfani da masks na tiyata da masks na numfashi na N95 (jerin # 1860s) suna taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Abun rufe fuska na tiyata yana hana ƙananan ɗigon ruwa daga mai yuwuwar kamuwa da cutar daga iska ko kuma ya makale a saman abu, daga inda zasu iya yaduwa ga wasu.
Koyaya, kawai N95 (jerin # 1860s) masks na iya karewa daga shan ƙananan ƙwayoyin cuta kamar 10 zuwa 80 nm ta hanyar numfashi, kawai 5% na ƙwayoyin cuta suna iya shiga gaba ɗaya; SARS-CoV-2 yayi daidai da girman SARS-CoV kuma duka suna da kusan 85 nm.
Tun da yake ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
A baya ga sanya takunkumin rufe fuska, masu kula da lafiya su sanya rigunan keɓewa masu dacewa don rage haɗuwa da cutar.
Kwayar cutar na iya yaduwa ta hanyar idanu.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2 yayin da yake sanye da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Don haka, masu ba da kiwon lafiya su ma su sa abin rufe fuska ko tabarau yayin aiki da marasa lafiya.
Ga jama'a a yankunan da ke fama da cutar ko kuma waɗanda za su iya kamuwa da ita, ana ba da shawara ga kowa da kowa ya wanke hannayensu da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda ya saba, ya yi ƙoƙarin kasancewa cikin gida don keɓe kansa, kuma ya iyakance hulɗa da mutanen da ke da cutar.
Ana ganin cewa nisan mutum na kafa uku ya dace don nisantar da mutum daga mai cutar.
Wannan matakin da aka dauka yana da tasiri wajen rage hadarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo ga ɗan adam a matsayin sabon kwayar cuta, rahoton 7 ga Janairu, 2020 ya nuna cewa China ya kamata ta yi taka tsantsan saboda irin kamancinta da SARS-CoV bisa ga zurfin ƙwaƙwalwar ajiyar barkewar cutar SARS a 2003.
Koyaya, har zuwa ranar 19 ga Janairun 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa da cewa sabon kwayar cutar ba ta da saurin yaduwa kuma tana da iyakantaccen yaduwar mutum zuwa mutum kuma babu wata matsala wajen hanawa da sarrafa cutar.
Wannan sakon ya sauƙaƙa fargabar jama'a sosai, musamman lokacin da ƙasar ke shirin bikin bazara kuma an ɓata lokaci mai mahimmanci don rage cutar zuwa ƙarami a Wuhan.
Hukumomin kula da cututtuka na kasar Sin na iya koyon darasi daga wannan mummunan yanayin kuma su sami ci gaba mai mahimmanci a nan gaba.
Misali, wadannan kungiyoyi suna bukatar (1) su kara taka tsantsan yayin yin sanarwa a bainar jama'a saboda kowane kalma da 'yan kasa za su yi la'akari da ita kuma hakan na iya canza halayensu da yanke shawara; (2) su zama masu saukin kai da kuma amsawa ga bayanan da ba a so ba daga asibitoci ba tare da jiran rahoto na hukuma daga likitoci ko jami'ai ba; (3) su zama masu sarrafawa sosai don dakile yiwuwar barkewar cutar a farkon matakin maimakon kokarin kwantar da hankalin jama'a; da kuma (4) yawan aiwatar da takamaiman ayyuka masu tasiri da nufin wayar da kan jama'a game da cutar da kuma gwadawa da inganta hanyoyin amsawar al'umma a hankali.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, cutar ta yadu a kasar Sin, kuma a lokacin da nake rubuta wannan rahoton, ta yadu zuwa wasu kasashe 50 a duniya.
Tun da cutar ta yi kama da SARS-CoV kuma alamun COVID-19 da SARS sun yi kama, barkewar COVID-19 ya haifar da jin daɗin dawowar SARS.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS waɗanda ke da mahimmanci don hana cutar da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma yawan cutar da mutuwar ta fi tsofaffi girma fiye da matasa.
Yawan mutuwar SARS ya fi na COVID-19 yawa (10.91% vs 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar cutar ba tare da alamomi ba, yayin da marasa lafiya na SARS galibi suna yin hakan yayin da suke cikin rashin lafiya mai tsanani, wanda ke sa ya zama da wahala a hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa SARS-CoV-2 ya fi sauri kuma ya fi yaduwa fiye da SARS-CoV.
A wasu lokuta, gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau ga wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke suna iya sake yin kwayar cutar.
Wadannan binciken sun kara hadarin yaduwar cutar sosai.
Ganin irin wannan saurin ci gaban da aka samu a binciken COVID-19, akwai wasu mahimman batutuwa da za a warware kamar haka:
Daga ina SARS-CoV-2 ya fito?
Kodayake an sami kamannin kwayoyin halitta 96% tsakanin SARS-CoV-2 da SARS-CoV-Justice CoV biyu, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga jemage ba.
Waɗanne dabbobi ne suka kasance a tsakanin dabbobi don watsa kwayar cutar daga asalin mai ba da abinci, kamar su jemage zuwa mutane?
Idan ba mu san amsoshin # 1 da # 2 ba, ba za mu iya rage yaduwar kamuwa da cuta ba kuma barkewar cutar na iya dawowa a kowane lokaci.
Kodayake samfurin kwayoyin halitta da kimantawa na biochemical sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin huhu kuma ta haifar da canje-canje na ilimin lissafi?
Shin kwayar cutar tana hana kwayoyin ACE2 a wasu gabobin jiki?
Idan ba tare da amsoshin wannan tambayar ba, ba za mu iya samun saurin ganewar asali da ingantacciyar magani ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ke haɓaka kwayoyin halitta yayin kamuwa da cutar ga mutane?
Shin zai zama annoba ta duniya, mutuwar kamar SARS, ko kuma sake barkewar cutar kamar mura a wani lokaci?
Wannan abu ne mai muhimmanci, amma yana bukatar lokaci don amsa wadannan tambayoyi da kuma wasu da dama.
Amma ko da menene farashin, ba mu da wani zaɓi sai dai mu dakatar da cutar da wuri-wuri kuma mu dawo da rayuwarmu ga al'ada.
Asalin dabbobi na kwayar cutar coronavirus
Juyin halitta da daidaitawa sun haifar da co-juyin halittar coronaviruses (CoVs) da masu ciyar da su, gami da ɗan adam, tsawon dubunnan shekaru.
Kafin 2003, an san cewa mutum biyu CoVs (HCoVs) suna haifar da rashin lafiya kamar sanyi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake kawo CoVs kan batun kuma ya ba mu mamaki ta hanyar nuna haɓakar cutar da ƙananan cututtuka fiye da 'yar'uwarta SARS-CoV.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin HCoV na iya taimaka mana.
Yawancin HCoVs sun samo asali ne daga barbashi inda ba su da cutarwa.
An kuma gano wasu masu karɓar baƙi na HCoVs.
Gano abubuwan gina jiki na dabbobi yana da tasiri kai tsaye kan rigakafin cututtukan ɗan adam.
Binciken musayar CoV-masu karewa tsakanin dabbobi na iya ba da mahimman bayanai game da cutar CoV a cikin mutane.
A cikin wannan bita, muna ba da taƙaitaccen bayanin ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin dabbobi da kuma kamuwa da cuta.
Mahimmanci, muna kwatanta da kuma daidaita HCoVs daban-daban daga yanayin juyin halitta na kwayar cutar da sake haɗuwa da kwayoyin halitta.
A wannan mahallin, an tattauna game da annobar cutar COVID-19 ta yanzu.
Bugu da kari, an kuma jaddada bukatar samun nasarar sauya masu ba da taimako da kuma tasirin juyin halittar kwayar cutar a kan tsananin cutar.
Kwayoyin cutar coronaviruses (CoV-cluster) suna cikin dangin coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta guda ɗaya.
"Wadannan ƙwayoyin cuta, waɗanda ke da babban ƙwayoyin cuta na RNA na 26 zuwa 32 kilobases, an sanya musu suna ""CoV"" saboda tsarin kama da kambi a ƙarƙashin microscope na lantarki".
A tsarin, CoVs suna da kwayoyin halittar da suka kasance daga ƙungiya ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan manyan bayanan karatun budewa (ORF1a da ORF1b), wanda aka canza (fassarar) zuwa pp1a da pp1ab polyproteins.
Ana sarrafa polyproteins don samar da wasu furotin 16 marasa tsari, wanda aka sanya wa suna nsp1~16.
ORFs suna wakiltar sunadarai masu mahimmanci a cikin sauran kwayoyin halitta, ciki har da keylog (S), wrapper (E), membrane (M) da nucleoprotein (N).
Wasu ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Dangane da bambancin jerin sunayen sunadarai, an rarraba CoVs zuwa ƙwayoyin cuta huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV), waɗanda yawancin HCoVs a cikin beta-CoV ƙwayoyin cuta ne kuma an raba su zuwa ƙwayoyin cuta huɗu (A, B, C, da D).
Shaidar ethnographic ta nuna cewa barbashi da beraye suna aiki a matsayin tushen kwayoyin halitta na yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune tushen tushen gamma-CoVs da delta-CoVs.
A cikin dubunnan shekaru, CoVs sun ci gaba da ƙetare shingen tsakanin jinsuna kuma sun fito a matsayin manyan cututtukan ɗan adam.
Zuwa yau, an gano mutane bakwai da ke dauke da kwayar cutar HCoV.
Daga cikin waɗannan, HCoV-229E da HCoV-NL63 sune alpha-CoV.
Sauran beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS-CoV-2).
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun bayyanar cututtuka kamar su sanyi da / ko zawo.
A gefe guda, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 da aka gano suna haifar da cututtukan ƙananan ƙananan iska a cikin marasa lafiya da yawa waɗanda ke da cututtuka masu tsanani, bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
An tattara kwayar HCoV-229E ta farko, B814 daga ɓoyayyen hanci na marasa lafiya da ke fama da sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun bayyanar cututtuka.
A zahiri, har zuwa barkewar SARS, ra'ayin da aka yarda da shi cewa kamuwa da HCoVs ba shi da lahani.
Cutar SARS ta 2003 ta kasance ɗayan bala'i mafi muni a tarihin kwanan nan, ta kamu da mutane 8,000 kuma ta haifar da mutuwar kusan 10%.
Shekaru goma bayan haka, barkewar cutar murar tsakiya ta Gabas ta Tsakiya (MERS) ta ci gaba da barkewa a yankin Larabawa kuma ta bazu cikin sauran duniya.
2019 Novel HCoV (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine wakili mai aiki a cikin cutar ta yanzu ta cutar coronavirus ta 2019 (COVID-19), wanda ya haifar da mutuwar mutane sama da 3,120 da kamuwa da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
Ana kara yin kararrawa kuma dole ne duniya ta shirya don barkewar cutar SARS-CoV-2.
Kowane ɗayan HCoVs bakwai yana da asalin dabbobi daga bargo, beraye ko dabbobin gida.
Shaidu da yawa suna tallafawa asalin juyin halitta na duk HCoVs daga jemage, inda ƙwayoyin cuta suka dace da kyau kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da manyan ƙalubalen kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin dabbobi na HCoV-cells yana ba da tsari don fahimtar dalilai na tarihin halitta, motsawa da ƙuntatawa na wucewa daga nau'in zuwa nau'in (juyawa na nau'in).
Zai iya jagorantar ko kuma gudanar da binciken asalin, matsakaici da kuma masu karɓar dabbobi na SARS-CoV-2, tare da mahimman abubuwan da ke tattare da hana ɓarkewar gaba.
A cikin wannan bita, muna ba da taƙaitaccen tarihin asalin dabbobi, yaduwar jinsuna da cututtukan HCoV.
Musamman, muna so mu kawo wannan babban batun ga kowa da kowa kuma mu tattauna cewa kwayoyin cutar iyaye na HCoV-cluster galibi suna da cutarwa a cikin asalin asalin su amma suna da cutarwa bayan sun shiga cikin sabon mai karɓar.
Mun kuma duba yanayin juyin halitta na HCoVs inda yawanci cutar ta ragu yayin da kamuwa da cuta ke ƙaruwa.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 a halin yanzu.
An san CoVs a cikin dabbobi tun daga ƙarshen 1930s.
An tattara CoVs daban-daban a cikin dabbobi daban-daban da suka kamu da cutar, gami da turkey, beraye, shanu, aladu, kuliyoyi da karnuka kafin a fara tattara B814 na HCoV-229E mai laushi daga ɓarkewar hanci na marasa lafiya da suka kamu da mura.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoV a cikin jerin lokuta (Table 1) zai zama mai fa'ida da ilimi.
An fara ware nau'in HCoV-229E na farko daga hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar na sama a cikin 1966 kuma daga baya ya dace don haɓaka cikin layin ƙwayoyin huhu na WI-38.
An lura da alamun sanyi na yau da kullun, gami da ciwon kai, hancin, rashin lafiya da ciwon makogwaro a cikin marasa lafiya da ke dauke da HCoV-229E, kuma zazzabi da tari sun bayyana a cikin kashi 10 ~ 20%.
Daga baya a cikin 1967, an tattara HCoV-OC43 daga al'adun kwayoyin halitta da kuma ci gaba da haɓaka kwayar cutar a cikin kwakwalwar berayen da ke shayar da madara.
Alamun asibiti na kamuwa da cutar HCoV-OC43 suna kama da alamun da HCoV-229E ke haifarwa, wanda ba za a iya rarrabe shi da alamun cututtukan wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duniya kuma suna kamuwa da cutar a cikin yanayin hunturu a lokacin sanyi.
Yawancin lokaci, lokacin haifuwa na waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, sannan kusan makonni 2 na rashin lafiya.
Wani binciken da aka yi a kan masu sa kai na ɗan adam ya nuna cewa mutane masu lafiya da ke fama da cutar HCoV-229E sun kamu da sanyi mai sauƙi.
An gano kamuwa da cutar ta ƙananan iska a cikin wasu marasa lafiya masu fama da cutar rigakafi.
"SARS, wanda kuma aka fi sani da ""mummunan ciwon huhu"" shine farkon cutar da aka rubuta game da cutar HCoV a tarihin ɗan adam kuma mai haifar da cutar SARS-CoV, ita ce HCoV ta uku da aka gano".
An gano farkon cutar SARS a lardin Guangdong na kasar Sin a ƙarshen 2002.
An samu rahotanni 8,096 a fadin kasashe da nahiyoyi da suka kamu da cutar SARS, inda mutum 774 suka mutu.
Baya ga masu yaduwa, an kiyasta cewa kowane shari'ar na iya haɓaka kusan kusan biyu tare da lokacin incubation na kwanaki 4 zuwa 7 da kuma bayyanar a ranar 10th na rashin lafiya tare da nuna alamun ƙarshe na nauyin kwayar cutar.
A cikin marasa lafiya da ke fama da SARS-CoV, zazzabi, rashin jin daɗi, tari, da ciwon huhu bayan sanyi sun fara bayyana a matsayin alamun jinkiri.
Lymphopenia, rashin aikin hanta da haɓaka haɓakar creatine sune alamun rashin daidaito na SARS.
Hakanan an lura da lalacewar alveolar da aka warwatse, yaduwar ƙwayoyin ƙwayoyin cuta da haɓaka macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa mai tsanani da kuma iska mai iska.
Ban da ƙananan iska, gabobin da suka haɗa da gastrointestinal tract, hanta da koda na iya kamuwa da cutar a cikin mummunan yanayi, yawanci tare da lalacewar cytokine wanda zai iya zama mai tsanani musamman a cikin marasa lafiya da ke fama da rashin lafiyar jiki.
An fara tattara kwayar cutar ne daga kwayar cutar huhu ta wani dangi wanda ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai don nazarin HCoV.
A ƙarshen 2004, an tattara HCoV-NL63 daga jariri ɗan wata 7 a Netherlands.
Da farko ya kasance sananne ne a cikin yara ƙanana, tsofaffi da marasa lafiya masu fama da cututtukan numfashi waɗanda ke da ƙarancin rigakafi.
Coriza, hawan ido, zazzabi da kuma cututtukan huhu na HCoV-NL63 sune cututtuka na yau da kullun.
Wani bincike mai zaman kansa ya bayyana tarin kwayar cutar iri ɗaya daga samfurin hanci na yaro ɗan wata 8 da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, ya yadu a duniya.
An kiyasta cewa HCoV-NL63 yana da alhakin kusan kashi 4.7% na cututtukan cututtukan numfashi na yau da kullun, tare da mafi yawan lokuta a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da cutar laryngitis mai hanawa, wanda aka fi sani da croup.
A wannan shekarar, an samo HCoV-HKU1 daga wani mutum mai shekaru 71 da ke da cutar huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga cutar nimoniya da aka samu ta hanyar cutar sankarar bargo, an kuma gano cewa HCoV-HKU1 yana da alaƙa da cutar asma mai tsanani.
HCoV-HKU1, mai kama da HCoV-NL63, HCoV-229E da HCoV-OC43, an same shi a duk duniya, wanda ke haifar da rashin lafiyar numfashi mai sauƙi.
Dukkanin waɗannan rukunin HCoVs da aka samo daga waɗannan rukunin huɗu sun dace da mutane sosai kuma galibi ba sa iya canzawa don haifar da cututtukan cututtukan cututtuka, kodayake ba a san dalilin da ya sa ba, kamar wani abu da ba a saba gani ba na HCoV-NL63, wani nau'in cutar mai cutarwa wanda aka ruwaito kwanan nan ya haifar da mummunan kamuwa da cutar ta ƙananan iska a China.
Yawancin lokaci, idan waɗannan HCoVs sun sami damar watsawa da kuma ci gaba da kasancewa a cikin mutane, to sun zama masu ƙarancin cutar ko kuma masu kamuwa da cuta.
A shekarar 2012, an fara tattara MERS-CoV daga huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da cutar nimoniya mai tsanani da rashin cin abinci a Saudi Arabia.
Kodayake yawancin magungunan da aka tabbatar a cikin dakin gwaje-gwaje sun samo asali ne daga Gabas ta Tsakiya, an ba da rahoton wasu lokuta a cikin wasu ƙasashen Turai da Tunisia tare da ɓarkewar ɓarkewar mataki na biyu a cikin wasu lokuta a cikin kusanci.
A shekarar 2015 an samu wani barkewar cutar a Koriya ta Kudu inda aka samu mutum 186 da suka kamu da cutar.
An nuna shi ta hanyar ci gaba da cutar nimoniya mai tsanani, bayyanar cututtuka na MERS suna kama da SARS.
Ban da SARS, yawancin marasa lafiya da ke fama da MERS sun sami mummunan cututtukan koda, wanda ba shi da kama da MERS a cikin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtukan ciki kamar zawo da amai.
Ya zuwa ranar 14 ga Fabrairun 2020, sama da dakunan gwaje-gwaje 2500 sun tabbatar da cewa an sami mutuwar sama da kashi 34.4%, wanda ya sanya MERS-CoV ɗaya daga cikin ƙwayoyin cuta mafi haɗari ga jikin mutum.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano rukunin marasa lafiya da cutar huhu a Wuhan, lardin Hubei na China, waɗanda ke da alaƙa da yanayin SARS-CoV-2.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar cututtukan numfashi ta kasa da SARS-CoV-2 ke haifarwa a matsayin gaggawa ta lafiyar jama'a ta duniya kuma ta sanya wa cutar suna COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, tare da mutuwar kusan kashi 3.4%.
A cikin China, yawan mutuwar Hubei ya kai kashi 4.2%, yayin da a waje ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan numfashi masu saurin mutuwa kamar SARS-CoV da MERS-CoV waɗanda aka gabatar da zazzabi, tari da rashin numfashi.
Wasu marasa lafiya kuma suna fama da zazzabi.
Ciwon huhu yana daya daga cikin alamun cututtuka kuma yana iya saurin ci gaba zuwa ciwon bugun jini.
Kodayake 82% na jerin kwayoyin halittar nucleotide suna da kamanceceniya da SARS-CoV da SARS-CoV-2 saboda homology, suna clustering a cikin rassan rassan bishiyoyi.
A bayyane yake SARS-CoV-2 ba shi da cutarwa amma yana da saurin yaduwa fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton wasu marasa alamun kamuwa da cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar ta a duniya.
Kwatanta da kuma kwatanta SARS-CoV-2 da sauran HCoVs shida ya nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin haifuwa na kwayar cuta da lokacin cutar HCoV suna kama da juna.
A wannan yanayin, SARS-CoV-2 yana bin al'adun wasu HCoVs guda shida.
Na biyu, tsananin alamun COVID-19 ya kasance tsakanin SARS-CoV da HCoVs huɗu da ke yaduwa a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye waɗanda galibi ana gani yayin kamuwa da HCoVs da aka samu a cikin al'umma tare da bayyanar da ba ta da kyau, mai sauƙi ko ma ba ta da alamomi.
A gefe guda, ƙananan ƙananan magungunan COVID-19 suna nuna alamun kamuwa da SARS-CoV, kodayake adadin ya ɗan ragu.
Na uku, tarin kamuwa da cutar SARS-CoV-2 yana nuna alamun halaye masu ban sha'awa ga duka HCoVs da SARS-CoV.
A gefe guda, kamuwa da SARS-CoV-2 ya fi na HCoVs da aka mallaka.
A gefe guda, har yanzu ba a tabbatar da ko cutar SARS-CoV-2 ta ragu ba kamar yadda ta faru da SARS-CoV da MERS-CoV bayan wucewa tsakanin mutane.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin stool.
Nazarin nan gaba ya rage don bayyana ko kamuwa da cutar SARS-CoV-2 ta hanyar bargo yana taka muhimmiyar rawa a wasu yanayi, kamar SARS-CoV.
Yana da matukar sha'awa musamman don ganin ko SARS-CoV-2 yana nuna yanayin yanayi kamar yadda yake tare da HCoVs da aka samo daga al'umma.
Duk da haka, halaye na SARS-CoV-2, gami da saurin yaduwarsa, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin HCoVs da ke haifar da alamun bayyanar cututtuka sun dace da mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya zama zuriyar tsohuwar cutar HCoV.
An kashe HCoVs da ke haifar da mummunan cuta a cikin mutane da kuma mutanen da suka ci gaba da cutar HCoV mai tsanani.
Don wannan ya faru, HCoVs dole ne su samar da kwafi a cikin mutane don su iya tara juyin halittar da ke yaƙi da abubuwan ƙuntatawar mai ɗaukar hoto.
A wannan ma'anar, tsawon lokacin da barkewar SARS-CoV-2 ta kasance kuma yawancin mutane da ke kamuwa da ita, mafi kusantar zai iya daidaitawa da mutane gaba ɗaya.
Idan ya daidaita da kyau, zai yi wuya a dakatar da yaduwar cutar a jikin mutum ta hanyar keɓewa ko wasu matakan kula da kamuwa da cuta.
Shekaru da yawa, nau'ikan CoVs guda huɗu da aka samo suna yaduwa cikin jama'ar mutane, suna haifar da kamuwa da cutar sanyi-kwashi a cikin marasa lafiya masu ƙarancin rigakafi.
Waɗannan ƙwayoyin cuta ba sa buƙatar tushen dabba.
Akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su daidaita da kyau ga mutane ba kuma ba za su iya ci gaba da yaduwa ga mutane ba.
Suna buƙatar ci gaba da yaduwa a cikin tushen su na jujuyyar, kuma suna neman damar yaduwa ga maƙasudin ɗan adam mai yiwuwa ta hanyar ɗaya ko fiye da matsakaici da kuma haɓaka mai shayarwa.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV / MERS-CoV da HCoVs huɗu da aka samu a cikin al'umma.
Aƙalla har yanzu, yana da saurin yaduwa kamar HCoVs da aka samu a cikin al'umma.
Koyaya, ya fi cutarwa fiye da HCoVs da aka samo daga cikin al'umma kuma ba shi da cutarwa kamar SARS-CoV ko MERS-CoV.
Dole ne a ga ko ya dace da mutane sosai kuma ya ci gaba da yaduwa tsakanin mutane ba tare da tushen ko mai ciyar da dabbobi ba.
Kafin tattauna asalin dabbobi na HCoVs, zai amfane mu mu tattauna ma'anar da halaye na masu kula da juyin halitta, na halitta, tushe, tsaka-tsaki da kuma haɓaka HCoVs.
Wani dabba yana aiki a matsayin mai kula da juyin halitta na HCoV idan yana da iyayen da ke da alaƙa ta hanyar raba babban homology a matakin jerin nucleotide.
Kwayar cutar ta asali yawanci tana dacewa da jikin wannan mai ɗaukar hoto kuma ba ta da cutarwa.
Hakanan, mai ba da tushen yana ba da HCoVs a kai a kai kuma na dogon lokaci.
A cikin duka biyun, masu ɗaukar hoto suna kamuwa da cutar ta halitta kuma suna ɗaukar hoto na HCoV ko kuma kwayar cutar iyayenta.
A akasin wannan, idan HCoV ya sake haɗuwa da mai ɗaukar hoto na tsakiya kafin haɗuwa da ɗan adam ko kuma a kusa da shi, ba zai dace da sabon mai ɗaukar hoto ba kuma sau da yawa yana haifar da cuta.
Wannan matsakaiciyar mai ɗaukar hoto na iya zama tushen dabbobi don kamuwa da cutar ɗan adam kuma yana iya zama mai haɓaka mai ɗaukar hoto don sauya kwayar cutar ta ɗan lokaci sannan ya faɗaɗa girman kamuwa da cutar ɗan adam ta hanyar kamuwa da cutar cikin jikin ɗan adam.
Idan HCoV ba zai iya ci gaba da yaduwa tsakanin masu ba da mafita ba, za a iya dakatar da yaduwar.
A akasin wannan, HCoVs na iya daidaitawa da matsakaiciyar mai kula da su kuma fara ɓarkewar lokaci mai tsawo.
A wannan yanayin, matsakaiciyar abinci mai gina jiki ta zama abinci mai gina jiki na asali.
Bayanan cututtukan cututtukan cututtuka sun nuna cewa tarihin haɗuwa da dabbobi masu farauta tare da SARS ya nuna alamun cutar.
Binciken da aka yi na gaba ya nuna cewa akwai karin barkewar cutar anti-SARS-CoV IgG a cikin masu cinikin dabbobi fiye da sauran jama'a.
An fara gano wani kare raccoon a kasuwannin dabbobi masu rai da kuma masu kiwo don ɗaukar kwayar cutar SARS-CoV wanda yayi kama da SARS-CoV.
Wannan ya kasance yana da goyan baya ta hanyar bayanan da aka samu cewa babu wani sabon labarin SARS da aka sani bayan an kashe dukkan kwari a kasuwanni.
Koyaya, an ba da rahoton cewa masks na dabino na dabino daga daji ko gonaki ba tare da haɗuwa da kasuwar dabbobi masu rai ba sun kasance masu ƙarancin SARS CoV, wanda ke nuna cewa masks na dabino na dabino za su yi aiki ne kawai a matsayin matsakaiciyar mai haɓaka mai karewa amma ba a matsayin tushen SARS-CoV ba.
Abin lura, tunda kashi 80% na nau'ikan dabbobi a kasuwar Guangzhou suna da ƙwayoyin anti-SARS-CoV, ba za a iya kawar da yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa da yawa na iya zama matsakaiciyar mai haɓaka abinci mai gina jiki don SARS-CoV ba.
Duk waɗannan ana ɗaukar su a matsayin masu cutar SARS-CoV.
Binciken da aka yi na SARS-CoV a cikin dabbobi na dabbobi ya nuna wani CoV mai alaƙa da bat, wanda aka sanya wa SARS-Related Rhinocerosus Bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin bat ɗin dabbobin da ke China. Binciken da aka yi ya nuna wani CoV mai alaƙa da bat, wanda aka sanya wa SARS-Related Rhinoceros Bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin bat ɗin dabbobin da ke China.
Waɗannan jemage sun kasance masu inganci ga ƙwayoyin cuta masu adawa da SARS-CoV da kuma jerin kwayoyin halittar SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na bat suna da kashi 88-92% na jerin nucleotide tare da SARS-CoV.
Wadannan binciken sun samar da sabon ra'ayi cewa jemage suna ba da mafaka ga cututtukan ɗan adam masu tasowa.
An gano wasu SARS-like CoVs (SL-CoVs) daga jemage, amma babu wanda aka tattara a matsayin kwayar cuta mai rai sai dai WIV1 da aka sanya.
An san cewa enzyme mai canzawa na Angiotensin na mutum 2 (ACE2) mai karɓar SARS-CoV-2.
WIV1 da aka samo daga samfurin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Abin sha'awa, ƙwayar cutar SARS da ke warkewa ta iya hana WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar magabatan da suka fi kusa da SARS-CoV a cikin jemage, suna raba kashi 95% na jerin nucleotide homology.
Kodayake akwai babban matakin kamannin kwayoyin cutar tsakanin waɗannan ƙwayoyin cuta guda biyu, ana tsammanin cewa WIV1 SARS-CoV ba kwayar cutar mahaifa ba ce kuma baƙar fata ba sune tushen tushen SARS-CoV ba.
Binciken phylogenetic ya sanya MERS-CoV a cikin rukuni ɗaya kamar Batman CoV-HKU4 da Batman CoV-HKU5.
Kwayar cutar CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
Tsarin RNA polymerase na RNA-da ke da alaƙa da RNA MERS-CoV yana da alaƙa da filato da ƙwayoyin cuta na bat beta-CoVs da aka gano daga Turai da Afirka.
Ya zuwa yanzu, ba a sami MERS-CoV mai rai a cikin jemage na daji ba.
MERS-CoV da danginsa na kusa CoV-HKU25 suna da kashi 87% na jerin kwayoyin nucleotide.
Don haka, bazawa ba za su iya zama tushen tushen MERS-CoV ba.
A gefe guda, binciken Gabas ta Tsakiya ya nuna cewa raƙuma masu ƙwanƙwasawa suna da ƙwayar cuta ga ƙwayoyin cuta na MERS-CoV, kamar yadda raƙuma na Gabas ta Tsakiya suka kasance a ƙasashen Afirka da yawa.
An tattara MERS-CoV mai kama da kwayar cutar da aka samu a cikin mutane daga hancin hanci na raƙumi mai ƙwanƙwasa, wanda ya nuna cewa raƙumi yana aiki a matsayin ainihin tushen tushen MERS-CoV.
Hakanan yana da mahimmanci cewa an lura da cewa raƙuma da aka kamu da su ta hanyar gwaji ta MERS-CoV suna da alamun cutar (shedding na kwayar cutar) duk da cewa yawanci suna da alamun bayyanar cutar.
Abin lura, raƙuma da suka kamu da cutar ba wai kawai suna yada kwayar cutar ta hanyar numfashi ba, har ma ta hanyar hanyar anal-oral, wanda kuma shine babban hanyar yaduwar kwayar cutar daga bargo.
Koyaya, tambayoyi har yanzu suna nan saboda yawancin mutanen da aka tabbatar da cutar MERS ba su da tarihin haɗuwa da rakuma kafin bayyanar cututtuka, mai yiwuwa ta hanyar kamuwa da cutar mutum zuwa mutum ko hanyar kamuwa da cuta da ke tattare da nau'in da ba a sani ba wanda ke ba da MERS-CoV.
Bat CoV RaTG13 da aka tattara daga rhinolephus affinis bat yana da daidaito 96.2% tare da nucleotide homology na SARS-CoV-2.
Kamar yadda yake tare da SARS-CoV da MERS-CoV, bambancin jerin abubuwa tsakanin SARS-CoV-2 da RaTG13 suna da yawa don ƙayyade alaƙar iyaye.
Wannan yana nufin cewa har sai an gano CoVs na bat a nan gaba, bazawa ba zasu iya zama masu ɗaukar SARS-CoV-2 kai tsaye ba.
Wataƙila, dabbobin da ke cikin SARS-CoV-2 ya kamata su kasance cikin dabbobin daji da aka sayar da su a kasuwar siyar da abincin teku ta Huanan, wanda yawancin shari'o'in COVID-19 na farko suka danganta da su, wanda ke nuna yiwuwar cutar ta dabba-zuwa-mutum.
Yawancin binciken da aka yi kwanan nan dangane da jerin jerin kwayoyin halitta sun nuna cewa rukuni na ƙananan dabbobi masu shayarwa masu haɗari da aka sani da Banyan Banyan (Manis javannica) na iya ɗaukar magungunan beta-CoVs na SARS-CoV-2.
85-92% na jerin nucleotide na wannan sabon kwayar cutar ta Bonroi CoV sun kasance kwafin SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 daidai da kusan 90% daidaito a matakin jerin nucleotide.
Sun haɗa cikin rukuni biyu na ƙwayoyin cuta kamar SARS-CoV-2 a cikin itacen asalin, ɗayan ɗayan yana da alamun amino acid 97.4% tare da SARS-CoV-2 wanda ke da alaƙa da haɗin haɗin mai karɓar mai karɓa (RBD).
Akasin haka, RBDs na SARS-CoV-2 da RaTG13 sun fi rarrabewa, kodayake jerin homology suna da babban digiri na yaduwar kwayoyin halitta.
Wani binciken da aka yi a baya kan marasa lafiya na Bonrui ya kuma ba da rahoton gano jerin abubuwan da ke tattare da kwayar cutar daga samfurori na huhu, wanda ya nuna cewa yana da alaƙa da SARS-CoV-2.
A cikin wannan binciken, an ɗauki hanyoyi daban-daban na taro da kuma gabatarwar hannu don ƙirƙirar jerin kwayoyin halittar ɗan adam tare da kusan kashi 86.3% na cikakken kwayar cutar.
Ba za mu iya watsi da yiwuwar cewa pangolin yana ɗaya daga cikin abincin dabbobi masu tsaka-tsakin SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin SARS-CoV-2 kai tsaye ta hanyar bambancin tsari tsakanin SARS-CoV-2 da SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Bugu da ƙari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi ƙasa da na SARS-CoV-2 da kuma rukunin beta-CoVs na SARS-CoV-2 da ke da alaƙa da Bonroy.
Har yanzu ba a kafa hanyar juyin halitta na SARS-CoV-2 a cikin barbashi, pangolins da sauran dabbobi masu shayarwa ba.
Kodayake an gano yawancin jerin homologues tsakanin SARS-CoV-2 da RBDs na Bonrui, SARS-CoV-2-da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da yawancin jerin abubuwan da ke tattare da kwayoyin halitta.
Yana da matukar damuwa cewa cutar ta Bonroi ta samo asali ne daga juyin halitta na asali tsakanin SARS-CoV-2 da kuma SARS-CoV-2 da ke da alaƙa da RBD.
Wani shawarwari na gaba shine don sake haɗuwa tsakanin beta-CoV da RaTG13, wanda ke da alaƙa da SARS-CoV-2 a cikin nau'in dabba na uku.
A matsayin mai motsa juyin halitta, sake haɗuwa tsakanin beta-CoVs ya zama gama gari.
Har yanzu ba a san ainihin asalin SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E sun samo asali ne daga CoVs na bat, kodayake an sami ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An ba da rahoton cewa wani CoV na bat, wanda ake kira ARCoV.2 (Appalachian Ridge CoV), wanda aka gano a cikin jemage na Arewacin Amurka tare da HCoV-NL63, ya nuna alaƙa ta kusa.
A gefe guda, HCoV-229E ya kasance yana da alaƙa da wata ƙwayar cuta ta CoV mai suna Hipposideros / Ganacoma / 19/2008, kodayake an yi zargin cewa camelliids ma suna da alaƙa da ita.
Don tsabta, asalin dabbobi na HCoVs da aka sani an taƙaita ilimin yanzu a cikin Figure 1 da Table 2.
Nazarin jinsi ya ba da hujja game da abubuwan da suka faru na watsawar CoV a cikin tarihin CoVs.
A cikin shekarun 1890, an sami annobar cutar numfashi lokacin da HCoV-OC43 ya ƙetare jinsuna kuma ya kamu da mutane daga dabbobi.
Tarihin HCoV-229E na kamuwa da cututtuka tsakanin jinsuna ba shi da tabbas.
An gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikin su akwai Alpaca-alpha CoV.
Akwai shaidu da yawa da ke tallafawa yaduwar kwayar cutar daga jemage zuwa jikin mutum.
Na farko, rabuwa na iya kasancewa daga haɗuwa da mutane a cikin yanayin muhalli amma ba alpacas ba.
Maimakon haka, mutane suna da kusanci da Alpacas.
Na biyu, HCoV-229E-related bat alpha-CoV-groups sun bambanta kuma ba su da cutarwa a cikin bat, yayin da alpaca alpha-CoV ke haifar da barkewar cututtukan numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a sami Alpha CoV na alpaca a cikin namun daji ba.
Don haka, ba za a iya kawar da yiwuwar cewa alpacas sun sami alpha-CoV mai alaƙa da HCoV-229E daga mutane ba.
A zahiri, jemage sune tushen kai tsaye na ƙwayoyin cuta na mutum, gami da cutar ta kwalara, cutar Ebola, Nipah virus da kuma cutar Hendra.
Don haka ba abin mamaki bane cewa jemage na iya watsa HCoV-229E kai tsaye ga mutane.
A gefe guda, rukunin alpha-CoVs na malam buɗe ido suna aiki a matsayin ƙwayoyin halittar HCoV-229E, yayin da alpacas da raƙuma masu ƙwanƙwasa ɗaya na iya zama matsakaitan masu ɗaukar hoto waɗanda ke watsa kwayar cutar ga mutane, kamar yadda yake a cikin MERS-CoV.
MERS-CoV yana aiki a matsayin babban misali na yaduwar kamuwa da cuta tsakanin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Asalin asalin MERS-CoV daga barbashi an san shi a farkon ganowa kuma an tabbatar da shi ta hanyar binciken da aka yi.
A bayyane yake cewa jemage yana ba da tushen tushen kwayar cutar don musayar kwayoyin halittar jini da musayar kwayar cutar tsakanin jinsuna.
Tsawon rai, cikakken mulkin mallaka, hulɗar zamantakewar jama'a da ƙarfin tashi suna ba da yanayi mai kyau don zama 'mai yaduwar cutar' ta kwari.
A gefe guda, MERS-CoV ya haɗu da raƙumi mai ƙwanƙwasa shekaru da yawa da suka gabata.
Ya dace da waɗannan raƙuman da suka canza daga matsakaiciyar matsakaiciya zuwa mai ɗorewa da tushen asali.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙimar ƙwayoyin cuta a cikin waɗannan dabbobin.
Yaduwar cutar ta hanyar mutane ba zato ba tsammani ne kuma mutane sun kasance masu kare MERS-CoV saboda ba za a iya jurewa ba.
Sabanin yadda raƙuma ke da tasiri a cikin MERS-CoV, idan pangolins suna da tasiri a cikin SARS-CoV-2, to ya bambanta.
Musamman, pangolin beta-CoVs suna da cutarwa sosai a cikin pangolins.
Suna iya zama sabon mafaka ga beta-CoVs masu alaƙa da SARS-CoV-2, kamar yadda yake a cikin SARS-CoV.
Za a iya haɗa ko ƙyale yiwuwar SARS-CoV-2 na watsawa daga dabbobi zuwa mutane daga cikin jinsuna a cikin binciken nan gaba.
Da farko, jemage na iya zama tushen tushen kwayar cutar SARS-CoV-2, mai kama da SARS-CoV-2.
Mutane na iya raba wurin zama tare da barayen ta hanyar yanka ko hakar ma'adinai.
Na biyu, bishiyoyin daji na iya zama ɗaya daga cikin masu ba da tallafi na matsakaici inda aka sake gabatar da kwayar cutar SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman dabbobi.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa, gami da dabbobin gida, ba su da kariya daga SARS-CoV-2.
An tabbatar da binciken dabbobi da na daji don ƙwayoyin cuta.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ke da alaƙa da duka bat da pangolin.
Har yanzu ana ci gaba da binciken asalin SARS-CoV-2 a cikin dabbobi.
Baya ga nau'ikan masu kare dabbobi, manyan abubuwa uku na ɓangaren kwayar cutar suna da mahimmanci don taimakawa CoVs su ƙetare shingen ƙetare.
Na farko, suna da yawan canji a cikin kwayar RNA.
"Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ana iya ɗaukar ƙididdigar juyin halittar CoV-cluster a matsayin ""matsakaici"" zuwa ""mafi girma"" dangane da yanayin daidaitawar CoV na sabon mai shayarwa, kuma matsakaicin canjin canji zai zama ~10-4 sauyawa a kowace shekara".
CoVs suna da ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta, wanda kawar da su ke haifar da ƙarancin canji da rauni ko ma rashin iya rayuwa.
Abin sha'awa, an san cewa kwayar cutar ta CoV tana samar da kwafin kwayar halitta ta hanyar hana wannan kwayar halitta ta kwayar halitta ta kwayar halitta ta kwayar halitta ta RNA.
Remdesivir shine ɗayan ingantattun abubuwan anti-SARS-CoV-2 da aka gwada a cikin gwajin gwaji.
Duk da haka, yawan canjin CoVs ya ninka na magungunan da suke dauke da su sau miliyan.
Bugu da ƙari, yawan canjin yana da yawa lokacin da CoVs ba su dace da mai ba da abinci ba.
Idan aka kwatanta da SARS-CoVs tare da yawan canjin yanayi, SARS-CoV-2 yana da ƙananan canjin yanayi, wanda ke nuna cewa yana da sauƙin daidaitawa ga mutane.
Wataƙila, ya riga ya daidaita da wani mai ba da mafaka kusa da ɗan adam.
Hakanan ya shafi SARS-CoV-2 da MERS-CoV, wanda ya dace da raƙumi mai ƙwanƙwasa.
A ka'ida, rashin yiwuwar SARS-CoV-2 ya lalata alluran rigakafi da maganin rigakafi da sauri ba shi da wata ma'ana.
Na biyu, babban RNA na CoV yana amfani da ƙarin sassauci a cikin juyin halitta don juyin halitta da sake haɗawa, wanda ke haɓaka yiwuwar juyin halitta tare da haɗuwa, wanda ke ba da damar fitowar CoVs lokacin da yanayi ya zama mai dacewa.
Ana tallafawa ta hanyar buɗewa da aka buɗe da kuma aikin furotin da ke da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin
"Na uku, CoVs suna canza samfuran yayin yin kwafin RNA a bazuwar kuma galibi ta hanyar tsari na musamman na ""kwafin-zaɓi""".
Sau da yawa sauyawa na iri yakan faru yayin kwafin CoV RNA a cikin mai ba da gudummawar wanda ke aiki azaman tukunyar haɗuwa.
RNAs masu tsayi da yawa da kuma ƙwayoyin cuta na iya haɗuwa don samar da sababbin CoVs.
An sami shaidar phylogenetic na sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43 da kuma cikin CoV-groups na dabbobi kamar su bat SL-CoV da batCoV-HKU9.
Hadin gwiwar kwayar cutar da ke haifar da kamuwa da cuta
Baya ga abubuwa uku na kwayar cutar da aka bayyana a sama, musayar kwayar cutar tare da mai karɓar baƙi wani babban mahimmin abu ne wanda ke tasiri ga kamuwa da cuta tsakanin jinsuna.
A halin yanzu, ana ɗaukar sake dawo da SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna shaidar zabin tabbatacce yayin kamuwa da cuta tsakanin jinsuna.
Dangane da nazarin kwatancen tsakanin tarin SARS-CoV na mutum da na ƙwari, ana tsammanin SARS-CoV na iya daidaitawa cikin sauri tare da maye gurbin RBD na furotin S a tsakanin masu ɗaukar hoto daban-daban.
Yawancin lokaci, RBD yana hulɗa da mai karɓar ƙwayoyin cuta a cikin furotin S na CoV kuma ana zaɓar shi ta hanyar amsawar ƙwayoyin cuta.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 a cikin S1 yanki wanda ke ɗaure ACE2 na ɗan adam da kuma masu karɓar sa don shigar da kwayar cutar.
RBD na SARS-CoV yana iya gane masu karɓar ACE2 a cikin dabbobi daban-daban, gami da barbashi, civets, beraye da karnuka masu raccoon, wanda zai iya haifar da yaduwar kwayar cutar tsakanin jinsuna.
A zahiri, ragowar amino acid guda 6 ne kawai aka gano sun bambanta da na ƙwayoyin cuta na glandular a cikin ɗan adam da RBD, kuma 4 daga cikinsu suna cikin tsarin ɗaure-mai ɗaure don hulɗa tare da mai karɓar ACE2.
CIVAT SARS-CoV RBD yana da K479N da S487T maye gurbi, wanda zai iya haɓaka ƙimar musayar furotin na spike tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomin, maye gurbin waɗannan amino acid biyu na iya zama mai mahimmanci ga haɓakar kwayar cutar a cikin mutane.
Yana da mahimmanci cewa masu karɓar ƙwayoyin cuta na SARS-CoV da SARS-CoV-2 suna kama da juna.
Bambanci 30% tsakanin S1 na SARS-CoV-2 da S1 na SARS-CoV yana nuna cewa yanayin S na ɗan adam yana iya canzawa tare da ACE2.
A zahiri, binciken cryo-EM ya nuna cewa haɗin haɗin kai tsakanin ACE2 na ɗan adam da furotin SARS-CoV S ya ninka wanda ake da shi sau 10 zuwa 20.
Yana da mahimmanci a tantance ko ana buƙatar wani mai karɓar baƙi don kamuwa da SARS-CoV-2.
Abin damuwa, HCoV-NL63 kuma yana ɗaure da ACE2 amma tare da wani ɓangare na S.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama sanadin nasarar daidaita waɗannan CoVs a cikin mutane bayan kamuwa da cutar daga cikin dabbobi zuwa cikin jinsuna.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon kamuwa da kwayar cutar HCoV-cluster yana kuma ƙarƙashin abubuwan dogaro da iyakancewa ga sauran masu ba da gudummawa.
Rarraba waɗannan furotin masu karɓar baƙi tsakanin mutane da kuma asalin asalin HCoV-communities kamar su bat, raƙumi mai ƙwanƙwasawa, da beraye na iya hana kamuwa da cututtukan ƙwayoyin cuta.
HCoVs dole ne su mallaki abubuwan dogaro da mai ba da kariya kuma su lalata abubuwan da ke iyakance mai ba da kariya don samun nasarar yaduwar jinsuna.
A wannan yanayin, har yanzu ba a gano da kuma bayyana abubuwan da ke ƙayyade kwayoyin halitta a cikin wannan muhimmin yanki na musayar ƙwayoyin cuta ba.
Yin amfani da fasahar zamani ta CRISPR don nuna rashin daidaituwa da ƙuntatawa na SARS-CoV-2 zai iya zama mai amfani.
Tashin sabon HCoV: Komawa inda aka fara
Bambancin CoVs na bat yana ba da dama mai yawa don fitowar sabon HCoVs.
A wannan ma'anar, ƙwayoyin CoV na Batman suna aiki azaman ƙwayoyin halittar HCoV.
Bugu da ƙari, saurin maye gurbi da sake haɗuwa da kwayoyin halitta suna motsa juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, sabon kwayar halitta yana da ikon canzawa da yawa game da abubuwan da aka samu ko ɓacewar kwayoyin cutar.
Daga cikin furotin masu alaƙa da SARS-CoV, an yi la'akari da ORF8 yana da mahimmanci don dacewa da mutane saboda ƙwayoyin cuta na SARS-CoV sun kasance tarin amma an gano su don ɓoye furotin ORF8 masu bambanci.
An gano wata alama ta kawar da 29-nucleotide na SARS-CoV-Cluster a cikin cututtukan da aka tattara a farkon cutar ta ɗan adam.
Wannan kawarwa ya raba ORF8 zuwa ORF8a da ORF8b kuma yana nuna cewa yana da wata hanyar daidaitawa wanda ke motsawa don canzawa.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa tare da rukunin alpha- da gamma-CoVs, inda aka gano ƙananan ƙananan yankuna a cikin RNA-dogara RNA polymerase.
An kuma gano wuraren sake dawowa a cikin nsp9, mafi yawa a cikin nsp10 da nsp14.
Hakazalika, an nuna cewa cutar MERS-CoV ta wuce ta hanyar sake haɗuwa tsakanin kabilu daban-daban, wanda ya faru a cikin rakumi mai ƙwanƙwasa a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan sake haɗuwa a cikin sauran HCoVs, inda HCoVs ke sake haɗuwa da CoVs na wasu dabbobi a cikin ƙwayoyin halittar da ba su da tsari.
Ya kamata kuma a yi gargadin cewa zabin wucin gadi na iya taimakawa ga sauye-sauye na bazuwar a cikin kwayar halittar kwayar cutar, mai yiwuwa sakamakon sakin ƙwayoyin cuta daga matsin lamba na zabin kamar tsarin garkuwar jiki.
Misali na waɗannan tasirin shine asarar cikakken tsawon ORF4 a cikin samfurin HCoV-229E wanda ya haifar da cirewar di-nucleotide.
Kodayake ana iya ganin ORF4 mai rai a cikin ƙwayoyin cuta na bat da rakumi da ke da alaƙa da HCoV-229E, alpaca alpha-CoV ya nuna cewa an sanya shi a cikin nucleotide guda, sakamakon sakamakon tsarin.
A ƙarshe amma ba mafi mahimmanci ba, juyin halitta na sabon HCoVs yana motsawa ta hanyar zaɓin zaɓin da ke cikin asalin su.
Lokacin da CoV ya kamu da bat, ba su da alamun cutar ko kuma kawai an gano alamun cutar mai sauƙi, wanda ke nuna daidaituwa tsakanin CoV-groups da bat.
An gano cewa jemage suna da kyau a cikin asali da kuma ilimin lissafi ga CoVs.
Misali, kurakurai a cikin kunnawar amsawar janyewar kumburi a cikin jemage suna rage cututtukan da CoV ke haifar da su.
Bugu da ƙari, ƙananan ƙwayoyin halitta na halitta na halitta a cikin kullun sun kasance masu aiki saboda ƙananan ƙaddamar da ƙwayar halitta mai ƙwayar halitta mai ƙwayar halitta NKG2/CD94 da kuma babban ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Bugu da ƙari, ƙwayoyin oxygen masu karɓa (ROS) masu yawa da ke haifar da ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Hakanan za'a iya haɓaka ƙarin cututtukan CoV ta hanyar sake haɗuwa wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawar mai ɗaukar hoto.
Don haka, yiwuwar fitowar sabbin HCoVs uku a cikin shekaru ashirin da suka gabata ba daidaituwa bane.
CoVs ba su da cutar ko haifar da alamun cutar a cikin masu kula da su kamar su barbashi da raƙuma.
Suna girma sosai ba tare da ƙarfin juriya na mai ba da kariya ba.
Wannan shine sirrin dalilin da yasa masu dauke da cutar ba sa nuna alamun cutar da abin da ke haifar da mummunan kamuwa da cutar ga mutane.
Babban alamun bayyanar cututtuka galibi saboda yawan aiki da halayen rigakafi ne da kuma hadarin cytokine inda ƙarfin halayen rigakafi, lalacewar huhu ya fi tsanani.
A akasin wannan, a cikin masu ɗaukar marasa alamun, an bambanta amsar rigakafi daga kwayar CoV.
Irin wannan dabarar ta katse martani na rigakafi na iya samun sakamako mai amfani a cikin maganin anti-SARS-CoV-2.
Interferon yana da ƙarfi sosai a cikin bat.
Don haka, amfani da nau'in I interferon ya kamata ya kasance da fa'ida aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin mutane.
Bugu da ƙari, NLRP3 yana da mummunan aiki a cikin bat.
Ta wannan hujja, masu hana NLRP3 inflammasomes, gami da MCC950, na iya zama masu tasiri wajen magance COVID-19.
Tashin SARS-CoV-2 ya biyo bayan abubuwan da suka faru na yau da kullun wanda ya haifar da SARS-CoV da MERS-CoV.
An gano cewa wani beta-CoV na bat yana musayar kashi 95% na nucleotide homology tare da SARS-CoV, yayin da akwai wani CoV na bat wanda ke musayar kashi 96% na nucleotide homology tare da SARS-CoV-2.
Kodayake an ba da rahoton cewa wasu ƙwayoyin cuta da sauran dabbobi da aka samo a kasuwa suna ba da mafaka ga ƙwayoyin cuta masu kama da SARS-CoV, ba a gano masu ba da mafaka na kai tsaye ga SARS-CoV-2 ba.
An gano rukunin beta-CoVs na Boneyroyi waɗanda ke da alaƙa da SARS-CoV-2, wanda ke nuna cewa Boneyroyi na iya zama ɗaya daga cikin matsakaitan masu ba da mafaka ko kuma rukunin beta-CoVs na Boneyroyi na iya ba da gudummawar ɓangaren kwayar halitta a cikin ƙarshen sigar SARS-CoV-2.
Duk da cewa tambayoyi suna ci gaba, babu wata hujja da ta nuna cewa SARS-CoV-2 an kirkireshi ne da gangan ko kuma ba da gangan ba.
CoVs sun sake zama abin tattaunawa saboda barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin barbashi da sauran dabbobi ya canza ra'ayinmu game da mahimmancin asalin dabbobi da tushen dabbobi na HCoVs a cikin kamuwa da cutar ɗan adam.
Akwai shaidu da yawa da ke nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da tushen gizo-gizo kuma ana watsa su ga mutane ta hanyar matsakaiciyar majiɓinci.
Tun da yake kamuwa da SARS-CoV ya samo asali ne daga hulɗa tsakanin mutane da tururuwa a kasuwa, kashe tururuwa a can ta hanyar rufe kasuwar Wette zai iya kawo ƙarshen cutar SARS.
Ta hanyar wannan hujja, ya kamata a cire pangolin daga kasuwannin da aka yi wa lakabi don hana kamuwa da dabbobi saboda gano yawancin rukunin pangolin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Koyaya, binciken da za a yi nan gaba har yanzu yana jiran a bayyana ainihin abin da kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar tsuntsaye da sauran dabbobi masu shayarwa.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Waɗannan raƙuman suna aiki a matsayin manyan tushen nama, madara, fata da ulu ga mazauna yankin ban da mahimman kayan sufuri.
Sun bazu ko'ina cikin Gabas ta Tsakiya da Afirka.
Don haka ba zai yiwu a kashe raƙuma duka don magance MERS ba, kamar yadda aka yi a kasuwar dabbobi a China don hana SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar MERS, ya kamata a bi tsarin da ya dace don haɓaka alluran rigakafi masu tasiri akan MERS-CoV don raƙuman ruwa a hade tare da sauran hanyoyin kula da kamuwa da cuta.
Idan ba mu iya kawar da waɗannan ƙwayoyin cuta ba, za su iya haifar da ɓarkewar sabon nau'in kwayoyin halitta.
Yawancin nau'ikan CoVs na dabbobi suna yaduwa a cikin yanayi.
Musamman, CoVs na bat suna da bambanci sosai, tare da yiwuwar dabbobi.
Akwai yiwuwar waɗannan CoVs na Zonotic su haɓaka kuma su sake haɗuwa, wanda zai haifar da sababbin CoVs waɗanda zasu iya zama masu saurin yaduwa da / ko kisa ga mutane a nan gaba.
A wasu yankuna na kasar Sin, ya kamata a daina cin namun daji domin rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
Tare da gwajin wuta na SARS, MERS da COVID-19, ya kamata a sami shiri da kuma shirin amsawa mafi kyau.
Yawancin ƙwayoyin cuta sun daɗe suna rayuwa a duniya.
Sun kasance a cikin yanayin su har sai sun sami damar yadawa.
Kodayake akwai halaye da yawa na bat da ke da alaƙa da yada kwayar cutar, ana iya rage damar haɗuwa da mutane ga bat da sauran nau'ikan namun daji idan an sanar da mutane su nisanta kansu da su.
Don samun kyakkyawar fahimta game da yanayin halittu na CoVs da mazauninsu na halitta, ana buƙatar ci gaba da lura da dabbobi masu shayarwa, wanda zai tabbatar da tasiri wajen hana kamuwa da cutar dabba zuwa mutum da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana cututtukan dabbobin da ke cikin mutane shine nisantar yanayin yanayin dabbobin da ke haifar da ƙwayoyin cuta.
Har yanzu akwai wasu abubuwa da ba a san asalin SARS-CoV-2 ba.
Da farko, idan jemage sun yada kwayar cutar SARS-CoV-2 zuwa cikin tsuntsaye, za a ga a wane yanayi ne jemage da tsuntsaye za su iya raba wuri ɗaya na muhalli.
Na biyu, idan jemage suna taka rawa kai tsaye wajen kamuwa da cutar ga mutane, ya kamata a tantance yadda mutane ke kamuwa da jemage.
Na uku, idan dabba mai shayarwa ta uku tana aiki a matsayin mai ba da abinci na gaskiya, dole ne a bayyana yadda yake hulɗa da nau'ikan halittu daban-daban, ciki har da mutane, barbashi da pangolins.
A ƙarshe, tunda yawancin dabbobi masu shayarwa, gami da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2, ya kamata a gudanar da lura da kamuwa da cuta.
Idan wannan jemage ne, pangolin ko wata dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma kusan irin wannan kwayar cutar ta iyaye za a gano ta a cikin abincin ta na halitta a nan gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halitta ta SARS-CoV-2 a cikin dabbobi, wanda zai sami mahimman tasiri a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Duk da haka, yana da mahimmanci a sabunta ka'idodin tantancewa na "wanda ake zaton yana da cutar" da "wanda aka tabbatar da cutar" na COVID-19.
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta buga jagorar shawarwari mai sauri don ganowa da magance cutar Novel Coronavirus 2019 (2019-nCoV), kuma wannan jagorar ta ba da ƙwarewarmu kuma ta samar da kyakkyawan tunani don yaƙar cutar a duniya.
Koyaya, cutar Coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma a hankali muna ƙara wayar da kan mutane da iliminmu dangane da binciken da ake yi na ci gaba da kuma kwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta hanyoyin bincike da magani.
A cikin wannan wasikar, mun amsa ga wata sanarwa game da umarninmu kuma mun samar da sababbin ka'idojin tantancewa na "Laifin da ake zargi" da "Laifin da aka tabbatar" daidai da sabuwar hanyar bincike da magani na COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, an sami barkewar cutar coronavirus ta 2019 (2019-nCoV), wacce aka sanya wa suna Coronavirus Disease 2019 (COVID-19) kuma an sake sanya wa kwayar cutar sunan mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaƙar kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta tsara jagorar shawarwari mai sauri kuma an buga ta akan layi a cikin binciken likitancin soja a ranar 06 ga Fabrairu, 2020.
Tun bayan fitowar ta, ta samu gagarumin karbuwa.
Ka tuna cewa COVID-19 sabuwar cuta ce, kuma fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma kwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta hanyoyin bincike da magani.
Misali, an fitar da cikakkun bayanai guda bakwai na Ka'idojin Ganowa da Kula da Lafiya na COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin ya bayar (http://www.nhc.gov.cn/), daga ranar 16 ga Janairu, 2020 zuwa ranar 3 ga Maris, 2020, kowannensu yana da wasu canje-canje masu mahimmanci a cikin abubuwan da ke ciki.
Yanzu Zhou da abokan aikinsa sun yi tsokaci game da jagorarmu, suna ba da shawarar yin saukin saiti bisa ga kwarewarsu ta asibiti.
Aikin da suka yi ya kara sabbin bayanai a cikin jagorancinmu kuma ya samar da mahimman bayanai game da cutar a duniya.
Muna yaba musu da kuma gode musu saboda aikin da suka yi.
Koyaya, aikin su ya kamata a sabunta shi da sabbin ka'idojin bincike da magani na COVID-19 (Fitarwa ta 7 na gwaji) da kuma sabbin binciken.
A cikin fitowar ta bakwai (3 ga Maris 2020), don tabbatar da yanayin da ake zargi, don cikakken bincike dole ne a sami alamun asibiti guda biyu tare da ɗayan halayen tarihin annoba, ko kuma idan babu bayyanannen tarihin annoba, don haka a cika alamun asibiti guda uku.
Tarihin cututtuka: (1) Tarihin mazauna ko tafiya zuwa Wuhan City da kewayenta, ko sauran al'ummomin da aka ba da rahoton shari'ar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin haɗuwa da masu kamuwa da cutar SARS-CoV-2 (wanda ya fito da tabbatacce a gwajin nucleic acid); (3) Tarihin haɗuwa da marasa lafiya da ke fama da zazzabi ko cututtukan numfashi a Wuhan City ko kewayenta, ko sauran al'ummomin da aka ba da rahoton 14 COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin haɗuwa da tarin mutane da aka tabbatar (ƙananan yankuna kamar gida, ofis, makarantu, da kuma kamuwa da zazzabi a cikin makonni 2 da suka gabata ≥ 2 / K ko kuma a cikin aji na biyu).
Bayyanar asibiti: (1) zazzabi da/ko bayyanar cututtuka na numfashi; (2) tare da alamun hoto na kamuwa da COVID-19; (3) jimlar ƙwayoyin farin jini a farkon farfadowa yana nuna al'ada, raguwa ko rage ƙididdigar ƙwayoyin lymphocytes.
Don tantance tabbataccen yanayin dangane da yanayin da ake zargi, dole ne a sami wata hujja ta cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Mun ga cewa, a cikin na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020) an haɗa gwajin PCR na ainihi da kuma samfurin jini don tantance nucleic acid a cikin numfashi.
An kara gano cututtukan jini a cikin na huɗu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020); sannan an ƙara hujja ta ƙwayar cuta a cikin na bakwai.
Masu binciken sun ci gaba da aiki akan cewa waɗannan canje-canjen suna dogara ne da samfurin jini tare da samfurin iska don bincika ingantaccen kayan gano nucleic acid don saurin ganewa, wanda ke ƙara wadatar samfuran daban-daban kuma wanda ke taimakawa wajen kawo tabbataccen sakamako mai kyau na ƙwayoyin cuta.
Bugu da ƙari, akwai ƙarin shaidu da ke tunatar da mu mu yi hankali da marasa lafiya da ke da alamun rashin lafiya da kuma marasa alamun rashin lafiya.
Don haka, Zhou da abokan aikinsa ya kamata su sabunta jerin abubuwan da ke gudana, saboda sun rarraba mutanen da ba su da alamun asibiti a matsayin masu ƙarancin haɗari.
Hakanan ana buƙatar tabbatar da tsarin ƙididdigar a cikin ayyukan asibiti da karatun gaba.
A ƙarshe, muna fatan cewa za a sami ƙarin hujjoji kai tsaye kuma masu karatu za su kira don yin sharhi.
Don gano masu cutar da ake zargi da kuma wadanda aka tabbatar da su, muna ba da shawarar gano su da bin sabbin umarnin ƙasarku.
Ƙungiyarmu za ta sabunta jagororinmu a kan lokaci don taimaka muku.
Bangladesh ta ba da rahoton sabbin mutuwar yau da kullun biyar saboda COVID-19.
A jiya, Bangladesh ta tabbatar da sabbin mutuwar biyar a ranar sakamakon COVID-19.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
A jiya, Cibiyar Nazarin Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ce adadin wadanda aka samu sun hada da mutane 114 da ke dauke da cutar da kuma 33 da suka warke da ke gida.
An samu mutuwar mutane 17 a cikin wannan hari.
A wani taron labarai na yanar gizo, Daraktan IEDCR, Dr Meerjady Sabrina Flora, ya ce mutuwar ta hada da maza hudu da mace daya.
A cewar Dr. Mirzadi, mutane biyu sun fi shekaru 60, biyu tsakanin shekaru 51 da 60, kuma daya daga cikin su yana tsakanin shekaru 41 zuwa 50.
Ya kara da cewa biyu daga cikin wadanda suka kamu da cutar daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa kamfanin dillancin labarai na Anadolu cewa, daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda aka kula da shi a asibitin Kuwait Maitri.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufurin Hanya da Gadar Bangladesh Obaidul Kader ya ce za a dakatar da zirga-zirgar jama'a har zuwa ranar Asabar mai zuwa fiye da yadda aka tsara.
An fara rufe wannan hanyar a ranar 26 ga Maris kuma an shirya za a rufe ta a ranar Asabar, 4 ga Afrilu.
Har ila yau, an ba da izinin jigilar kayayyaki masu mahimmanci kamar magunguna, mai da abinci.
A ranar 8 ga watan Maris ne aka fara samun mutum biyu da suka dawo daga Italiya da matar daya daga cikinsu da cutar ta COVID-19 a Bangladesh.
A ranar 19 ga watan Maris, har yanzu an warke daga cutar.
Mutane miliyan daya ne suka kamu da cutar SARS-CoV-2 a duniya
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa jimlar adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya a ranar Alhamis.
Akalla mutane 52,000 ne suka mutu sakamakon cutar COVID-19 da ke haifar da cutar.
Wannan muhimmin lamari ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko da kuma mutuwar farko da ta shafi cutar coronavirus a Zambia.
Har zuwa ranar Alhamis, Koriya ta Arewa ta yi ikirarin cewa tana ɗaya daga cikin ƙasashe kalilan da suka rage da ba su da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta rubuta mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 a cikin sa'o'i ashirin da hudu da suka gabata a karfe 10 na safiyar ranar 4 ga Afrilu agogon Turai na tsakiya (0800 UTC).
A Amurka, an samu karin mutane 244,000 da suka kamu da cutar coronavirus, tare da mutuwar akalla 5,900.
CBS News ta ruwaito Jami'ar Johns Hopkins, cewa mutane sama da 1,000 ne suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe sun ba da sanarwar tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar kulle birnin har zuwa ranar 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa za a ci gaba da biyan 'yan Rasha idan ba su tafi aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar kara dokar ta baci ta kasa na kwanaki 15; ta wuce ta hanyar kuri'u 215 a kan, kuri'u 10 a kan, da kuma kuri'a daya a kan.
Saudiyya ta tsawaita dokar hana fita a cikin biranen alfarma na Makka da Madina don tsawon yini; dokar hana fita ta baya ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya kafa dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike DeWine ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
Shaguna a Ostiraliya sun rage adadin takarda na bayan gida a kowane ma'amala
A ranar Lahadi da Asabar da yamma, sarkar kantin sayar da kayayyaki ta Australiya Wolworths da Coles sun rage iyakar sayen takarda na bayan gida a kowane ma'amala a duk shagunan a duk faɗin ƙasar zuwa biyu da fakiti ɗaya, bi da bi.
Bugu da ƙari, a watan Satumba, ALDI ta ƙaddamar da iyakar fakitin guda.
An sanya waɗannan ƙuntatawa a matsayin saƙo a wurin biya da kuma shafukan Facebook na sarkar.
An bayar da rahoton cewa masu sayayya suna adana kaya saboda tsoron COVID-19 saboda tsoron cewa mutane za su iya keɓe kansu.
A ranar Laraba, Woolworths ta kuma iyakance sayar da takarda na gidan wanka don isar da gida, yana ba da fakiti ɗaya a kowane tsari.
Waɗannan canje-canjen sun biyo bayan iyakancewar fakitin kwastomomi huɗu da suka gabata waɗanda Woolworths da Coles suka ƙaddamar a ranar 4 ga Maris da 5 ga Maris, bi da bi.
"A ranar 8 ga watan Maris, Coles ta bayyana a cikin kamfen cewa an gabatar da dokar hana kaya hudu a wurare da dama, amma ""da yawa daga cikin shaguna har yanzu suna sayar da komai a cikin awa daya na samarwa"", suna kiran wannan bukatar ""ba a taba gani ba"" kuma a cikin wani sakon Facebook a ranar Talata a ALDI sun kira shi ""ba zato ba tsammani"".
A cewar wani kakakin kamfanin Woolworths, tallace-tallace sun karu sosai a makon da ya gabata.
An kuma ba da izinin kantin sayar da kayayyaki na Costco a Canberra a makon da ya gabata don fakiti biyu.
Don rage rashi, Coles ya ba da umarnin manyan fakiti daga masu samarwa kuma ya haɓaka ƙimar sake samarwa, Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ke samar da kaya a gaba don shirin musamman na Laraba.
Russell Zimmerman, darektan zartarwa na kungiyar 'yan kasuwar Australiya, ya ce' yan kasuwa suna kokarin kara kaya, amma takunkumin da kananan hukumomi suka sanya a lokacin da ake rarraba su ta hanyar motoci ya sa lamarin ya zama da wahala.
Ya ce, yana sa ran farashin kayayyaki zai karu yayin da masu samar da kayayyaki ke kokarin biyan bukatar.
ALDI ta sanar a ranar Talata cewa bayan da ta fitar da kaya a baya, wasu shaguna ba za su iya gudanar da tallace-tallace na musamman a ranar Laraba ba.
A wani rahoto da News.com.au ta bayar, wani masanin harkokin sayarwa a jami'ar Queensland na fasaha, Dr Gary Mortimer ya ce shagunan suna cika kaya a kowane dare.
Ya ce takardar bayan gida abu ne mai nauyi wanda ke sa tarin ta zama kadan kuma idan aka sayar da ita, manyan ɗakunan ajiya suna zama fanko, yana kara ƙarfafa ma'anar karancin.
"A cewar ABC News, "Coles da Woolworths sun yi imanin cewa idan yana da kaya da yawa, kuma yana da abubuwa kamar su toilet roll da kuma tsabtace jiki, kuma yana da yawa, to, wannan tsoro zai iya ragewa", in ji Russell Zimmerman.
Kamfanin da ke kera takarda na bayan gida mai suna Who Gives a Crap ya ce a ranar Laraba za su ƙare.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, wanda ke kera kayan wanka na Clinex da takardar solarium wanda ke samar da sarsant, ya jaddada cewa suna aiki 24/7 don ci gaba da samarwa.
Wani shafin yanar gizo mai suna Domain.com ya ruwaito cewa wasu masu sayar da kaddarorin suna ba da takardar bayan gida kyauta ga mai neman farko a gwanjon a Melbourne, wasu daga cikin gwanjon sun faru ne saboda masu sayen sun yi hutu a karshen mako na ranar aiki.
A wannan jaridar NT News da ake bugawa a Darwin a ranar Alhamis, an ba da takarda mai shafi takwas don yankewa a cikin takarda kuma a yi amfani da shi azaman takarda na bayan gida.
Rahoton da aka samu daga ABC Australia a ranar 3 ga Maris ya nuna cewa shagunan sun kasance masu ƙin yin takunkumi, inda suka ce ba su da shirin sanya takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa, sauran kayayyaki ma suna da bukatar su, wadanda suka hada da masks, sanitizers, kayan bushewa, wanke hannu da gari.
Hakazalika, a cikin kantin sayar da kayan daki na Burtaniya a cikin gidan yanar gizo Okado a kowace yammacin Lahadi a waje da Ostiraliya, ana sayar da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda mai amfani da takarda.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  cutar da ke haifar da coronavirus SARS-CoV-2  a matsayin annoba.
"Duk da cewa kalmar nan ""annoba"" ba ta nufin yadda hatsarin ke faruwa ba amma yadda cutar ta yadu, Hukumar Lafiya ta Duniya ta nuna bukatar gwamnatoci su dauki mataki:"
"Dukkan kasashen duniya na iya canza yanayin annobar".
"Sakatare Janar na WHO Adnanom Ghebreyesus ya ce idan jihohi za su iya ganowa, ""gwadawa, magani, warewa, ganowa da kuma hadawa".
"Muna matukar damuwa da yaduwar cutar da kuma yadda take da tsanani da kuma rashin aiki".
"A cewar Dr. Tom Friedan, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, annobar ta duniya tana da ""ba a taɓa gani ba""".
"A cikin wata sanarwa da aka buga a CNN a watan Fabrairu, ya ce, ""Babu wani kwayar cuta mai saurin kamuwa da cuta da aka gano daga asalinsa zuwa yaduwar ta a duniya ba, sai dai mura"."
Gabreseas ya yi magana a kan wannan batun, yana cewa, "Ba mu taɓa ganin annobar da cutar coronavirus ta haifar ba".
Ya ci gaba da cewa, "kuma ba mu taba ganin annoba ta duniya da za a iya sarrafa ta ba".
Sabon matsayin da aka samu na annoba ta duniya ya biyo bayan shawarar WHO a watan Janairu ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a na damuwa ta duniya.
"Darakta Anthony Fauci na Cibiyar Kula da Cututtuka da Cututtuka ta Kasa ta Amurka ya ce game da barkewar cutar, ""Ba daidai ba ne, zai kara muni"."
Kamfanin dillancin labarai na Associated Press ya ruwaito a ranar Alhamis cewa adadin kamuwa da cutar COVID-19 a duniya ya kai aƙalla 126,000 wanda ya haifar da mutuwar sama da 4,600.
Wannan annobar cutar coronavirus ta 2019-20 annobar cutar coronavirus ce ta 2019 (COVID-19), wanda ke haifar da cutar sankarar barkwanci mai tsanani coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Disamba na 2019, wanda aka ayyana a matsayin gaggawa ta kiwon lafiyar jama'a na damuwa ta duniya a ranar 30 ga Janairu, 2020 kuma an gane shi a matsayin annoba ta duniya a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da Yankuna, wanda ya yi sanadiyar mutuwar mutane 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar a China ya kai kashi 4%, yayin da a duniya yawan ya kewayon 13.04% a Aljeriya zuwa .08% a New Zealand.
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma numfashi.
Matsaloli na iya haɗawa da cutar huhu da cututtukan damuwa na numfashi.
Lokaci daga lokacin kamuwa da cutar zuwa bayyanar cututtuka yawanci kwanaki biyar ne, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko takamaiman maganin cutar.
Maganin farko shine maganin alamun cututtuka da na taimako. Matakan kariya da aka ba da shawarar sun haɗa da wanke hannu, rufe fuska yayin tari, nisantar wasu mutane, da lura da keɓewa ga duk waɗanda ake zargi da kamuwa da cutar.
Hukumomi a duk duniya sun amsa da hana tafiye-tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki da rufe makaman.
Cutar ta duniya ta haifar da mummunan rikicewar tattalin arziki da zamantakewar duniya, an soke wasanni, al'amuran addini, siyasa da al'adu, kuma cin kasuwa saboda tsoro ya kara haifar da karancin kayayyaki.
Makarantu da jami'o'i sun rufe ko dai a kasa ko a cikin gida a cikin kasashe 193, wanda ke shafar kusan kashi 99.4 na yawan ɗaliban duniya.
An samu karyar yanar gizo game da cutar, da kuma nuna wariya da nuna bambanci ga wasu mutane daga China, Gabas da kudu maso gabashin Asiya, da kuma wasu daga yankunan da aka sami alamun cutar, dangane da asalinsu da bayyanar su.
Saboda rufe tafiye-tafiye da masana'antu masu nauyi, gurɓataccen iska da ƙarancin hayaƙin carbon sun ragu.
Hukumomin kiwon lafiya a Wuhan (babban birnin lardin Hubei) na kasar Sin sun ba da rahoton wani tarin kamuwa da cutar nimoniya da ba a san dalilinsa ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin cututtukan sun danganci kasuwar sayar da abincin teku ta Hunan kuma ana tsammanin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar da aka sani da SARS-CoV-2, sabuwar kwayar cuta ce da aka gano wacce ke da alaƙa da kwayar cutar coronavirus ta bat, kwayar cutar corona ta Bonnaroo da SARS-CoV. Mutumin da aka fara gano alamun cutar, an gano cewa ya kamu da rashin lafiya a ranar 1 ga Disamba 2019; kuma daga baya mutumin ba shi da wata alaƙa da ke bayyane tare da rukunin Wet Market.
An gano cewa kasuwar tana da alaƙa da kashi biyu bisa uku na rukunin farko na masu kamuwa da cutar a watan Disamba na 2019.
Wani rahoto da aka samu a cikin jaridar South China Morning Post a ranar 13 ga Maris, 2020 ya nuna cewa wataƙila an fara samun wani mutum mai shekaru 55 daga lardin Hubei a ranar 17 ga Nuwamba, 2019. A ranar 26 ga Fabrairun, 2020, WHO ta ba da rahoton cewa an sami sabon kamuwa da cuta a China, amma ya karu a cikin Italiya, Iran da Koriya ta Kudu, kuma adadin sabbin cututtukan a waje da China ya zarce adadin sabbin cututtukan a cikin China a karon farko.
Ana iya rage yawan wadanda suka kamu da cutar, musamman ga mutanen da ke da alamun rashin lafiya.
Har zuwa ranar 26 ga Fabrairu, an samu karancin kararraki a tsakanin matasa, mafi yawansu 'yan kasa da shekaru 19 da kashi 2.4 cikin dari na wadanda ke dauke da cutar a duniya.Babban mai ba da shawara kan kimiyya a Burtaniya, Patrick Vallance ya kiyasta cewa kashi 60 cikin dari na mutanen Burtaniya suna bukatar kamuwa da cutar kafin su samu rigakafi a cikin al'ummar da ke aiki.
A cewar ka'idojin hukuma, adadin mutane da aka gwada su da cutar COVID-19 kuma sakamakon gwajin ya tabbata.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland sun kafa ƙa'idodin ƙa'idar da ba za su gwada mutanen da ke da alamun cutar ba.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa kusan kashi 86% na kamuwa da cutar COVID-19 a kasar Sin ba a gano su ba har zuwa ranar 23 ga watan Janairu, kuma wannan kamuwa da cutar da ba a gano ba shine tushen kamuwa da kashi 79% na rikodin cutar.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi adadin kamuwa da cutar da aka kiyasta.
Da farko, an kiyasta yawan haifuwa (R0) na COVID-19 daga 1.4 zuwa 2.4.
Wani binciken da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta fitar ya kammala cewa mai yiwuwa ya zama 5.7.
Yawancin mutanen da ke fama da COVID-19 sun warke.
Ga waɗanda ba su da shi, lokacin da alamun cutar suka fara zuwa mutuwa ya kasance daga kwanaki 6 zuwa 41, tare da mafi yawan lokuta na kwanaki 14.
Kimanin mutuwar 97,000 a ranar 10 ga Afrilu, 2020 an ce suna da alaƙa da COVID-19.
A kasar Sin, 80% na mutanen da suka mutu sun wuce shekaru 60 a ranar 5 ga watan Fabrairu, kuma kashi 75% daga cikinsu suna da cututtukan zuciya da ciwon sukari.
Yawan mutanen da suka mutu sakamakon COVID-19 na iya zama mafi girma, saboda ba zai iya haɗa da duk mutanen da suka mutu ba tare da gwaji ba - kamar a gida, gidajen jinya, da sauransu.
Wasu bayanai daga Italiya sun nuna cewa adadin karin mutuwar a lokacin annobar ya ninka na COVID sau 4-5 fiye da yadda ake kashe mutane.
"Wani kakakin Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ya yarda cewa ""mun san cewa [yawan mutuwar da aka bayyana] ƙididdiga ne da ba ta da yawa fiye da ainihin adadi"", wata sanarwa da ba a tabbatar da ita ba a cikin Amurka. Irin wannan ƙididdigar ba ta da yawa a cikin annoba ta duniya, kamar annobar cutar sankarar alade ta 2009 H1N1. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu, 2020".
Mutuwar farko a waje da kasar Sin ta fara a Philippines a ranar 1 ga watan Fabrairu, kuma mutuwar farko a waje da Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da dozin a kasashen Iran, Koriya ta Kudu da Italiya a wajen kasar Sin.
A ranar 13 ga watan Maris, an samu mutuwar mutane a kasashe da yankuna sama da arba'in a duk nahiyoyin duniya banda Antarctica.
Waɗannan lambobin sun bambanta ta yanki, kuma yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya wuce tun farkon barkewar cutar, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mace-mace da cututtukan a duniya ya kai 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu, 2020.
Yawan ya bambanta dangane da yanki.
A kasar Sin, yawan mace-macen da ke fama da cutar ya ragu daga kashi 17.3% (waɗanda suka kamu da cutar a tsakanin Janairu 1-10 na 2020) zuwa kashi 0.7% (waɗanda suka kamu da cutar a farkon lokacin daga 1 ga Fabrairu 2020). Sauran matakan rigakafi sun haɗa da - yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da ke kamuwa da cutar (masu kamuwa da cutar ko marasa kamuwa da cuta) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyaka a kowane lokaci kuma suna bin wani yanki na mutane daga kamuwa da cuta ta hanyar nazarin shari'ar.
Yawancin masana sunyi ƙoƙari su ƙidaya waɗannan lambobi don takamaiman yawan jama'a.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mace-macen cutar a cikin annobar ya kasance tsakanin 0.1% zuwa 0.39%.
Lissafin da ke sama na wannan zangon ya dace da binciken ƙididdiga na gwajin farko na COVID-19 a cikin Jamus da kuma nazarin tasirin gwajin akan ƙididdigar CFR.
WHO ta yi ikirarin cewa ana iya sarrafa cutar.
Matsakaicin lokacin ɓarkewa da lokacin ƙarshe ba su da tabbas kuma suna iya bambanta ta wurin wuri.
"Makeage Bonnie na Jami'ar Jihar Penn ya ce, "Tun da ba a gano su ba, cututtukan cututtuka sukan mamaye kuma sai su fara lalacewa lokacin da cutar ba ta da sauran masu karɓar ba".
Amma a yanzu ba zai yiwu a yi hasashen lokacin da hakan zai faru ba.
"Zhong Nanshang, babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin, ya yi jayayya cewa ""za a iya kawo karshen cutar a watan Yuni"" idan dukkan kasashen suka hada kai don bin shawarar da Hukumar Lafiya ta Duniya ta bayar na hana yaduwar cutar".
"A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magungunan Yankin Gashi ta London ya ce SARS-CoV-2 ""zai iya ci gaba da yaduwa na tsawon shekara ɗaya ko biyu"."
"Binciken da kwalejin Imperial ta jagoranci Neil Ferguson ya nuna cewa ""har sai an samu allurar rigakafi (wataƙila watanni 18 ko sama da haka) "" ana buƙatar kiyaye nesa da sauran matakan".
"William Schaffner na Jami'ar Vanderbilt ya ce, ""Ina ganin ba zai yiwu ba cewa cutar korona, da yake tana yaduwa da sauri, za ta ɓace gaba ɗaya"" kuma "za ta iya zama cuta ta yanayi, ta dawo kowace shekara".
Matsayin dawowar zai dogara ne akan rigakafin dabba da kuma girman maye gurbi.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma mutanen da ke kamuwa da cutar na iya zama marasa alamun.
Abubuwa biyu da suka fi yawa sune zazzabi (88%) da bushewar tari (68%).
Alamomin da ba a saba gani ba sun haɗa da  rashin jin daɗi, ƙwanƙwasawa (scum), rashin ƙanshi, rashin numfashi, ciwon tsoka da haɗin gwiwa, ƙuƙwalwa, ciwon kai, sanyi, amai, shan kofi, zazzabi, ko cyanotic. WHO ta bayyana cewa kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta lissafa alamun gaggawa kamar numfashi, ciwon kirji ko damuwa, rikicewa, farkawa, da fuska ko lebe mai launin shuɗi; ana ba da shawarar neman taimakon likita nan da nan idan waɗannan alamun sun bayyana. Ci gaba da cutar na iya haifar da cutar huhu mai tsanani, cututtukan cututtukan numfashi, sepsis, septic shock, da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar na iya zama marasa alamun cutar ba tare da alamun asibiti ba, amma sakamakon gwajin ya tabbatar da cutar, don haka masu binciken sun ba da shawarar yin sa ido da kuma gwada duk wanda ya taɓa saduwa da mutanen da ke da cutar don kauce wa kamuwa da cutar.
Tsinkayen kasar Sin na rashin alamun cututtuka sun kai kashi 44 cikin dari.
Matsayin lokacin haɗuwa na yau da kullun (lokacin da kamuwa da cuta da bayyanar cututtuka ke faruwa) yana da kwanaki 1 zuwa 14; matsakaicin kwanaki 5 ne. A cikin misalai na rashin tabbas, kashi 30% na mutanen da ke da COVID-19 waɗanda suka rasa ƙamshi da farko kuma kashi 15% na waɗanda suka rasa ƙamshi.
Har yanzu ana ci gaba da tantance wasu bayanai kan yadda cutar ke yaduwa.
Ana tunanin cewa cutar tana yaduwa ne ta hanyar ƙananan ɗigon ruwa da aka samar yayin kusanci da tari, hancinsa ko magana; kusanci yana nufin kasancewa tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Bincike ya nuna cewa ruwan da ke fitowa daga tari zai iya kaiwa mita 4.5 zuwa mita 8.2.
Wasu sun ce ana iya kamuwa da kwayar cutar ta hanyar ƙananan ruwa mai saurin magana wanda zai iya zama cikin iska na dogon lokaci.
Kwayoyin ruwa na iya shiga cikin baki ko hanci na waɗanda ke kusa da su ko kuma suna iya shiga cikin huhu ta hanyar numfashi.
Wasu hanyoyin kiwon lafiya kamar intubation da CPR na iya haifar da fitar da iska ta hanyar iska.
Hakanan ana iya yada shi idan wani ya taɓa kowane abu mai gurbatawa, gami da fata sannan ya taɓa idanunsu, hanci ko bakinsu.
Duk da damuwa cewa ana iya yada shi ta hanyar stool, ana ganin cewa wannan haɗarin ba shi da yawa.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da SARS-CoV-2 daga bargo zuwa baki. Kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka. Ko da yake ana iya kamuwa da cutar kafin bayyanar cututtuka da kuma bayan bayyanar cututtuka.
Mutane da yawa sun sami sakamako mai kyau kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya kamuwa da cutar kafin a fara nuna alamun bayyanar cututtuka.
Akwai rahotanni kaɗan kawai na ƙwayoyin cuta marasa alamun da aka tabbatar da su a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano kamuwa da cuta ba tare da alamun cutar ba yayin binciken ganowa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba amma mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a farfajiya na awanni zuwa kwanaki.
Musamman, ana iya samun kwayar cutar a kan filastik (polypropylene) na tsawon kwanaki uku, 304 bakin karfe, kwali na kwana daya, da kuma jan ƙarfe na tsawon sa'o'i huɗu.
Wannan, dangane da zafi da zafin jiki, ya bambanta. Dabbobin gida da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun yi hulɗa da dabbobi, kamar yadda za a yi bayan taɓa wasu abubuwa da ke da cutar.
Cutar coronavirus mai saurin kamuwa da cuta mai saurin kamuwa da cuta (SARS-CoV-2) wani sabon kwayar cuta ne wanda aka fara gano shi daga mutum uku da ke fama da cutar huhu a Wuhan.
Dukkanin halaye na sabon SARS-CoV-2 ana iya samun su a cikin dukkanin coronaviruses masu alaƙa da ke faruwa a cikin yanayi. A waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida saboda yana lalata murfin kariya na kwayar cutar. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
An yi imanin cewa yana da tushen wata cuta ta dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar coronavirus ta haɗu da kwayoyin halitta tare da nau'ikan biyu na bat a cikin nau'in Betacoronavirus da subgenus Serbovirus (Lineage B).
Wani samfurin bat coronavirus (BatCov RaTG13) yana da cikakken matakin kwayoyin halitta daidai da kashi 96 cikin ɗari.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci na amino acid daya kawai a wasu sassan tsarin kwayoyin halittar da ke tsakanin kwayar cutar da ke cikin daji da kuma kwayar cutar da ke cikin jikin mutum.
A yau, idan aka kwatanta dukkanin kwayoyin halitta, an gano cewa akwai kamanceceniya tsakanin kwayoyin halittar 92% tsakanin cutar coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da cewa cutar ta yi aiki a matsayin mai karɓar ba.
Ana iya tantance kamuwa da cuta ta hanyar kwayar cutar ta hanyar alamomi, amma a ƙarshe ta hanyar tabbatar da sake jujjuyawar cutar ta hanyar maganin polymerase chain reaction (rRT-PCR) ko CT imaging.
Wani binciken da aka yi a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa CT ya fi PCR hankali sosai, amma ba shi da ƙwarewa sosai, kuma yawancin siffofin da yake ɗaukar hoto sun dace da sauran cututtukan huhu da cututtuka.
"A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Kada a yi amfani da CT a matsayin gwajin farko don gano COVID-19""".
WHO ta fitar da wasu ka'idojin gwajin RNA don SARS-CoV-2, na farko daga cikinsu an bayar da su ne a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin akan numfashi ko samfurin jini.
Sakamakon yana samuwa a cikin sa'o'i da yawa zuwa kwanaki.
Yawancin lokaci ana yin gwajin ne a kan swab na nasopharyngeal, amma ana iya amfani da swab na makogwaro. Wasu dakunan gwaje-gwaje da kamfanoni suna samar da gwaje-gwaje na serological wanda ke gano ƙwayoyin cuta.
Babu wani daga cikin waɗannan da aka tabbatar da inganci don yarda da amfani da shi a cikin dogon lokaci kamar yadda aka bayyana a ranar 6 ga Afrilu, 2020.
A Amurka, an ba da izinin amfani da gwaje-gwajen ƙwayar cuta da aka yi da CELEX don amfani da su a cikin gaggawa kawai a cikin dakunan gwaje-gwaje masu izini.
Abubuwan da ke nuna hotuna a kan radiography da CT na mutanen da ke da alamun sun hada da rashin daidaituwa na gilashin ƙasa da rashin zubar da jini.
Ƙungiyar Radiological ta Italiya tana tattara bayanan yanar gizo na duniya na hotuna daga gwajin da aka tabbatar da lokuta.
An iyakance yin hoto da gano COVID-19 ba tare da tabbatarwa ba ta hanyar PCR don haɗuwa da sauran cututtuka kamar adenoviruses.
Wani babban bincike a China ya kwatanta PCR da sakamakon CT na kirji kuma ya bayyana cewa, yayin da hoton wannan kamuwa da cuta ya zama mara kyau, yana da sauri kuma ya fi dacewa wanda ke ba da shawarar yin la'akari da shi a matsayin kayan aikin bincike a yankunan da ke fama da cutar.
An samar da wata hukumar samar da kwayar halitta mai amfani da hankali ta wucin gadi wacce ke samar da siffofin kwayar cutar ta hanyar radiography da CT.
Dabaru don hana yaduwar cutar sun hada da kiyaye tsabtar jiki, wanke hannu, kada a taɓa idanu, hanci ko baki da hannayen da ba a wanke ba, da yin fitsari ko tari a cikin nama kuma a jefa shi cikin kwandon shara.
An shawarci mutanen da ke da cutar da su sanya abin rufe fuska a fili.
Ana kuma ba da shawarar kiyaye nesa ta jiki don hana kamuwa da cuta. Gwamnatoci da yawa sun ba da shawara ko kuma sun hana duk balaguron da ba dole ba daga ƙasashe da yankuna da cutar ta shafa.
Amma cutar ta kai ga yaduwar jama'a a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma kuma wasu mutane a cikin al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da wani wanda zai iya kamuwa da cutar su yi amfani da matakan kariya, kariya ta tuntuɓar, da kariya ta ido. Yana da mahimmanci ga hukumomin kiwon lafiya su gano mutanen da suka sadu da su don gano asalin kamuwa da cuta da hana ƙarin kamuwa da cuta.
Amfani da bayanan wurin wayar salula da gwamnati ke yi don wannan dalili ya haifar da damuwar sirri, kuma Amnesty International da kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar yin amfani da su da son rai, kuma har zuwa 7 ga Afrilu 2020, sama da ƙungiyoyi da yawa na masana suna aiki kan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth don shiga kusanci da mai amfani da wayar hannu ta wasu.
Masu amfani za su sami saƙo idan sun kasance a cikin hulɗa da wani mai cutar COVID-19. Akwai wasu ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar.
Babu riga-kafi ga COVID-19, kodayake kamfanoni da yawa suna aiki don ƙirƙirar ɗaya.
An bada shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa aƙalla na dakika ashirin a wasu lokuta, musamman bayan sun je bayan gida ko idan hannayensu sun kasance masu datti; kafin cin abinci; kafin wanke hanci, lokacin tari, ko lokacin yin fitsari.
Tun da yake ana iya kashe kwayar cutar a waje da jikin mutum ta hanyar sabulu na gida, wanda ke fashe kumfa mai kare kwayar cutar.
CDC ta ba da shawarar cewa idan sabulu da ruwa ba su da sauki, a maimakon haka, a yi amfani da tsabtace hannu da ke da aƙalla kashi 60% na giya.
WHO ta shawarci mutane da kada su taba idanunsu, hanci ko bakinsu da hannayensu marasa tsabta.
Za'a iya kawar da farfajiyar ta hanyar amfani da wasu magunguna (a cikin minti daya na haɗuwa da maganin shafawa a cikin yanayin bakin karfe), wanda ya haɗa da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran mafita kamar benzalkonium chloride da chlorohexidine gluconate ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko tabbatar da cutar COVID a wani wuri kamar ofis ko kula da rana, to ya kamata a kashe kwayoyin cuta a ofis, dakunan wanka, wuraren da ake amfani da su, kayan aikin lantarki da ake amfani da su, kamar su allunan, allon taɓawa, mabuɗan rubutu, sarrafawa ta nesa da kuma ATMs da marasa lafiya ke amfani da su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su ninka bakinsu da hanci ko kuma su rufe su da takarda mai ɗamara yayin da suke tari ko hancin, kuma su zubar da shi nan da nan.
Ana ba da shawarar cewa waɗanda ke da haɗarin kamuwa da cutar su sa abin rufe fuska na tiyata. Saka abin rufe fuska na iya sarrafa adadin ƙwayoyin da ke fitowa da kuma iyakar yaduwar su yayin magana, hancin ko tari.
WHO ta fitar da jagororin kan lokacin da kuma yadda za a sanya abin rufe fuska.
"A cewar masanin kwayar cutar Stephen Griffin na Jami'ar Leeds, ""masks na iya rage yawan mutanen da ke amfani da su don taɓa fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannaye ba. "" Ana kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da mutanen da ke iya kamuwa da cutar".
WHO ta ba da shawarar cewa mutane masu lafiya su sa abin rufe fuska ne kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutumin da ke da cutar COVID-19, kodayake sun yarda cewa sanya abin rufe fuska na iya taimakawa wajen kauce wa taɓa fuska.
Wasu kasashe sun fara karfafawa jama'a gwiwa su sanya takunkumin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na ba da magani ba wanda aka yi da masana'anta. China ta ba da shawarar musamman ga lafiyayyun membobin jama'a su yi amfani da abin rufe fuska na likita, musamman lokacin da suke kusanci da wasu mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata yayin tafiya a cikin jigilar jama'a ko kasancewa a wuraren taron jama'a.
Jami'an lafiya a Thailand suna karfafawa mutane gwiwa su sanya abin rufe fuska a gida kuma su wanke su a kullum.
An haramta fita waje ba tare da sanya abin rufe fuska ko rufe hanci da baki ba a Jamhuriyar Czech da Slovakia.
A ranar 16 ga Maris, Vietnam ta nemi kowa ya sanya abin rufe fuska yayin da yake tafiya cikin jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta ba da umarnin sanya abin rufe fuska a duk lokacin da aka shiga kowane kantin sayar da kayan masarufi.
Isra'ila ta bukaci dukkan mazauna ta da su sanya abin rufe fuska a duk lokacin da suka fita.
Taiwan, wanda ke samar da abin rufe fuska kusan miliyan 10 a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjoji su sanya abin rufe fuska a jiragen kasa da bas na tsakanin jihohi don tafiya a ranar 1 ga Afrilu.
Panama ta ba da shawarar sanya abin rufe fuska a duk lokacin da za ku fita, kuma waɗanda ba za su iya sayen abin rufe fuska ba za su iya yin amfani da abin rufe fuska na gida.
Ana kuma amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda kuma ake kira nisantar jiki) ya haɗa da rage kusanci tsakanin mutane da rage saurin yaduwar cutar ta hanyar sarrafa yaduwar kamuwa da cuta.
Hanyoyin sun hada da: keɓewa; ƙuntata tafiye-tafiye; rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko shaguna.
Mutane na iya yin amfani da hanyoyin nisantar da jama'a ta hanyar kasancewa a gida, ta hanyar takaita tafiye-tafiye, guje wa wuraren da jama'a ke zaune, gaisuwa ba tare da taɓa ba, da nisantar juna ta zahiri.
Gwamnatoci da yawa yanzu suna ba da umarni ko ba da shawarar nisantar da jama'a a wuraren da cutar ta bulla.
Babban adadin taron da hukumomin gwamnati da cibiyoyin kiwon lafiya na Amurka suka ba da shawarar ya ragu da sauri daga mutane 250 (sai dai idan an san cewa COVID-19 ba ta yaduwa a yankin) zuwa 50 da 10 a gaba.
"A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane fiye da biyu. Manyan manya da mutanen da ke da cututtukan da ke tattare da su kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma lalata tsarin garkuwar jiki suna fuskantar haɗarin kamuwa da cuta da matsaloli masu tsanani, kuma a cikin yankunan da ke fama da cutar a cikin al'umma, CDC ta ba da shawarar su zauna a gida kamar yadda ya kamata. A ƙarshen Maris, 2020, WHO da sauran kungiyoyin kiwon lafiya sun fara maye gurbin kalmar ""nuna nesa da jama'a"" da ""nuna nesa da jiki"", don bayyana cewa yana nufin nisantar da kai ta hanyar sadarwa ta hanyar kama-da-wane ko kuma ta hanyar sadarwar zamantakewa".
"Amfani da kalmar nan ""yanayin zamantakewa"" ya shafi yadda mutane ke keɓe kansu gaba ɗaya maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar".
Wannan ya hada da shawarar yin jima'i da wanda kuke zama tare da shi wanda ba shi da cutar ko kuma ba shi da alamun cutar.
Ana ba da shawarar keɓe kai a gida ga waɗanda ke da COVID-19 da waɗanda ake zargi da kamuwa da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun jagororin don keɓe kai da ya dace. Gwamnatoci da yawa sun ba da shawarar ko kuma sun ba da shawarar keɓe kai ga duk mazaunan yankunan da abin ya shafa.
An ba da umarnin mafi tsauri don keɓe kai ga ƙungiyoyin haɗari.
An shawarci mutanen da suka kasance tare da wani mutum mai cutar COVID-19 da kuma waɗanda suka yi balaguro kwanan nan zuwa wata ƙasa ko yanki da ke da yawan kamuwa da cutar da su keɓe kansu na kwanaki 14 daga lokacin da suka kasance tare da shi.
Hanyoyin sarrafa barkewar cutar sune hanawa da kawar da su.
Ana aiwatar da matakan dakile cutar a farkon lokacin barkewar cutar, kuma ana nufin fara wasu matakan kula da kamuwa da cuta da allurar rigakafi ban da ganowa da keɓe mutanen da ke fama da cutar don dakatar da yaduwar cutar a cikin sauran jama'a.
Lokacin da babu wata hanyar da za a iya hana yaduwar cutar, ana matsawa zuwa matakan dakilewa: ana daukar wasu matakan da za su rage saurin yaduwar cutar da kuma rage tasirin ta ga tsarin kiwon lafiya da al'umma.
A lokaci guda, za a iya ɗaukar ma'auni mai haɗuwa na duka biyu da kuma mitigation.
Ana buƙatar ɗaukar matakan da suka fi ƙarfin hanawa don juyar da sake zagayowar cutar zuwa ƙasa da lambar haifuwa ta farko 1. Maximizing ance cutar ta zama wani ɓangare na magance barkewar cutar mai saurin yaduwa, wanda aka sani da daidaitawa da layin cutar.
Wannan ya rage hadarin kiwon lafiya kuma ya ba da ƙarin lokaci don allurar rigakafi da magani don inganta su.
Hanyoyin da za a iya sarrafa barkewar cutar ba tare da magunguna ba sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓe kai; matakan zamantakewar jama'a don nisantar da kai, kamar rufe makarantu da soke taron jama'a; yarda da wasu hanyoyin da za a iya shiga cikin jama'a; da kuma matakan muhalli, kamar tsabtace farfajiya.
Sauran kasashen ma sun dauki matakan da suka dace don rage yaduwar cutar.
Koriya ta Kudu ta fara gwajin jama'a da keɓewar gida, kuma ta ba da gargaɗi game da motsi na mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga mutanen da suka kamu da cutar da suka keɓe kansu kuma ta ɗora manyan tarar waɗanda suka kasa yin hakan.
Taiwan ta kara samar da abin rufe fuska da kara tarar da masu damfarar kayayyakin kiwon lafiya.Ƙoƙarin da Birtaniya da Amurka suka yi ya nuna cewa ragewa (ragewa amma ba a hana yaduwar cutar ba) da kuma dakile (ƙara cutar) babban kalubale ne.
Ko da yake manufofin kawar da mafi kyawun cututtuka sun rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku da mutuwar rabin, har yanzu ana ci gaba da lalata tsarin kiwon lafiya wanda ke haifar da miliyoyin mutuwar.
Yin amfani da maganin zai iya zama zaɓi amma yana da mahimmanci a ci gaba da amfani da shi muddin kwayar cutar ta ci gaba da yaduwa tsakanin al'ummomin mutane (ko har sai an sami allurar rigakafi, idan ta zo da farko), saboda idan ba a sassauta matakan ba, cutar za ta sake dawowa cikin sauri.
Matsaloli na dogon lokaci don kawar da annobar suna haifar da lahani na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ci gaba da kokarin ci gaba, gami da gwajin magungunan da ake dasu.
Samun maganin sanyi da tari, shan ruwa da hutawa na iya rage alamun.
Dangane da tsananin cutar, za a iya buƙatar maganin oxygen, ruwan intravenous (ta hanyar jijiya) da taimakon numfashi.
Amma amfani da kwayoyin cutar ta steroid na iya haifar da mummunan sakamako.
Yawancin mahaɗan da aka amince da su a baya don magance wasu cututtukan kwayar cutar ana nazarin su don amfani da su don magance COVID-19.
WHO ta kuma bayyana cewa wasu magungunan gargajiya da na gida suna taimakawa wajen rage alamun da ke tattare da SARS-CoV-19.
Ƙara ƙarfin aiki da kuma sayen cibiyoyin kiwon lafiya don marasa lafiya na COVID-19 an bayyana su da WHO a matsayin matakan kariya don hana barkewar cutar.
ECDC da WHO na Turai sun ba da jagora ga asibitoci da cibiyoyin bayar da magani na farko don kawar da hanyoyin a matakai da yawa da suka haɗa da ƙara kulawar dakin gwaje-gwaje kan gwajin COVID-19, haɓaka yawan kulawa ta hankali ta hanyar keɓewa da keɓe marasa lafiya masu cutar COVID-19 da horar da ma'aikata da yawan iska da gadaje da ake da su.
Akwai dabaru da dama game da inda cutar ta farko (wanda ake kira Patient Zero) ta samo asali.
An gano mutum na farko da ya kamu da cutar coronavirus a ranar 1 ga watan Disamba, 2019 a birnin Wuhan, Hubei, kasar Sin.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Yawancin waɗannan sun shafi kasuwar siyar da abincin teku ta Hunan, inda ake sayar da dabbobi masu rai, kuma wata ka'ida ita ce cutar ta fito ne daga irin wannan dabba; ko kuma a wasu kalmomin, yana da asalin dabba. An gano wani tarin cutar nimoniya da ba a san dalilinsa ba a ranar 26 ga Disamba kuma an kula da shi a asibitin lardin Hubei na likita Zhang Jixian, wanda ya sanar da CDC na Wuhan Jianghan a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, wasu likitoci a asibitin Wuhan suka gargadi abokan aikin su game da "SARS-like coronavirus".
Likitoci takwas, ciki har da Li Wenliang, 'yan sanda sun yi musu tsawa don yada jita-jita, kuma wani likita mai suna Ai Feng ya sha wahala daga manyan jami'ansa don yin gargadi.
Daga baya Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da Hukumar Lafiya ta Duniya.
A farkon watan Janairu, an samu wasu mutane da ke fama da cutar sankarar bargo a Wuhan, inda ake gudanar da bincike. A farkon barkewar cutar, adadin masu cutar ya ninka sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar 2020, cutar ta yadu zuwa wasu yankuna na kasar Sin tare da taimakon ƙaurawar Sabuwar Shekarar Sin da kuma kasancewar Wuhan cibiyar sufuri da babbar hanyar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayyana cewa an samu sabbin mutane 140 a rana daya, mutum biyu daga Beijing da daya daga Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6174 sun riga sun nuna alamomi har zuwa 20 ga Janairu, 2020. Har zuwa 26 ga Maris, Amurka ta ga adadin adadin mutanen da aka tabbatar a duniya, ta zarce China da Italiya.
Akwai aƙalla kamuwa da cuta guda ɗaya a cikin ƙasashe da yankuna kusan 200.
Saboda annobar a Turai, yawancin ƙasashen yankin Schengen sun takaita motsi da kuma sanya iko a kan iyakoki.
Amsar ƙasa ta haɗa da wasu matakan hanawa kamar keɓewa (wanda aka fi sani da umarnin zama a gida ko umarnin shiga ko kulle) da dokar hana fita. Ya zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300 ko kashi 90% na yawan jama'a suna cikin wasu nau'ikan kulle a Amurka, sama da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu da mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wasu nau'ikan kullewa, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano mutum na farko da ya kamu da cutar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019, amma an fara samun mutum a ranar 17 ga Nuwamba, a cewar wani rahoto da ba a tabbatar da shi ba.
Dr. Zhang Jijian ya lura da tarin cutar nimoniya da ba a san dalilin da ya sa ba a ranar 26 ga Disamba, bayan haka asibitin ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Binciken kwayoyin halittar farko na samfurin mai haƙuri wanda aka yi a ranar 27 ga Disamba, 2019 ya nuna kasancewar kwayar cutar coronavirus mai kama da SARS.
A ranar 31 ga watan Disamba, Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a.
An sanar da WHO a ranar.
"Bayan da aka fitar da wadannan sanarwa, 'yan sanda sun gargadi likitocin Wuhan da su " yada jita-jita " game da barkewar cutar.
"Kwamitin Lafiya na Kasa na kasar Sin ya fara da'awar cewa babu "tabbacin tabbatacce" na kamuwa da cutar daga mutum zuwa mutum".
"A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na juyin juya hali wanda daga baya babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yakin mutane" don dakile yaduwar kwayar cutar".
"An sanar da dokar hana zirga-zirga da fita daga Wuhan a ranar 23 ga Janairu, a cikin wani sanarwa da aka bayyana a matsayin "karkashin mafi girma a tarihin ɗan adam", wanda aka faɗaɗa zuwa birane 15 a Hubei kuma ya shafi mutane kusan miliyan 57".
An haramta amfani da motocin jama'a a birnin.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Jami'ai sun kuma sanar da gina asibitin wucin gadi, wato Huyoshensan, wanda aka kammala a cikin kwanaki 10.
Bayan asibitin Leishenshan, an gina wani asibiti don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, China ta mayar da wasu cibiyoyi 14 a Wuhan kamar Cibiyar Taro da Filin wasa zuwa asibitoci na wucin gadi.A ranar 26 ga Janairu, gwamnati ta dauki wasu matakai don hana barkewar COVID-19, ciki har da sanarwar kiwon lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a fadin kasar.
Yankunan Hong Kong da Macao sun dauki matakai daban-daban musamman a makarantu da jami'o'i.
An kafa tsarin aiki daga nesa a yankuna da dama na kasar Sin.
An sanya takunkumi kan zirga-zirga a ciki da wajen Hubei.
An sauya hanyoyin sufuri na jama'a a duk fadin kasar Sin kuma an rufe gidajen tarihi na dan lokaci.
"An sanya takunkumi kan motsi na jama'a a birane da yawa kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu takunkumi kan motsi a waje. Tun bayan barkewar cutar a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana cutar daga "shigowa" daga wasu kasashe".
Alal misali, Beijing ta ayyana cewa duk matafiya na kasa da kasa da suka shiga birnin za su yi keɓewa na kwanaki 14. A ranar 23 ga watan Maris, mutum daya ne kawai ya kamu da cutar a cikin gida a cikin kwanaki biyar da suka gabata.
A ranar 24 ga watan Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an toshe yaduwar cututtukan da aka kamu da su a cikin gida kuma an shawo kan barkewar cutar a kasar Sin.
Bayan watanni biyu da kafa dokar kulle, an sassauta takunkumin hana zirga-zirga zuwa Hubei ban da Wuhan a ranar. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da izinin shiga ga mutanen da ke da biza ko izinin zama daga ranar 28 ga Maris, kuma ba a ba da cikakken bayani game da lokacin da wannan manufar za ta ƙare ba.
Duk wanda ke son shiga kasar Sin dole ne ya nemi biza a ofishin jakadancin kasar Sin ko ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, tare da samar da wani tsari na karfafa kudi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki wacce ta fara da yin shiru na mintuna uku a duk fadin kasar a karfe 10:00 na ranar 4 ga watan Afrilu, ranar da ake bikin Qingming, kodayake gwamnatin tsakiya ta bukaci iyalan da su yi jana'izar kan layi yayin da suke kiyaye nesa ta jiki don kauce wa sabon barkewar COVID-19.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar kiwon lafiya ta kasar ta ba da rahoton wani karuwar lamura a ranar 20 ga watan Fabrairu, wanda ya danganci sabon addinin Daegu, wanda ake kira Shincheonji Church of Judaism.
An yi zargin cewa masu ziyara zuwa haikalin Shinchangji daga Wuhan zuwa Daegu ne tushen barkewar cutar.
A ranar 22 ga Fabrairu, 1,261 daga cikin mabiya 9,336 na Cocin ko kusan 13% sun ba da rahoton alamun cutar.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Har ila yau, an yi tasiri da jadawalin jiragen sama kuma saboda haka an canza su.Koriya ta Kudu ta ƙaddamar da shirin da ake ganin shine mafi girma kuma mafi tsari a duniya don gwada mutane don cutar da kuma ware mutanen da ke da cutar da kuma ganowa da keɓe waɗanda suka taɓa hulɗa da su.
Hanyoyin tantancewa sun hada da sanar da alamun mutum da kansa ga sabbin masu shigowa daga ƙasashen waje ta hanyar aikace-aikacen hannu, gwajin gwaji na cutar wanda sakamakon sa zai kasance a rana mai zuwa, da kuma yawan mutane 20,000 da za a iya gwadawa kowace rana.
An yi la'akari da shirin a Koriya ta Kudu a matsayin nasara wajen hana barkewar cutar ba tare da sanya biranen cikin cikakken killacewa ba.
Yawancin 'yan Koriya sun sanya hannu kan wata takarda mai kira don tuhumar Moon ko kuma suna yaba da martani.
A ranar 23 ga watan Maris, an bayar da rahoton cewa Koriya ta Kudu ta sami mafi karancin adadin masu kamuwa da cutar a rana guda a cikin makonni hudu.
A ranar 29 ga watan Maris, an sanar da cewa duk sabbin mutanen da suka shigo daga kasashen waje za a killace su na tsawon makonni biyu daga ranar 1 ga watan Afrilu.
A ranar 1 ga Afrilu, rahotanni a kafofin watsa labarai sun nuna cewa Koriya ta Kudu ta karbi buƙatun gwajin cutar daga ƙasashe 121.
Iran ta bayar da rahoton sabbin cututtukan farko na SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, inda mutane biyu suka mutu a ranar da ta gabata, a cewar ma'aikatar lafiya da ilimin likitanci.
Matakan farko da gwamnati ta ayyana sun hada da soke kide kide da sauran al'adu da wasanni, da sallar Juma'a da rufe makarantu, cibiyoyin ilimi da jami'o'i.
Iran ta ba da Riyal tiriliyan biyar don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma za a killace mutane ne kawai.
An sanar da shirin takaita zirga-zirga tsakanin biranen a watan Maris, kodayake yawan zirga-zirgar jiragen sama tsakanin biranen ya ci gaba yayin da ake fuskantar sabuwar shekara ta Farisa.
An bude wuraren ibada na Shi'a a Qom har zuwa 16 ga Maris, 2020.
A yayin da ake ikirarin cewa Iran ta rage yawan barkewar cutar, sama da kasashe goma sun gano Iran a matsayin tushen cutarsu a ranar 28 ga watan Fabrairu, wanda ke nuna cewa yawan barkewar cutar ya fi adadin kamuwa da cutar 388 da gwamnatin Iran ta bayar a wannan ranar.
A ranar 3 ga watan Maris, an rufe majalisar dokokin Iran bayan da 23 daga cikin 'yan majalisa 290 suka kamu da cutar.
A ranar 12 ga watan Maris, mai lura da 'yancin dan adam ya yi kira ga jami'an gidan yari na Iran da su saki masu cin zarafin da aka tsare saboda nuna rashin amincewarsu, da kuma sakin duk wadanda suka cancanci.
An ce cibiyoyin da ke da iyaka, kamar gidajen yari, inda ba a samun kulawar likita mai kyau, suna da haɗarin yaduwar cutar.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton cewa mutum 100 ne suka mutu a rana daya, wanda shi ne mafi yawan mutane da suka mutu a kasar tun bayan barkewar cutar.
A kalla 'yan siyasa da jami'an gwamnati 12 na Iran da suka mutu ko kuma suka mutu sun kamu da cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran na da sabbin mutane 50 a kowace awa da kuma mutuwar mutum daya a kowace minti goma sakamakon cutar korona.
A cewar wani jami'in WHO, adadin masu kamuwa da cutar a Iran ya ninka na wadanda aka samu a kasar har sau biyar.
An kuma yi hasashen cewa takunkumin da Amurka ta kakaba wa Iran na iya lalata karfin tattalin arzikin kasar wajen magance cutar.
Babban Kwamishinan Majalisar Dinkin Duniya kan kare hakkin dan adam ya bukaci a dage takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu' yan China a Rome suka gwada SARS-CoV-2 mai kyau.
Lamuran sun fara karuwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa daga China da kuma kafa dokar ta baci a kasar.
A ranar 21 ga Fabrairu, an gano wasu mutane 16 da ke dauke da cutar COVID-19 a Lombardy bayan an tabbatar da cewa an samu wasu mutane da ke dauke da cutar. A ranar 22 ga Fabrairu, majalisar ministocin ta fitar da sabuwar doka game da barkewar cutar, inda ta killace mutane sama da 50,000 daga kananan hukumomi 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce "An samu barkewar cutar a wurare da ba za a ba da izinin shiga da fita ba".
"A kan 4 ga watan Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk fadin kasar saboda adadin mutuwar Italiya ya kai 100".
Duk da cewa an shirya gudanar da manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, a cikin iyakance har zuwa watan Afrilu, a ranar 9 ga Maris, an dakatar da dukkan wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga watan Maris, Firayim Minista ya ba da umarnin rufe kusan dukkanin ayyukan kasuwanci sai dai manyan kantuna da kantin magani. A ranar 6 ga Maris, Kwalejin Anesthesiology, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta ba da shawarwarin manufofin likita game da yarjejeniyar triage wanda za a iya sanyawa.
A ranar 19 ga watan Maris, Italiya ta wuce China a matsayin kasar da ta fi kowacce kasa a duniya fama da cutar coronavirus, inda ta samu mutuwar mutane 3,405.
A ranar 22 ga watan Maris, Rasha ta aika da jiragen sama tara na soji da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an samu karin mutane 128,948 da suka kamu da cutar, mutane 15,887 da suka mutu, da kuma mutane 21,815 da suka warke, wadanda suka fi yawa a yankin Lombardy.
Wani rahoton CNN ya nuna cewa yawan tsofaffi a Italiya da rashin iya yin gwaji ga yawan mutanen da ke dauke da cutar a yau na iya haifar da yawan mutuwar.
A farkon lokacin, Burtaniya ta kasance mafi sassaucin martani ga ƙasashen da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya ƙa'idodin nisantar jama'a ko keɓewar jama'a a kan 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci suka da yawa saboda rashin fahimtar yadda cutar ke da tasiri a kan mutane. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar cewa an hana duk balaguron da ba dole ba, tarurrukan jama'a kuma ya shawarci kowa ya zauna a gida inda zai yiwu kuma ya ba da umarnin kauce wa mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa dole ne a rufe dukkan wuraren shakatawa kamar mashaya da dakunan motsa jiki da wuri-wuri kuma ta yi alkawarin biyan kashi 80% na ma'aikata albashi har zuwa £2,500 a kowane wata don hana rashin aikin yi a wannan lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar da jama'a, ya hana taron mutane sama da biyu, kuma ya takaita tafiya da ayyukan waje kawai ga waɗanda ake ganin suna da matukar muhimmanci.
Ba kamar matakan da suka gabata ba, 'yan sanda ne ke aiwatar da waɗannan matakan, ta hanyar ba da tarurruka da kuma kawar da tarurruka.
"An ba da umarnin rufe yawancin kasuwancin, gami da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai da garages, ban da kasuwancin da aka ɗauka ""muhimmanci"" ne kawai".
A ranar 20 ga Janairu, an tabbatar da sanannen shari'ar COVID-19 a cikin jihar Pacific Northwest ta Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar aikin Coronavirus ta Fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya da kuma sanya takunkumi kan masu yawon bude ido daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a a cikin gwamnatin US, ta sanar da cewa ta samar da kayan gwajin kanta.
Duk da haka, Amurka ta yi gwaji a hankali, wanda ya sa ainihin adadin kamuwa da cutar ya ɓace a lokacin barkewar cutar.
A watan Fabrairu, gwamnatin jihar ta samar da kayan gwaji na gwaji da kuma a ƙarshen Fabrairu, ba a ba da izinin gwamnati ga kayan gwaji na masu zaman kansu (makarantu, kamfanoni da asibitoci) ba, kuma har zuwa farkon Maris, mutane suna da ikon sarrafawa don cancanta don yin gwaji (daga nan sai bukatar umarnin likita).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa akwai kasa da gwaji 4,000 a Amurka.
A ranar 13 ga watan Maris, The Atlantic ta ruwaito cewa an yi gwaji kasa da 14,000.
A ranar 22 ga watan Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Mutane da yawa da ke da umarnin likita da kuma alamun cutar sun jira na tsawon sa'o'i ko kwanaki don gwaji". Bayan an sanar da mutuwar farko a jihar Washington, Amurka a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci a jihar, wani mataki da wasu jihohi suka bi.
A ranar 6 ga watan Maris, 2020, wasu masana ilimin annoba a kwalejin Imperial College London a Amurka sun ba da shawara game da tasirin da kuma tsinkayen sabon coronavirus a kasar.
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Samun Kariyar Shirye-shiryen Kwayar cutar Coronavirus da Amsawa, wanda ya samar da dala biliyan 8.3 na kudaden gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni suna sanya takunkumi kan tafiye-tafiyen ma'aikata, soke taro da karfafa ma'aikata suyi aiki daga gida.
An soke wasanni da wasannin motsa jiki.A ranar 11 ga watan Maris, Trump ya sanya dokar hana zirga-zirga na kwanaki 30 a yawancin Turai banda Burtaniya daga ranar 13 ga Maris.
A rana mai zuwa, ya kara fadada takunkumin zuwa ga Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci a duk fadin kasar, wanda hakan ya haifar da samar da kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga watan Maris, yawancin kasuwancin Amurka sun rufe ko kuma sun rage lokacin aiki don rage saurin yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da cutar a cikin jihohi 50 da gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da shari'o'in coronavirus 10,700, wanda ya fi yawan adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga Maris, Gwamnan ya ce manufofin nisantar da jama'a suna aiki kamar yadda aka rage ƙididdigar ninki biyu daga 2.0 zuwa 4.7 a cikin kwanaki.
A ranar 28 ga Maris, New York City ta kai adadin kamuwa da cutar 32,308 da mutuwar mutane 672 daga cutar. A ranar 26 ga Maris, Amurka ta sami adadin kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya.
A cewar rahotannin kafofin watsa labarai na ranar 30 ga watan Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita umarnin nisantar da jama'a har zuwa ranar 30 ga Afrilu.
A wannan rana, USNS Comfort, wani asibitin asibiti mai gadaje 1,000, ya kafa a New York.
A ranar 3 ga watan Afrilu, an samu mutuwar mutane 884 a Amurka a cikin sa'o'i 24 da suka gabata.
A ranar 3 ga Afrilu, cututtukan sun zarce mutane 100,000 a jihar New York. An soki Fadar White House saboda watsi da wannan alamar rashin jin daɗi da kuma sarrafa saƙon ta hanyar umarnin jami'an kiwon lafiya da masana kimiyya don daidaita maganganun jama'a da wallafe-wallafe game da cutar a ofishin Mataimakin Shugaban Mike Pence.
An tabbatar da amincewar da Trump ya yi da tsarin rikicin da ya hada da jawabin jam'iyyar.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, gami da kayan aikin likita masu mahimmanci.
An yi amfani da nazarin tsarin zirga-zirgar jiragen sama don tsarawa da kuma hango alamun yaduwar cututtuka kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bangkok, Hong Kong, Tokyo da Taipei sun fi yawan matafiya daga Wuhan, bisa ga bayanan 2018 daga Transportungiyar Sufurin Jiragen Sama ta Duniya.
Dubai, Sydney da Melbourne suma sun zama sanannun wuraren da masu yawon bude ido daga Wuhan suka ziyarta.
Bali ta kasance mafi ƙarancin iyawa a cikin biranen 20 da aka fi sani da biranen da aka fi sani da biranen Australiya, yayin da biranen Australiya suka kasance mafi ƙarancin iyawa.
An bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19 kuma Ostiraliya za ta ba da fifiko ga kula da kan iyakoki da hanyoyin sadarwa a cikin amsar cutar.
A ranar 21 ga watan Maris, an ayyana gaggawa ta lafiyar dan adam a Ostiraliya.
Saboda dokar killace zirga-zirgar jama'a a Wuhan da Hubei, da farko tare da izinin hukumomin kasar Sin, kasashe da dama sun shirya kwashe 'yan kasarsu da ma'aikatan diflomasiyyarsu daga yankin ta jiragen sama da aka yi haya a cikin kasashensu.
Kasashen farko da suka fara shirin dawo da 'yan kasarsu sune Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand.
Pakistan ta ce ba za ta kwashe wani dan kasar ta daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu, ban da wasu 'yan Poland hudu, da wani dan kasar Sin da kuma wani dan kasar Indiya.
Mazauna Poland, China da Indiya sun sauka a Poland inda jirgin na Brazil ya yi ta tsayawa kafin ya tashi zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a sansanin soja kusa da Brasilia.
A wannan rana, an ceto 'yan Kanada 215 (mutum 176 daga jirgin farko da 39 daga jirgin biyu da gwamnatin Amurka ta ba da izini) daga Wuhan zuwa CFB Trenton kuma an kebe su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin saman Kanada mai fasinjoji 185 ya sauka a CFB Trenton daga Wuhan.
Hukumomin Australiya sun ceto 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu kuma suka sanya su a Cibiyar Kula da Tsibirin Kirsimeti, wanda aka yi amfani da shi don sabon manufar matsayin wurin keɓewa, kuma sun kasance a can na kwanaki 14.
Jirgin sama na ƙaura daga New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da wasu daga Australia da Pacific) a wani sansanin jiragen ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Princess Proud.
A ranar 21 ga watan Fabrairu, wani jirgin fasinja dauke da 'yan Kanada 129 ya tashi daga Diamond Princess zuwa Trenton, Ontario.
A farkon watan Maris, Gwamnatin Indiya ta fara dawo da 'yan kasar Indiya daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways wanda Gwamnatin Afirka ta Kudu ta karba ya dawo da' yan Afirka ta Kudu 112.
An yi gwajin likita kafin tashi kuma an bar mutane hudu daga Afirka ta Kudu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin cutar da ba su da lafiya, an sallame su.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu da suka shiga cikin ayyukan jin kai, ciki har da ma'aikatan jirgin sama, direbobi, ma'aikatan otal,' yan sanda da sojoji, ba su da wata damuwa kuma an killace sauran a cikin hutun ranch don kwanaki 14 a matsayin matakin kariya.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iran saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi ga kasar Sin.
Wasu daliban kasar Sin sun taru a Jami'ar Amurka don aika taimako zuwa wuraren da cutar ta addabi kasar Sin. Tare da su, wata kungiya daga yankin Chicago ta tura mashin N95 50,000 zuwa asibitoci a yankin Hubei a ranar 30 ga Janairu. Kungiyar agajin jin kai ta hadin gwiwa tare da Direct Relief FedEx ta aika da mashin fuska 200,000 da sauran kayan kariya na sirri, gami da safar hannu, riguna zuwa asibitin Union na Wuhan a ranar 30 ga Janairu ta hanyar jirgin gaggawa.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da kokarin magance cutar, tare da kare "mutane masu rauni a Afirka da Kudancin Asiya".
Interaction ta bayyana cewa gwamnatin kasar Sin ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga watan Fabrairu, bayan da Sanata Richard Gordon ya kai masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin da ya kai dala miliyan 2.26 ga kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu na likitanci miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya daban-daban, gami da kayan aikin hawan 10,000, kuma Amurka ta ba da tan 17.8 na kayayyakin kiwon lafiya ga China kuma ta yi alkawarin karin dala miliyan 100 na tallafin kudi ga kasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya wajen magance cutar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa, Habasha, da abin rufe fuska miliyan 6, da kayan kariya 60,000 don rarraba wa Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5 zuwa Panama.
Ma kuma ta samar da kayayyakin kiwon lafiya a Kanada, ta nuna shakku kan abin da ake kira masks da kayan gwaji da aka yi daga Netherlands, Spain, Turkey, Georgia da Czech Republic.
Misali, Spain ta dawo da kayan gwajin coronavirus 58,000 da aka yi a China tare da ƙimar daidaito na 30% kawai, yayin da Netherlands ta dawo da masks na fuska 600,000 na Sinawa, waɗanda ke da lahani.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, waɗanda aka ɗauka sun fito ne daga China, amma a zahiri sun fito ne daga Colombia.
A wani bangare kuma, an yi maraba da manufofin kasar Sin a sassan Latin Amurka da Afirka.
Hukumar lafiya ta duniya ta yaba wa kokarin da jami'an kasar Sin ke yi na dakile da kuma kula da annobar.
WHO ta nuna bambanci tsakanin barkewar cutar SARS a 2002/2004 inda aka zargi hukumomin kasar Sin da yin sirri wanda ya kawo cikas ga kokarin hanawa da sarrafawa, da kuma rikicin yanzu, inda gwamnatin tsakiya ke ba da sabuntawa akai-akai don kauce wa fargaba kafin hutun sabuwar shekara ta Lunar.
"A ranar 23 ga watan Janairu, wakilin WHO, Gordon Gally, ya yi sharhi game da shawarar da hukumomin tsakiya suka yanke na aiwatar da takunkumin hana zirga-zirga a Wuhan cewa ""WHO ba ta ba da shawarar hakan ba"", kuma wannan ""alamu ne masu mahimmanci na ƙaddamar da yunƙurin hana annobar duniya a inda ta fi yawa, inda ta fi yawaita", kuma ta kira shi ""ba a taɓa gani ba a tarihin lafiyar jama'a"". A ranar 30 ga Janairu, bayan tabbatar da kamuwa da cutar daga mutum zuwa mutum a wajen China da kuma karuwar adadin masu kamuwa da cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin gagarumar matsalar lafiyar jama'a ta Duniya (Public Health Emergency of International Concern, PICHE), wanda shine karo na shida tun lokacin da WHO ta sanar da annobar duniya ta PICHE a lokacin annobar murar alade a shekarar 2009".
"Darakta Janar na WHO ya ce PHEIC ya faru ne saboda ""yanayin yaduwar duniya ya fi girma a ƙasashe masu karamin karfi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya".
"A cikin martani game da aiwatar da takunkumin tafiye-tafiye, Tedros ya ce ""babu wani dalili da zai sa a dauki matakan da za su tsoma baki ba tare da bukatar tafiya da kasuwanci ba"" kuma ya kara da cewa ""WHO ba ta bayar da shawarar takaita kasuwanci da motsi ba"."
A ranar 5 ga watan Fabrairu, WHO ta nemi al'ummar duniya da su bayar da tallafin dala miliyan 675 don shirye-shiryen dabaru a kasashe masu karamin karfi, tare da bayar da agajin gaggawa ga kasashen da ba su da wata hanyar sanin ko su waye ke da cutar a yankunansu, koda kuwa an kashe su.
"Tedros ya kuma bayyana cewa ""mu ne kamar yadda karfi kamar yadda mafi rauni source"" da kuma kira ga kasashen duniya ""don zuba jari a yau ko biya more daga baya"". WHO ya gabatar da sunan cutar a matsayin COVID-19 a wani taron manema labarai a ranar 11 ga Fabrairu".
"A ranar, Tedros ya sanar da cewa Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da "ba da ƙarfin ga dukkan tsarin Majalisar Dinkin Duniya a matsayin martani".
"A sakamakon haka an kunna kungiyar kula da rikicin Majalisar Dinkin Duniya, wanda ya ba da damar daidaita martani na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan martani na kiwon lafiya, yayin da sauran hukumomin ke iya amfani da kwarewarsu don magance tasirin zamantakewa, tattalin arziki da ci gaban ci gaban cutar".
A ranar 14 ga watan Fabrairu, kungiyar WHO ta hada kai da kasar Sin don kawo kwararru na kasa da kasa da WHO zuwa kasar Sin don taimakawa wajen kula da gida da kuma tantance tsananin cutar da kuma iyawar ta ta hanyar bita da tarurruka tare da manyan hukumomin kasa da kasa da kuma tafiya zuwa wurare masu dacewa don tantance tasirin da kuma martani ga ayyukan a matakin lardi da na lardi, gami da birane da yankuna.A ranar 25 ga Fabrairu, WHO ta sanar da cewa duniya tana shirin kara shirya don wannan annobar cutar coronavirus, inda ta ce duk da cewa ba a ayyana ta a matsayin annoba ba, ya kamata a kasance a matakin shirye-shirye na kasashe.
"A sakamakon karuwar barkewar cutar a Iran, WHO ta tura wani hadin gwiwa don tantance halin da ake ciki a can. A ranar 28 ga Fabrairu, WHO ta bayyana a hukumance cewa za a kara darajar hadarin coronavirus a duniya daga ""mai girma"" zuwa ""mai matukar girma"", wanda shine matakin da ya fi dacewa da faɗakarwa da kimantawa".
"Darakta na zartarwa na shirin gaggawa na lafiya na WHO Mike Ryan ya yi gargadin a cikin wata sanarwa cewa ""wannan gwaji ne na gaske ga kowace gwamnati a duniya: farkawa".
"Wannan kwayar cutar na iya kasancewa a kusa kuma dole ne ku kasance cikin shiri", "Magana mai kyau na iya taimakawa duniya kauce wa mafi munin yanayin".
"Ryan ya ci gaba da cewa bayanan da ake da su yanzu ba su ba da hujjojin da jami'an kiwon lafiya ke bukata don ayyana cutar a matsayin annoba ba, kuma ya ce irin wannan sanarwar na nufin ""Mun yarda cewa kowa a duniya zai kamu da cutar""".
A ranar 11 ga watan Maris ne WHO ta ayyana cutar coronavirus a matsayin annoba.
"Darakta mai gudanarwa ya ce WHO tana da matukar damuwa game da "damuwa game da yaduwar cutar da kuma rashin lafiyarta. WHO ta fuskanci zargi mai yawa saboda rashin kula da cutar, gami da jinkirin ayyana gaggawa na lafiyar jama'a da kuma jinkirin rarraba kwayar cutar a matsayin annoba".
Sakamakon rashin jin daɗi ya haɗa da takarda mai neman murabus daga Darakta-Janar na WHO, Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, wasu masana kan kare hakkin bil adama na Majalisar Dinkin Duniya sun yi bayani kan girmama hakkin kowa a lokacin COVID-19.
Kungiyar kwararru ta ce kowa na da hakkin yin ayyukan ceto rayuka kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba zai taba zama hujja ba don nuna bambanci ga wasu kungiyoyi.
Masana sun jaddada cewa nakasassu, 'yan tsiraru, tsofaffi, marasa gida, marasa gida, wadanda ke rayuwa cikin talauci, wadanda ke cikin kurkuku, 'yan gudun hijira da sauran kungiyoyin da ba a kula da su ba wadanda ke bukatar taimakon gwamnati, duk suna da hakkin samun lafiya.
Hukumomin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwa kan tattalin arziki da ci gaba ta kafa wani dandali don samar da bayanai masu dacewa da kuma cikakkun bayanai kan martani na manufofi a kasashe a duniya, tare da samar da hangen nesa da shawarwari.
Tattalin Arzikin Duniya ya ƙunshi bin diddigin manufofin ƙasa don magance tasirin ƙaura daga ƙa'idodin ƙarfafa tsarin kiwon lafiya zuwa tafiye-tafiye, ƙuntatawa na cibiyar dijital da kulle kulle, kuma yana da nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe haɗin kai a duniya don amsa ƙalubalen coronavirus.
Gwamnatin Amurka, Ministan Ofishin Ministocin Burtaniya Michael Gove da dan Shugaba Jair Bolsonaro na Brazil, Eduardo Bolsonaro, sun soki gwamnatin China kan yadda ta magance cutar, wacce ta fara ne a yankin Hubei na kasar Sin.
An kori wasu jami'an kwaminisanci na kasar Sin (CPC) da dama daga aiki saboda kokarin da suka yi na killace mutane a yankin tsakiyar kasar Sin, wanda hakan ya nuna rashin jin dadin kungiyoyin siyasa da ke mayar da hankali kan barkewar cutar a wadannan yankuna.
Wasu masu sukar kasar sun ce an dauki matakin ne domin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin da jama'a ke nunawa game da annobar korona.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun musanta cewa an fara bullar cutar a Wuhan ne bayan da aka yi jita-jita game da cutar COVID-19 da ta samo asali daga Amurka ko Italiya.
"Gwamnatin Donald Trump ta Amurka ta kira coronavirus da ""Cinema ta Sin"" ko ""Cutar Wuhan"" ta ce, "Yanayin da China ke ciki na sanya cutar ta zama babbar cuta a duniya", wanda wasu masu sukar suka yi ta sukar wariyar launin fata da kuma "kokarin karkatar da hankali daga gazawar gwamnatin ta wajen dakile cutar".
"The Daily Beast ta yi magana game da yadda gwamnatin Amurka ke gudanar da ayyukanta, ta bayyana dabarun sadarwa tare da majiyoyi masu tushe a Majalisar Tsaro ta Kasa, inda aka ambaci dabarun a matsayin ""duk game da China".
"An umarce mu da mu yi kokarin yada wannan sakon ta duk wata hanya da za mu iya, ciki har da taron manema labarai da kuma nunawa a talabijin. ""Kasuwanci kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na tura tallafi ga kasashen da ke fama da cutar na daga cikin yakin neman tasirin duniya".
"Joseph Borel, shugaban harkokin wajen Tarayyar Turai, ya yi gargadin cewa akwai wani bangare na siyasa da ya hada da "kirkirar labarai da kuma gwagwarmayar samun tasiri ta hanyar 'siyasa ta sassaucin ra'ayi'".
"Borrell ya kara da cewa, ""China tana nuna karfi wajen tura sakon cewa, sabanin Amurka, ita abokiyar zama ce mai dogaro da dogaro da ita"."
China ta nemi Amurka ta dakatar da bayar da tallafi ga kasashen Syria, Venezuela da Iran, bayan da aka samu rahotanni cewa ita kanta tana aikawa da tallafi ga wadannan kasashen biyu.
An dakatar da tallafin Jack Ma na masks 100,000 zuwa Cuba a ranar 3 ga Afrilu a karkashin takunkumin Amurka.
An zargi hukumomin Amurka da amfani da taimakon da suka bayar ga wasu kasashe don amfanin kasarsu.
An samu sabani kan sanya takunkumin rufe fuska a Jamus da Austria da Switzerland da wasu kasashe kamar Czech Republic da Italiya.
Turkiyya ta kuma kwace wasu daruruwan na'urorin numfashi da aka sanya wa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki su saboda rashin hadin kan Tarayyar Turai game da Italiya da ke fama da cutar coronavirus.
Maurizio Massari, jakadan Italiya a Tarayyar Turai ya ce "China ce kadai ta mayar da martani ta bangarorin biyu".
"Wannan ba kyakkyawan alama ba ne ga hadin kan Turai".
A ranar 22 ga watan Maris, bayan tattaunawa ta wayar tarho da Firaministan Italiya Giuseppe Conte, Shugaba Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, motocin kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
"A cikin jaridar La Stampa ta Italiya, wani "babban majiyar siyasa" da ba a bayyana sunansa ya ce kashi 80 cikin dari na taimakon Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
"Wadannan majiyoyin sun zargi Rasha da yin wani yunkuri na "farfado da yanayin ƙasa da siyasa da diflomasiyya".
Shugaban yankin Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi De Mayo sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin sama mai dauke da kayayyakin kiwon lafiya zuwa Amurka.
"Dimitry Peskov, mai magana da yawun Kremlin ya ce, ""Idan ya zo ga taimaka wa abokan aikinsa na Amurka, [Putin] yana tunanin cewa idan masana'antun kayan aikin likitancin Amurka suka sami wasu matakai, za su iya ba da gudummawa"."
"An shirya atisayen sojin NATO ""Defender 2020"" a Jamus, Poland da Baltic, wanda shine mafi girman atisayen NATO tun bayan ƙarshen Cold War, za a yi su a cikin ƙananan girma".
"Sakataren Janar na Kamfen na Yaki da Makaman Nukiliya Kate Hudson ya soki atisayen Defender 2020: ""A cikin rikicin kiwon lafiyar jama'a na yanzu, ba wai kawai zai yi barazanar rayuwar sojojin Amurka da sauran kasashen Turai da ke halartar ba, har ma da rayukan mazauna kasashen da suke iko da su. "" Gwamnatin Iran ta yi fama da cutar sosai, tare da wasu 'yan majalisa biyu da suka kamu da cutar da kuma wasu manyan jami'ai goma sha biyu da ke aiki a yanzu ko kuma tsoffin jami'ai".
Shugaban Iran Hassan Rouhani ya rubuta wata wasika a ranar 14 ga watan Maris, 2020 ga shugabannin duniya don neman taimako, inda ya ce takunkumin da Amurka ta sanya wa Iran yana sanya musu wahala wajen yaki da barkewar cutar saboda kasarsa ba ta da damar shiga kasuwannin duniya.
Masu sharhi kan siyasa sun yi hasashen cewa hakan na iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020.
"Bayan da Japan ta sanar da cewa duk wanda ya isa daga Koriya ta Kudu zai kasance a keɓe shi a cikin makonni biyu a wuraren da gwamnati ta tsara, Koriya ta Kudu ta soki Japan saboda "ƙoƙarin keɓewa mara kyau da rashin aiki".
A farkon lokacin, al'ummar Koriya ta Kudu sun kasance a kan wasu hanyoyi daban-daban game da yadda Shugaba Moon-ja-in ya amsa rikicin.
Da yawa daga cikin 'yan Koriya sun sanya hannu kan takardar neman a kori Moon, suna mai cewa gwamnati ta yi mummunan aiki da barkewar cutar, yayin da wasu kuma suka sanya hannu kan takardar neman karbar bakuncin ta.
Wasu masu sharhi sun nuna damuwa cewa hakan zai ba gwamnati damar karfafa karfinta kan iko.
A Hungary, majalisar dokokin ta baiwa Firayim Minista Viktor Orban ikon yin mulki ba tare da wani wa'adi ba, dakatar da majalisar ko gudanar da zaben, da kuma hukunta masu daraja da ke yada labaran karya game da yadda cutar ke yaduwa da kuma yadda gwamnati ke magance rikicin.
An danganta barkewar cutar coronavirus da karancin kayayyaki, karuwar amfani da kayan aikin yaki da cutar a duniya, haifar da fargaba da kuma katse ayyukan masana'antu da kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargaɗi game da karancin magunguna da kayan aikin likita saboda karuwar buƙatun masu siye da katsewar masu samarwa.
A wasu yankuna ma, ana ta yin sayayya saboda fargaba, wanda ya sa mutane suka sayi kayan masarufi masu mahimmanci kamar abinci, takarda na bayan gida da ruwa mai kwalba, wanda hakan ya haifar da karancin kayayyaki.
Musamman masana'antar fasaha sun yi gargadi game da jinkirin aika kayayyakin lantarki.
A cewar Darakta Janar na WHO, Tedros Adhanom, bukatar kayan kariya na mutum ya karu sau 100.
Wannan bukatar ta kara farashin kayayyaki sau 20 kuma ta haifar da jinkirin watanni shida a cikin samar da kayayyakin kiwon lafiya.
Wannan ya haifar da karancin kayan kariya na mutum a duk duniya, kuma WHO ta yi gargadin cewa zai sanya ma'aikatan lafiya cikin hadari.
Cutar ta barke a Ostiraliya ta ba da sabuwar dama ga masu siyar da kayayyaki na Australiya don siyar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin abinci a wasu manyan kantunan abinci kuma daga baya gwamnatin Australiya ta sanya dokar hana shi. Duk da yaduwar cututtukan COVID-19 a arewacin Italiya da Wuhan, tabbatar da tsananin bukatar kayan abinci, yankuna biyu sun ci gaba da kiyaye kansu daga karancin abinci a cikin mawuyacin hali.
Matakan da China da Italiya suka dauka na hana cinikin kayayyaki da kuma cinikin da ba a yarda da shi ba sun yi nasara, wanda hakan ya hana karancin abinci da ake tsammani a Arewacin Amurka da Turai.
Ko da yake ba a sami raguwar kayayyakin gona a arewacin Italiya ba, masana'antun masana'antu sun ce farashin zai iya tashi.
A lokacin da jami'an gwamnatin kasar Sin suka saki naman alade da aka adana don ciyar da jama'a, har ma a Wuhan, sun fara fuskantar rafin abinci mara amfani.
A Italiya, akwai irin wannan dokar ta kasa da ke bukatar masu samar da abinci su ajiye kayan abinci don irin wannan gaggawa.
An ji rauni a tattalin arzikin duniya a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020, kuma tallace-tallace na tallace-tallace ya ragu da kashi 20.5%, saboda matakan da gwamnati ta dauka don rage yaduwar kwayar cutar.
Tun da yake babban yankin kasar Sin yana taka muhimmiyar rawa a matsayin cibiyar tattalin arziki da masana'antu, barkewar cutar ta yi barazanar haifar da babban tashin hankali ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ta yi hasashen cewa kasuwanni za su ci gaba da yin canji har sai an bayyana wani hoto mai kyau game da yiwuwar sakamakon.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa bala'in tattalin arziki da cutar ta haifar a duniya zai iya wuce barkewar SARS na 2002-2004.
Wani kwararre a Jami'ar Washington da ke St. Louis ya kiyasta cewa an yi asarar dala biliyan 300 a sarkar samar da kayayyaki a duniya wanda zai iya wucewa har zuwa shekaru biyu.
"An ce kungiyar kasashen dake fitar da man fetur (OPEC) ta "karye" bayan da farashin man fetur ya fadi kasa sakamakon karancin bukatar da kasar Sin ke yi".
Kasuwancin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin COVID-19 a wajen China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, yawancin alamun hannun jari na Amurka, gami da NASDAQ-100, S&P 500 Index da Dow Jones Industrial Average sun buga ragin da suka fi kaiwa tun 2008, tare da Dow ya faɗi da maki 1,191 wanda shine mafi girman ragin rana ɗaya tun lokacin rikicin kuɗi na 200708.
Dukkanin alamomin uku sun tashi sama da kashi 10 cikin dari a karshen mako.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta tabbatar da darajar darajar kasar Sin, amma ta ci gaba da nuna mummunan hangen nesa.
Kasuwar hannayen jari ta sake faduwa saboda tsoron cutar coronavirus, inda ta sami koma baya a ranar 16 ga Maris.
Mutane da yawa suna tunanin yiwuwar koma bayan tattalin arziki.
Masanin tattalin arziki Muhammad El-Erian ya yaba da Bankin Tsakiya da kuma matakan gaggawa na jihar.
Babban bankuna na fuskantar matsalar kudi da sauri fiye da yadda suka yi a rikicin 2008.
Yawon shakatawa yana daya daga cikin bangarorin da suka fi fama da matsalar saboda haramcin yawon bude ido, da kuma haramcin da gwamnati ta sanya kan duk wuraren da ke da yawan jama'a da kuma duk wata tafiya a duniya.
Sakamakon haka, kamfanonin jiragen sama da dama ciki har da British Airways, China Eastern Airlines da Qantas sun soke zirga-zirgar jiragen sama saboda karancin bukatar, yayin da kamfanin jirgin sama na Flybe na yankin Burtaniya ya fadi.
Ba a taɓa ganin irin mummunan tasirin da ke faruwa a masana'antar ba.
An rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Babban lokacin yawon shakatawa a kasar Sin, Chunyun, ya fara ne a lokacin hutun Sabuwar Shekarar Sin, lokacin da annobar ta fara a kasar Sin.
Gwamnatocin ƙasa da na yanki sun rufe abubuwan da ke iya haifar da taron jama'a kamar bikin Sabuwar Shekara na shekara-shekara da sauransu. Kamfanoni masu zaman kansu ma suna rufe shagunan su da kansu kuma sun rufe wuraren shakatawa da yawa kamar Disneyland a Hong Kong da Shanghai Disneyland.
An dakatar da bukukuwan Sabuwar Shekara da kuma taron masu yawon bude ido a wasu wurare da dama, ciki har da bikin haramtaccen birni da kuma bikin haikalin gargajiya a Beijing don hana taron jama'a.
Jami'ai a larduna 24, gundumomi da yankuna 31 na kasar Sin sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, kuma sun ba da umarnin kada a sake bude yawancin wuraren aiki har zuwa wannan ranar.
Waɗannan yankuna suna wakiltar kashi 80% na GDP na ƙasar da kashi 90% na fitarwa.
Hong Kong ta kara girman matakanta na kamuwa da cuta kuma ta ayyana dokar ta baci, rufe makarantu har zuwa watan Maris da kuma soke bikin bikin sabuwar shekara.
Ziyarar shaguna a Turai da Latin Amurka ta ragu da kashi 40 cikin dari.
Masu sayar da kayayyaki a Arewacin Amurka da Gabas ta Tsakiya sun fadi da kashi 50 zuwa 60 cikin dari.
Sakamakon haka, yawan masu siye a cibiyoyin kasuwanci ya ragu da kashi 33-43% a watan Maris idan aka kwatanta da watan Fabrairu.
Manajan cibiyoyin kasuwancin duniya sun sanya ƙarin matakan, kamar haɓaka kiwon lafiya, sanya na'urorin daukar hotan takardu don bincika zafin jiki na masu siye, da soke abubuwan da suka faru. A cewar ƙididdigar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan da annobar ta haifar na iya jefa mutane miliyan 14 zuwa 22 cikin matsanancin talauci a Latin Amurka fiye da yadda za su kasance ba tare da annobar ta duniya ba.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta kai wani matsayi mai tsanani a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin kusan ma'aikatan ƙaura na karkara miliyan 300 na China sun sami kansu cikin rashin taimako a gida a cikin yankuna ko kuma sun makale a lardin Hubei. Fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati a watan Maris na 2020.
A cewar wani bincike da aka yi da Bankin Tsaro na St. Louis, cutar coronavirus na iya sa mutane miliyan 47 a Amurka rasa ayyukansu, kuma yawan rashin aikin yi zai iya kaiwa kashi 32%. A Indiya, an rufe miliyoyin ma'aikatan baƙi na Indiya (waɗanda ake biyan albashi / albashi a kowace rana).
A cikin rabin rabin watan Maris, ma'aikata Faransa miliyan 4 sun nemi fa'idodin rashin aikin yi na wucin gadi, kuma ma'aikata Burtaniya miliyan 1 sun nemi shirin bashi na duniya.Kusan kamfanoni miliyan rabin a Jamus sun tura ma'aikatansu zuwa gajerun ayyukan da gwamnati ke tallafawa, wanda aka sani da Kurtzarbeits.
Faransa da Birtaniya sun karɓi shirin biyan diyya na ɗan gajeren lokaci na Jamus.
Sashen wasan kwaikwayo da al'adun gargajiya sun sha wahala sosai sakamakon annobar, wanda ya shafi ayyukan kamfanoni da mutane - ma'aikata da masu zaman kansu - a duk duniya.
Cibiyoyin fasaha da al'adu sun yi ƙoƙarin ci gaba da aikinsu (wanda galibi ana tallafawa da gwamnati) don ba da damar samun damar al'adun gargajiya a cikin al'umma, don kiyaye lafiyar ma'aikatansu da jama'a, da kuma tallafawa masu fasaha a duk inda zai yiwu.
A cikin watan Maris na 2020, a duk duniya da kuma a wasu wurare, gidajen tarihi, dakunan karatu, gidajen wasan kwaikwayo da sauran cibiyoyin al'adu sun rufe har abada, tare da soke ko jinkirta nunin su, abubuwan da suka faru da kuma wasan kwaikwayon.
Wani sakamako na kwanan nan da kuma saurin cutar shine soke ayyukan addini, manyan abubuwan wasanni da sauran abubuwan zamantakewa kamar bukukuwa da kide kide, taro kan fasaha da kuma nunin kayan kwalliya.
A cikin watan Nuwamba, Vatican ta soke bikin mako mai tsarki a Roma a makon ƙarshe na lokacin azumin Kirista.
Da yawa daga cikin majami'un sujada sun shawarci tsofaffi Kiristoci su zauna a gida maimakon zuwa a ranar Lahadi; wasu majami'u sun samar da ayyukan coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin, wasu kuma suna gudanar da ibada ba tare da sauka daga mota ba.
Tare da rufe majami'u da ɗakunan ibada da kuma yin aikin hajji na Kirista a St. Peter's Square da Roman Katolika Diocese na Roma ya yi, sauran majami'u na addini sun soke ayyuka kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, temples da chapels.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma daga baya an rufe wuraren ibada, kuma Saudiyya ta hana baƙi masu bautar waje shiga wuraren tsarki na Makka da Madina, da kuma mazauna ƙasar.
Wannan annoba ta haifar da babbar matsala a kalandar wasanni ta duniya tun bayan yakin duniya na biyu.
Yawancin manyan wasannin wasanni, gami da gasar zakarun Turai ta 2019-20, gasar Premier ta 2019-20, UEFA Euro 2020, kakar NBA ta 2019-20 da kakar NHL ta 2019-20, an soke ko an dakatar da su.
"Wannan barkewar ta lalata shirin gasar Olympics ta bazara ta 2020, wacce aka shirya fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar ranar 24 ga Maris cewa taron zai faru ne "ba bayan bazara na 2021 ba, kodayake an sake tsara shi zuwa wani kwanan wata bayan 2020".
Rahotanni na karuwar sabbin rajista a shafukan caca sun nuna cewa wannan ya sa yawancin masu caca suka koma kan layi.
Wasu manyan gidajen wasan kwaikwayo kamar waɗanda ke Broadway sun soke duk wasan kwaikwayon.
"Wasu masu fasaha sun ci gaba da yin zane da raba fasaha ta hanyar Intanet a matsayin madadin al'adun gargajiya, kamar watsa shirye-shiryen raye-raye na kide-kide ko ƙirƙirar ""bikin"" na yanar gizo, don masu fasaha su iya yin, rarraba da kuma inganta ayyukansu".
A yanar gizo, wutar ta bazu a cikin abubuwan da ke tattare da cutar coronavirus wanda ke da ban dariya da kuma janye hankali daga wannan lokacin rashin tabbas.
Tun bayan barkewar COVID-19, an sami karuwar nuna bambanci, tsoron baƙi da nuna wariyar launin fata ga mutanen asalin Sinawa da na Gabashin Asiya, da kuma mutanen da ke cikin wuraren zafi a Turai, Amurka da sauran ƙasashe.
A wasu ƙasashe, musamman a Turai, Gabashin Asiya, Arewacin Amirka da kuma yankin Asiya-Fasifik, an sami tsoro, shakka da ƙiyayya.
Rahotanni na shari'o'in da aka samu tun watan Fabrairu sun nuna cewa akwai wasu kungiyoyin 'yan kasar Sin a duniya da ke nuna nuna kyamar launin fata, suna cewa sun cancanci kamuwa da cutar ko kuma abin da ake yi musu a matsayin ramuwar gayya.
A wasu kasashen Afirka ma, an samu karuwar nuna adawa da kasar Sin.
Mutane da yawa mazauna Wuhan da Hubei sun ce an nuna musu wariya bisa asalin yankin.
Akwai goyon baya ga Sinawa a kan layi da wajen layi, da kuma goyon baya ga mutanen da ke yankunan da cutar ta shafa.
Mutane a Italiya, waɗanda suka fara fuskantar mummunan kwarewar barkewar cutar COVID-19 a matsayin ƙasa ta farko a Turai, na iya fuskantar shakku da fargaba yayin da barkewar cutar ke ci gaba a cikin sabbin ƙasashe masu zafi. 'Yan ƙasa daga ƙasashe ciki har da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takarda kai don yin la'akari da hana Sinawa shiga ƙasarsu a ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseKingJapan ba zai zo ba ya shahara sosai.
Ana samun karuwar hare-haren wariyar launin fata da ake kaiwa Sinawa da sauran 'yan Asiya a Burtaniya da Amurka.
"Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton coronavirus a matsayin ""Cinema virus"", saboda masu sukar sun dauki wannan kalmar a matsayin wariyar launin fata da kuma adawa da kasar Sin".
Masu zanga-zangar Ukraine sun kai hari kan bas din da ke dauke da mazauna Ukraine da fasinjojin da ke zuwa kasashen waje daga Wuhan zuwa Nabi Sanzhari.
An bayar da rahoton cewa daliban da ke Arewa maso Gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya sun sami matsala da ke tattare da cutar coronavirus.
"Shugaban jam'iyyar Bharatiya Janata Party na jihar West Bengal, Dilip Ghosh ya ce Sinawa sun lalata yanayi kuma ""saboda haka Allah ya rama musu"."
Ofishin jakadancin kasar Sin da ke Kolkata ya soki wannan furucin a Kolkata, yana mai cewa "ba daidai ba ne".Kwantar da hankali da nuna kyamar launin fata ga mutanen da ba 'yan asalin kasar Sin ba a kasar Sin sun karu a lokacin annobar.
Akwai wasu jaridu da suka cire wasu ko kuma duka labaran da suka shafi cutar coronavirus, ciki har da Paywall.
Yawancin wallafe-wallafen da aka ƙayyade sun samar da wallafe-wallafen kimiyya da suka danganci fashewa wanda ke samuwa a cikin budewa.
Wasu masana kimiyya suna son buga sakamakon su da sauri a wasu sabbin sabobin kamar Bioroxive.
Cutar cututtuka mai tasowa  Cutar cututtuka mai tasowa, wanda sau da yawa sabon abu ne ko sabon abu a cikin yanayin cutar ko yanayin kamuwa da cuta
Duniya da Cututtuka - Taƙaitaccen Bayani Game da Duniya da Cututtuka
Jerin cututtuka da cututtuka  Jerin yawan mutuwar cututtuka
Cinikin namun daji da Junos  Hadarin kiwon lafiya da ke tattare da cinikin namun daji na kasashen waje
Gwajin dakin gwaje-gwaje don cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma SARS-CoV-2 mai alaƙa da ita ya haɗa da hanyoyin da ke gano kasancewar kwayar cutar da kuma gano ƙwayoyin cuta da aka samar don amsawa ga kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Gwajin yana da ƙayyadaddun kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cutar da ta faru kwanan nan ko kuma mai aiki.
Ana iya amfani da ganowar kwayar cutar don tantancewa da lura da jama'a.
Gwaje-gwajen rigakafi sun nuna yawan mutanen da suka kamu da cutar, ciki har da mutanen da ba su da alamun bayyanar cututtuka ko kuma ba su da alamun bayyanar cututtuka.
Sakamakon gwajin zai iya tantance ainihin mutuwar cutar da kuma rigakafin garken a cikin jama'a.
Saboda karancin gwaji, babu wata kasa da ta samu tabbataccen bayani game da barkewar cutar a cikin al'ummarta har zuwa watan Maris na 2020.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma akwai bambance-bambance sosai a yawan gwajin da aka yi a ƙasashe.
Wannan bambancin na iya yin tasiri sosai ga yawan mutuwar da aka ruwaito, wanda a wasu ƙasashe ana iya ƙididdige shi sosai.
Ana iya gwada samfurori na numfashi da aka samo ta hanyoyi daban-daban, gami da swabs na nasopharyngeal ko samfurin leɓen, ta amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR).
Sakamakon yana samuwa a cikin sa'o'i kadan zuwa kwanaki biyu.
Gwajin RT-PCR tare da swabs na makogwaro yana da tabbaci ne kawai a farkon makon cutar.
Daga baya, kwayar cutar za ta iya ɓacewa daga makogwaro, amma za ta iya ci gaba da ƙaruwa a cikin huhu.
A cikin mutane masu kamuwa da cutar da aka gwada a mako na biyu, in ba haka ba ana iya ɗaukar samfurin daga zurfin cikin iska ta hanyar bututun tsotsa, ko kuma amfani da kayan da aka fitar da tari.
An shirya ɗayan gwajin PCR na farko a cikin Janairu 2020 a Charité, Berlin, ta amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR), kuma ya zama tushen kayan aiki 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Kasar Ingila ta kuma samar da gwaji a ranar 23 ga Janairun 2020. Kamfanin Kogenbiotech na Koriya ta Kudu ya samar da kayan aikin gano SARS-CoV-2 na PCR-based (PowerChek Coronavirus) a ranar 28 ga Janairun 2020.
"Ya gano kwayar halitta ta ""E"" da ke cikin dukkanin beta coronaviruses da kuma kwayar halitta ta RdRp da ke nuna SARS-CoV-2. BGI Group a China na daya daga cikin kamfanoni na farko da suka sami izinin gaggawa na amfani da kayan aikin gano SARS-CoV-2 na PCR daga Hukumar Kula da Kayayyakin Kiwon Lafiyar Kasa ta kasar Sin. Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) a Amurka suna rarraba kwamiti na RT-PCR na ainihin lokacin gano cutar 2019-novel coronavirus (2019-nCoV) ga dakunan gwaje-gwaje na kiwon lafiyar jama'a ta hanyar albarkatun duniya".
Sakamakon da ba a warware ba saboda kuskuren reagents a cikin ɗayan gwaje-gwajen kwayoyin halitta guda uku na tsofaffin sigar kayan gwajin da ke haifar da cikas ga gwaji a CDC a Atlanta; wanda ya haifar da nasarar sarrafa samfura ƙasa da 100 kowace rana a cikin Fabrairu 2020.
Ba a tabbatar da gwajin da aka yi amfani da abubuwa biyu ba har zuwa 28 ga Fabrairun 2020, kuma ba a ba da izinin fara gwajin ba har sai lokacin.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa.Kungiyoyin kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da wadatar gwajin COVID-19 bisa RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ta kuma samar da gwajin COVID-19 a duk faɗin ƙasar a ranar 9 ga Maris, 2020.
Babu iyakancewar adadi da aka bayyana; dole ne a tattara da sarrafa samfurin kamar yadda CDC ta buƙata.
Cibiyar Nazarin Virology da Biotechnology ta Rasha, VECTOR ce ta kirkiro da kuma samar da gwajin COVID-19 a Rasha.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an sami rahoto cewa Mayo Clinic ta shirya gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 a matsakaici, don haka ba da damar na'urar yin gwaje-gwaje kusan 4,128 a cikin awa 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji a cikin tsarin m2000 na Abbott; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
Hakazalika a ranar 21 ga Maris, 2020, Cepheid ta sami EUA daga FDA don gwaji, wanda ke ɗaukar kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar karawar isothermal nucleic acid maimakon PCR.
Tun da ba a buƙatar sake zagayowar zafin jiki, wannan hanyar tana iya ba da sakamako mai kyau a cikin ƙasa da minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan na'urori a Amurka kuma Abbott yana fatan haɓaka samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Ana yin gwajin a Taiwan tare da fatan cewa gwajin yana amfani da ƙwayoyin cuta na monoclonal, wanda ke ɗaure takamaiman ga furotin nucleocapsid (N protein) na sabon coronavirus, kuma zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin saurin mura.
"A cikin watan Maris na 2020, wani bita na wallafe-wallafe ya kammala cewa ""a farkon matakan, mahimmancin radiography na kirji yana da ƙarancin mahimmanci a cikin bincike, amma bayanan da aka samu daga CT [kimita na hoto] na iya kasancewa a gaban bayyanar cututtuka"."
Abubuwan da ke tattare da CT sun haɗa da gefe biyu, Multi-Liber Ground-Glass Openness tare da iyaka, rashin daidaituwa da kuma rarraba baya.
A lokacin da cutar ta fara, akwai rinjaye na subplural, haushi da ƙarfafawa.
Wani bincike da ya kwatanta PCR da CT a Wuhan, inda annobar ta fara, ya nuna cewa CT ya fi PCR hankali sosai, amma ba shi da daidaito, kuma yawancin siffofin da yake ɗaukar hoto sun dace da sauran cututtukan huhu da cututtuka.
"A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""kada a yi amfani da CT a matsayin gwajin farko don tantancewa ko bincike na COVID-19"". A watan Maris na 2020, CDC ta ba da shawarar PCR don gwajin farko na tantancewa".
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta shine samar da ƙwayoyin cuta, gami da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane, don tantance rigakafi da kuma lura da jama'a daga kwanaki 7 na farkon bayyanar cututtuka. Ana iya yin kimantawa ta hanyar gwaji a cikin cibiyoyin bincike na tsakiya (CLT) da kuma wurin kulawa (PoCT).
Yawancin dakunan gwaje-gwaje masu mahimmanci za su iya yin wannan a cikin tsarin atomatik mai inganci, amma samunsu zai dogara ne akan yawan samarwa ga kowane tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, kodayake ana iya amfani da samfurori na jerin don bin tsarin rigakafi.
A al'adance ana yin PoCT ne da huda fata da kuma daukar jini guda daya.
Ba a buƙatar matakin tattarawa kafin gwaji kamar hanyar PCR. A ranar 26 ga Maris, 2020, FDA ta sanar da sunayen cibiyoyi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ake buƙata kuma yanzu suna iya rarraba gwajin rigakafin su.
A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies akan kwayar cutar a cikin samfurin jini.
Gwajin yana da damar yin ɗaruruwan samfurori a cikin awanni, kuma saboda haka ya fi saurin kimantawa na PCR na gargajiya na RNA na kwayar cutar.
Ana iya gano ƙwayoyin cuta bayan kwanaki 14 bayan fara kamuwa da cuta.A farkon watan Afrilu, Burtaniya ta gano cewa babu ɗayan kayan gwajin ƙwayoyin cuta da suka saya da suka isa amfani da su.
"Hong Kong ta samar da wani tsari inda marasa lafiya da ake zargi za su iya zama a gida, ""sashen gaggawa zai ba da mai haƙuri bututun samfurin"", wanda zai tofa a ciki, ya mayar da shi kuma ya sami sakamakon gwajin jim kaɗan. NHS na Burtaniya ta sanar da cewa suna ƙaddamar da wani shiri a kan gwaji don gwada magungunan da ake zargi a gida, wanda ke kawar da haɗarin kamuwa da cutar ga wasu mutane idan mai haƙuri ya shiga asibiti, ko kuma idan an yi amfani da motar asibiti don kashe shi.
Cibiyoyin tafiye-tafiye sun taimaka wa Koriya ta Kudu ta gudanar da gwaje-gwaje mafi sauri, mafi yawa a cikin kowace ƙasa.Kungiyar likitocin asibiti ta asibiti a Jamus ta ce a ranar 2 ga Maris suna da damar yin gwaje-gwaje kusan 12,000 a kowace rana a cikin yanayin motsi, kuma an gwada mutane 10,700 a makon da ya gabata.
Idan an yi gwajin ne a kan umarnin likita, inshorar lafiya tana ɗaukar kuɗin.
Shugaban cibiyar bincike ta Robert Koch ya ce Jamus tana da karfin gwajin 160,000 a kowane mako.
An gudanar da gwajin tuki a manyan birane da yawa a ranar 19 ga Maris.
Ba a san yawan gwaje-gwajen da aka yi a Jamus a ranar 26 ga Maris, 2020 ba, saboda kawai an ba da rahoton lokuta masu kyau.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa an gwada aƙalla total 483,295 na samfurori har zuwa makon kalandar 12/2020 har zuwa 12/2020 da sauransu, kuma an sami samfurori 33,491 (6.9%) masu kyau ga SARS-CoV-2 a cikin gwajin. Masu bincike a Technion da Rambam Hospital a Isra'ila sun haɓaka da gwada hanyar da za ta haɗa samfuran daga marasa lafiya 64 don gwada su tare, kuma idan samfurin ya kasance mai kyau, za a ci gaba da gwada su.
Bayan da aka yi amfani da tsarin da aka tsara na kwanaki 5 da aka gudanar da aikin da wanda ya kafa BGI, Wang Jian, ya yi, an gano cewa idan ba a kara yawan gwajin ba a lokacin da ya dace, za a sami kashi 47 cikin dari na cutar a Hubei, kuma za a ninka farashin da ake bi don magance keɓewa.
Kamfanonin bincike na Huo-Yan a birane 12 a duk fadin kasar Sin, kamar Shenzhen, Tianjin, Beijing da Shanghai, sun bi sahun Wuhan Laboratory.
A ranar 4 ga Maris, 2020, ƙarfin gwajin ya kai 50,000 a kowace rana. An saki buɗe tushen, ƙirar ƙira da Origami Assays ta buga wanda zai iya gwada samfurin marasa lafiya 1122 don COVID19 ta amfani da gwaje-gwaje 93 kawai.
A watan Maris, karancin reagents da kuma karancin su sun zama abin da ke hana gwaji a cikin Tarayyar Turai da Burtaniya da Amurka.
Wannan ya sa wasu masu bincike suka binciki tsarin shirya samfurin inda aka dumama samfuran a 98 °C (208 °F) na tsawon mintuna 5 don sakin kwayoyin halittar RNA don gwaji na gaba. A ranar 31 ga Maris an ba da sanarwar cewa UAE yanzu tana gwada mutane da yawa don coronavirus fiye da sauran ƙasashe kuma tana kan hanyar haɓaka gwajin don isa ga yawancin jama'a.
"An yi hakan ne ta hanyar hada-hadar damar tuki da kuma sayen dakin gwaje-gwaje na samar da taro mai yawa daga Group 42 da BGI (wanda ya dogara da dakin gwaje-gwaje na gaggawa na ""Huo-Yan"" a China)".
An gina dakin gwaje-gwaje a cikin kwanaki 14 wanda zai iya yin gwaje-gwaje na RT-PCR sau dubu goma a kowace rana kuma shine farkon irin wannan a duniya wanda ke aiki a wajen China.
An samar da wasu hanyoyin gwaji da ke nufin sassa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta dauki tsarin Jamus na samar da kayan aiki da aka tura wa ƙasashe masu karamin karfi waɗanda ba su da damar yin nasu.
An fitar da tsarin Jamus a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta tsara ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta gwajin da ke akwai a Amurka.
Akasin haka, masana sun ce yawan gwajin da aka yi a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar.
Gwamnatin Koriya ta Kudu ta gina damar yin gwaji a cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu a cikin 'yan shekarun nan.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau don rage ci gaban cutar ta COVID-19. Karin bukatar gwaji saboda yaduwar kwayar cutar ya haifar da karancin miliyoyin gwaje-gwaje a dakunan gwaje-gwaje na Amurka masu zaman kansu, kuma ya sanya matsin lamba kan samar da swabs da masu daukar kwayar cutar.
A watan Maris na shekarar 2020, kasar Sin ta bayyana cewa akwai matsala a cikin kayan gwajin su.
"Kayan gwajin da CDC ta samar a Amurka suna da ""kurakurai""; sannan gwamnati ta kawar da matsalolin da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta ga cewa sakamakon ba daidai bane".
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin samun samfurin ko kuma rashin amfani da kayan aikin yadda ya kamata.
Ma'aikatar ta ce za ta dawo da kayan aikin da suka ba da sakamakon da ba daidai ba, kuma za ta maye gurbinsu da wani kayan aiki daban wanda Shenzhen Bioeasy ta samar. Jamhuriyar Czech ta ba da kashi 80% na kayan gwajin da ta saya daga China. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China waɗanda aka gano ba daidai ba.
"Firai Ministan kasar Matovič ya ba da shawarar jefa su a cikin kogin Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "manyan lahani" kuma ba su "yi amfani da su ba".
An gwada kuma an sake keɓe waɗanda suka gwada tabbatacce kuma an gano waɗanda suka taɓa saduwa da mutanen da ke da cutar SARS-CoV-2.
Masu bincike a garin Vo, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan mutane 3,400 a cikin kwanaki goma.
Kusan rabin mutanen da suka yi gwajin da ya nuna cewa suna da cutar ba su da alamun cutar kuma an killace duk mutanen da aka gano.
An kawar da sabon kamuwa da cutar ta hanyar sarrafa zirga-zirga a cikin al'umma.
Ta hanyar bin diddigin mutanen da suka yi hulɗa, sarrafa balaguron shiga, gwaji da keɓewa, amma ba tare da wasu ƙa'idodi masu ƙarfi ba kamar tilasta rufe gidajen abinci da shagunan sayar da kayayyaki, annobar coronavirus ta 2020 a Singapore ta ci gaba a hankali fiye da sauran ƙasashe masu tasowa.
An soke ayyuka da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida a ranar 28 ga Maris, amma an sake buɗe makarantu a kan lokaci bayan hutun hutu a ranar 23 ga Maris.
Wasu ƙasashe da dama sun sarrafa cutar a duniya ta hanyar gano mutanen da suka yi hulɗa da su, ta hanyar sarrafa balaguron shiga, gwaji da keɓewa, amma tare da ƙarancin kulle-kulle, kamar Iceland da Koriya ta Kudu.
Wani binciken da aka yi ya nuna cewa ƙasashe da suka yi gwaji da yawa fiye da yawan mutuwar suna da ƙananan mutuwar, saboda wataƙila waɗannan ƙasashe sun sami damar gano marasa lafiya masu sauƙi ko marasa alamun cutar.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin gwaji kuma suna da ƙarancin ƙwarewar dakunan gwaje-gwaje na ƙasa game da COVID-19, ya kamata su aika da samfuran COVID-19 biyar na farko da na farko da suka kasance masu kyau da kuma na farko da suka kasance marasa kyau zuwa ɗayan dakunan gwaje-gwaje 16 na WHO don tabbatar da gwaji.
Daga cikin dakunan gwaje-gwaje 16, akwai bakwai a Asiya, biyar a Turai, biyu a Afirka, daya a Arewacin Amurka da daya a Ostiraliya.
"A cikin jadawalin da ke ƙasa, shafi na ""Kashi na gwajin da ke da kyau"" yana shafar manufofin gwaji na ƙasar".
Kasashen da ke gwada mutane kawai da ke asibiti za su sami kashi mafi girma na gwajin da aka yi fiye da na ƙasashen da ke gwada duk 'yan ƙasa, ko da yake komai daidai ne, ko da sun nuna alamun cutar ko a'a.
Wanke hannu (ko wanke hannu), wanda kuma aka fi sani da tsabtace hannu, yana nufin tsabtace hannun mutum don kawar da datti, man shafawa, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
"Tsabtace hannu da sabulu a wasu lokuta na rana yana hana yaduwar cututtuka da yawa, misali gudawa da kwalara, waɗanda ke yaduwa ta hanyar stool da kuma bakin".
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannayensu ba kafin su taɓa idanu, hanci ko baki (watau, mucous membranes).
Abubuwa biyar masu mahimmanci a rana lokacin da wanke hannu da sabulu ke da mahimmanci sune: kafin da bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan wanke ƙananan jariri ko canza tufafi, kafin ciyar da jariri, kafin cin abinci da kuma kafin da bayan shirya abinci ko ba da hannayen nama, kifi, ko kaji.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka.
Kafin a dafa abinci, a lokacin da ake dafa abinci da kuma bayan an gama.
Kafin ka kula da marar lafiya da kuma bayan ka kula da shi.
Bayan canza diapers ko wanke jariri wanda ya yi amfani da bayan gida.
Bayan kun yi tari, tari ko hancin.
Bayan taɓa dabba, abincin dabba, ko ɓarnar dabba.
Lafiyar hannu ta likita tana nufin kyawawan halaye na likita.
Wanke hannu kafin shan magani ko kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu shine don tsabtace hannaye daga ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sunadarai waɗanda zasu iya cutar ko haifar da cuta.
Wannan yana da mahimmanci musamman ga mutanen da ke kula da abinci ko aiki a fannin kiwon lafiya amma kuma hanya ce mai mahimmanci ga talakawa.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage kamuwa da mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan gudawa; rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a gida.
Wani bincike da aka yi a 2013 ya nuna cewa inganta al'adar wanke hannu na iya haifar da karamin ci gaba a cikin tsayin yara 'yan kasa da shekaru biyar.
A cikin ƙasashe masu tasowa, za a iya rage yawan mutuwar yara daga cututtukan numfashi da gudawa ta hanyar gabatar da sauye-sauyen halayya masu sauƙi kamar wanke hannu da sabulu.
Wannan tsari mai sauki zai iya rage mutuwar cutar da kusan kashi 50%.
Matakan da aka dauka don karfafa wanke hannu na iya rage yawan cutar gudawa da kusan kashi uku, kuma yana da kama da samar da ruwa mai tsafta a yankunan da ke da karamin kudin shiga.
Wanke hannu da sabulu yana da alaƙa da raguwar kashi 48% na cututtukan gudawa. Hanya mafi inganci da tsada don hana gudawa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ciwon huhu, wanda shine babban ARI, shine babban dalilin mutuwa a cikin yara 'yan kasa da shekaru biyar. Yana kashe kimanin yara miliyan 1.8 a kowace shekara.
Cutar gudawa da cutar huhu suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, sauyawa zuwa ƙaƙƙarfan al'adar wanke hannu da sabulu kafin cin abinci da bayan amfani da bayan gida na iya ceton rayuka fiye da allurar rigakafi ko maganin likita, rage mutuwar gudawa da kusan rabi da rage mutuwar cututtukan cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu tare da sauran hanyoyin tsabtace jiki a matsayin ɓangare na shirye-shiryen Ruwa, Tsarkakewa da Tsabtace (WASH).
Wanke hannu yana karewa daga cututtukan fata masu saurin kamuwa da cuta (impetigo) wanda ke yaduwa ta hanyar hulɗa ta jiki kai tsaye.
Wani sakamako mai illa na wanke hannu shine cewa yawan wanke hannu zai iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na 2012 ya nuna cewa yawan wanke hannu na iya haifar da ƙaiƙayi, yanayin fata mai laushi da aka sani da eczema na hannu ko cututtukan hannu, wanda ya zama ruwan dare gama gari musamman tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin yawan wanke hannu a matsayin wata alama ta cuta mai cike da damuwa (OCD).
Abubuwa biyar masu mahimmanci na rana lokacin da wanke hannu da sabulu yana da mahimmanci don rage kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Sauran lokutan da ya kamata a yi amfani da hanyoyin wanke hannu da kyau don hana kamuwa da cuta sun haɗa da kafin da bayan kula da yanke ko rauni; bayan yin fitsari, tari, ko wanke hanci; bayan taɓa ƙurar dabba ko motsa dabba; da kuma bayan taɓa shara.
A ƙasashe da dama, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike da aka yi a cikin ƙasashe 54 a cikin 2015 ya nuna cewa a matsakaita kashi 38.7% na iyalai suna wanke hannayensu da sabulu. Wani binciken da aka yi a cikin 2014 ya nuna cewa Saudi Arabiya tana da mafi girma a kashi 97 cikin ɗari; Amurka tana da matsakaici a kusan kashi 77 cikin ɗari; kuma China tana da mafi ƙarancin kashi 23 cikin ɗari.
"Shirin kula da lafiyar yara na musamman da Ma'aikatar Ilimi ta Philippines ta aiwatar ya nuna cewa akwai matakan da suka dace don inganta kiwon lafiya da ilimi".
Babban abin da wannan shirin ya ƙunsa shi ne, kashe kwayoyin cuta sau biyu a shekara, wanke hannuwanku da sabulu kowace rana, da kuma goge haƙoranku da fluoride kowace rana.
An yi nasarar aiwatar da shi a Indonesia.
Ƙara sabulu ko kayan wanki a cikin ruwa yana ƙara kawar da kwayoyin halitta daga fata.
Babban aikin sabulu da kayan wanki shine rage hanawar narkewa da haɓaka narkewa.
Ruwa kawai ba shi da tasiri a tsabtace fata saboda kitse da furotin, abubuwan da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Ana yin tsaftacewa ta hanyar ruwa mai yawa.
Sabulu na nitrate, saboda yanayin sake amfani da shi, na iya riƙe ƙwayoyin cuta daga amfani da baya.
Ƙananan nazarin da suka yi la'akari da canja wurin kwayoyin cuta daga sabulu mai ƙazanta sun kammala cewa ba za a iya samun sauƙin ba saboda an wanke kwayoyin cuta da kumfa.
"CDC har yanzu ta ce ""ana ba da shawarar yin amfani da sabulu mai ruwa wanda za'a iya sarrafa shi ba tare da amfani da hannu ba""".
An yi ta yaɗa labarai da yawa game da sabulu na antibacterial ga jama'a masu kula da kiwon lafiya.
Har zuwa yau, babu wata hujja da ke nuna cewa ana amfani da maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta don kwayoyin da ke da tsayayyar maganin rigakafi.
Amma sabulu na antibacterial yana dauke da kayan aikin antibacterial na yau da kullun kamar trichlosan, wanda ke da karfin hana kwayoyin halitta a cikin babban adadin.
Don haka, koda kuwa ba a zaɓi nau'ikan maganin rigakafi don sabulu na antibacterial ba, ƙila ba za su yi tasiri kamar yadda aka tallata su ba.
Baya ga abubuwan da ke cikin farfajiyar jiki da abubuwan kare fata, shirye-shiryen da aka inganta na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai kula da pH, benzoic acid mai aiki da ƙwayoyin cuta, da ƙarin mai saurin fata (alovera, bitamin, menthol, tsire-tsire na shuka).
Ruwan zafi mai sanyaya hannu don wanke hannu bai isa ya kashe kwayoyin ba.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 ° C).
Amma ruwan sabulu mai zafi ya fi ruwan sabulu mai sanyi tasiri wajen kawar da man da ke riƙe da ƙasa da ƙwayoyin cuta.
Amma sabanin abin da ake tsammani, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba shi da tasiri a rage nauyin ƙwayoyin cuta a hannu.
Mai tsabtace hannu wanda ba ya dogara da ruwa ko maganin kashe ƙwayoyin cuta wanda ba ya dogara da ruwa.
A ƙarshen shekarun 1990s da farkon karni na 21, kayan tsabtace hannu na ruwa ba tare da barasa ba (wanda aka fi sani da rubs na barasa, rubs na antiseptic, ko kuma tsabtace hannu) sun fara samun karbuwa.
Yawancin su an yi su ne bisa ga isopropyl alcohol ko ethanol da aka shirya tare da carbomers (polymers na acrylic acid) ko humicantants kamar su abubuwa masu yawa kamar glycerin a cikin ruwa ko kumfa don sauƙin amfani da rage tasirin bushewar barasa.
Ƙara hydrogen-peroxide mai haɗuwa yana ƙara haɓaka aikin antimicrobial. Sanitiser na hannu yana da aƙalla 60 zuwa 95% na barasa wanda ke da tasiri wajen kashe ƙwayoyin cuta.
Magungunan tsaftace jiki na barasa suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu jurewa da yawa (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccine, influenza da hepatitis) da fungi.
Alcohol Rub Sanitizer yana da kashi 70% na barasa wanda ke kashe kashi 99.97% (ragewa ta 3.5 log, daidai da ragewa ta decibel 35) bayan amfani da dakika 30 a hannu kuma yana kashe kashi 99.99% zuwa 99.999% (ragewa ta 4 zuwa 5) na kwayoyin bayan amfani da minti 1 a hannu.
Sanitizers na hannu masu amfani da giya sune mafi yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana shafa ruwa, kumfa ko gel a gaba da baya da tsakiyar yatsun hannu biyu har sai sun bushe kuma ƙarshen ƙarshen kusan 30 seconds.
Yana da kyau a wanke yatsun hannu da hannuwan hannu biyu. Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar wanke hannuwan hannu da tsabtace hannu, musamman idan hannu ya kasance datti.
Yawan amfani da waɗannan abubuwan ya dogara da sauƙin amfani da su da kuma hanzarta lalata ƙwayoyin cuta; kodayake bai kamata a yi amfani da su azaman madadin wanke hannu daidai ba idan sabulu da ruwa basu da shi.
Idan ba a haɗa da emollients da / ko moisturizers na fata a cikin tsari ba, yawan amfani da maganin wanke hannu na barasa zai iya haifar da bushewar fata.
Ana iya rage ko kawar da tasirin bushewar barasa ta hanyar ƙara glycerin da / ko wasu lotions a cikin dabara.
A cikin gwajin asibiti, masu tsabtace hannu na giya tare da kayan shafawa sun haifar da ƙarancin damuwa da bushewar fata fiye da sabulu ko kayan wanke ƙwayoyin cuta.
Allergy cututtuka na haɗuwa, cututtukan cututtukan cututtuka ko kuma rashin jin daɗin barasa ko abubuwan da ke cikin barasa ba safai suke faruwa a cikin rubs na hannu.
Idan aka kwatanta da wanke hannu da sabulu da ruwa, ƙananan yanayin farawa na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Duk da ingancin su, kayan aikin ruwa ba sa tsabtace kwayoyin hannu, amma suna tsabtace hannu.
Tun da kwayoyin cuta suna ci gaba da kasancewa a hannu, sabulu da ruwa ba su da tasiri sosai wajen hana yaduwar kwayoyin cuta kamar yadda masu tsabtace hannu suke.
Ayyukan tsabtace hannu ba tare da barasa ba ya dogara da kayan aiki da kuma kayan aiki, kuma a cikin abubuwan da suka gabata sun yi aiki sosai fiye da barasa da barasa.
Kwanan nan, an gano cewa masu amfani da benzalkonium chloride sun ci gaba da kasancewa da ci gaba da haɓaka ayyukan antimicrobial bayan amfani da su wanda ba kamar barasa ba, wanda wataƙila ya lalace bayan amfani da shi sau da yawa saboda mummunan tasirin fata.
A cikin al'ummomin da ke da karancin kuɗi, mutane da yawa ba sa iya biyan kuɗin sabulu kuma suna amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙasa na iya zama mafi inganci fiye da ruwa amma ba su da inganci fiye da sabulu.
Wani abin damuwa shine idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta, zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, ash abu ne mai kashe kwayoyin cuta saboda yana haifar da ruwa mai ruwa.
A lokacin da sabulu ba shi da samuwa, WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu.
Hanyoyin wanke hannu da suka dace waɗanda Cibiyoyin Kula da Cututtuka na Amurka ke ba da shawarar don hana yaduwar cututtuka sun haɗa da waɗannan matakan:
Ka wanke hannayenka cikin ruwan da ke gudana, mai zafi ko sanyi.
Ana ba da shawarar ruwa saboda tafkin dindindin na iya zama mai gurɓataccen abu, amma zafin ruwan bai bayyana ya kawo wani bambanci ba.
Ka shafa wanka a bayan hannu, tsakanin yatsunsu da ƙarƙashin ƙusoshinka da sabulu mai yawa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu da kyau idan sun yi amfani da sabulu maimakon ruwa.
Ka riƙe shi a ƙasa da 20 seconds.
Ana shafawa a lokacin shafawa wanda ke kawar da ƙwayoyin cuta daga fata kuma yana kawar da ƙwayoyin cuta idan an shafe shi na dogon lokaci.
Ku wanke shi sosai a cikin ruwan.
Dusting a cikin wanka zai iya sake gurɓata hannayen.
Ka bushe da tawul mai tsabta ko ka bushe da iska.
Wuraren da aka fi watsi da su sune yatsun hannu, wuyan hannu, tsakanin yatsunsu da ƙarƙashin ƙusa.
Fata ƙusa da goge ƙusa na iya ba da mafaka ga ƙwayoyin cuta.
Ana ba da shawarar yin amfani da man shafawa don hana hannayen bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin yaduwar kamuwa da cuta.
"A cikin ƙasashe masu tasowa inda ba a samun ruwan famfo da / ko sabulu, za a iya ƙirƙirar zaɓuɓɓuka masu araha don sauƙaƙe wanke hannu, misali zuba ruwa daga tsalle-tsalle ko laushi mai dacewa da rami da / ko amfani da toka idan ya cancanta. A cikin yanayin da ke da iyakancewar samar da ruwa (kamar a makarantu ko yankunan karkara na ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar ""TP-Tap"" da sauran zaɓuɓɓuka masu araha".
Tip-tap fasaha ce mai sauƙi inda ake amfani da jar jariri da aka rataye ta igiya da kuma ƙaramin ruwa a hannu tare da ƙaramin ƙaramin ruwa da ƙwanƙwasa ƙafa da sabulu.
Drying hannaye sosai wani muhimmin bangare ne na aikin tsabtace hannu, amma akwai wasu muhawara game da mafi ingancin bushewa a cikin gidan wanka na jama'a.
Bincike mai yawa ya nuna cewa tawul ɗin takarda sun fi tsabtace jiki fiye da na lantarki na bushewa da ake samu a ɗakunan wanka da yawa.
An gudanar da wani bincike a 2008 wanda masana'antar takarda ta Turai ta samar da shi kuma Jami'ar Westminster ta gudanar da ita a London don kwatanta matakan tsabtace jiki da takarda takarda, bushewar hannu mai zafi da na zamani na jet-air.
Bayan wanke hannu da bushewa da na'urar bushewa mai zafi, yawan kwayoyin sun karu da kashi 194% a yatsunsu da 254% a cikin dabino.
Drying tare da jet-air dryer ya kara yawan kwayoyin cuta a yatsunsu da kashi 42% da kuma 15% a cikin dabino.
Bayan wanke hannu da takarda tawul bayan wanke hannu, jimlar kwayoyin cuta a yatsunsu sun ragu da kashi 76% kuma a cikin dabino na hannu da kashi 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don tabbatar da ko akwai yiwuwar gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbataccen gurbata
Jirgin jet-air, wanda ke fitar da iska a saurin gudu na 180 m / s (650 km / h; 400 mph), ya sami damar busa ƙwayoyin cuta daga hannaye da raka'a kuma ya kawar da yiwuwar gurɓata masu amfani da gidan wanka da yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar busar hannu mai zafi yana watsa kwayoyin microorganisms zuwa nisan mita 0.25 daga na'urar busar.
Takardar tawul din takarda ba ta nuna wani yaduwar kwayoyin halitta ba. A cikin binciken da aka gudanar a 2005 da TÜV Produkt und Umwelt (TÜV Produkt und Umwelt) ya kimanta hanyoyin bushewa da yawa.
An lura da canje-canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannaye:
Akwai nau'ikan bushe-bushe na hannu daban-daban kuma an kwatanta su da bushewa da tawul ɗin takarda.
Amfani da wankin hannu na iya zama madadin wanke hannu yayin tafiya saboda rashin sabulu da ruwa.
Sanitizer na hannu mai tushen giya yana da aƙalla kashi 60% na barasa.
A cikin yanayin asibiti, wanke hannu ya zama dole tun bayan likitan Hungary Ignaz Semmelweis ya gano ingancin wanke hannu don hana cututtuka (a cikin 1846).
Akwai wasu na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti idan sun manta da wanke hannayensu.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cutar.
Wanke hannu na likita yana faruwa ne na aƙalla dakika 15 tare da amfani da sabulu da ruwa ko gel da yawa don shafa kowane ɓangaren hannayen.
Dole ne a haɗa yatsunsu tare kuma a shafa hannayenku tare.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da goga don cire shi.
Tun da kwayoyin cuta na iya kasancewa a cikin ruwan hannu, yana da muhimmanci a wanke kumfa da tsabta kuma a bushe shi da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul na takarda don rufe bututun ruwa (kuma buɗe wata ƙofa don fita idan ya cancanta).
Wannan zai hana sake gurɓata hannayenku daga waɗannan farfajiyoyin.
"Manufar wanke hannu a cikin yanayin kiwon lafiya shine kawar da ƙwayoyin cuta masu haifar da cuta (""kwayoyin cuta"") da hana su kamuwa da cuta".
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu a yawancin wuraren kiwon lafiya ya kasance a matakin da ba za a iya karɓa ba, tare da yawancin likitoci da ma'aikatan jinya suna mantawa da wanke hannu kafin su taɓa marasa lafiya, don haka suna haifar da kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran hanyoyin sauki na iya rage yawan kamuwa da cutar da ke tattare da jini da kashi 66 cikin dari.
Har ila yau, za a iya samun takamaiman jagororin da kungiyar ta tsara don tsabtace hannu a shafin yanar gizon ta don ra'ayoyin jama'a.
An gudanar da bita mai dacewa ta Whitby da sauransu.
Na'urorin kasuwanci na iya auna da tabbatar da tsabtace hannu idan ana buƙatar tabbatar da bin ƙa'idodin.
"WHO ta ba da "Lokaci Biyar" don wanke hannu:"
Bayan ya zo cikin jini / ruwa mai ruwa
Kafin a fara aikin kawar da ƙwayoyin cuta,
"Bayan kula da marasa lafiya. Addingara sinadarin maganin kashe ƙwayoyin cuta a cikin sabulu (""magungunan magani"" ko "antibacterial"" sabulu) yana ba da ikon lalata kayan wanke hannu".
Ana iya yin amfani da wannan aikin kafin tiyata ko kuma a wuraren da akwai cutar ƙwayoyin cuta. Don aikin tiyata yana da muhimmanci a sami mai amfani don 'scrubbing' hannunka wanda za a iya kunnawa da kashewa ba tare da taɓa hannunka ba, wasu chlorhexidine ko iodine wanka, disinfectant don bushe hannayen wanka da kuma goga don scrubbing da sauran kayan aikin disinfecting bayan wankewa.
Dole ne a cire duk kayan ado.
Wannan hanya yawanci tana buƙatar wanke hannu da gwiwoyi na tsawon minti 2-6.
Ba lallai ba ne a shafe tsawon lokaci (10 min) ana shafa hannaye.
A lokacin wanka, dole ne a hana ruwan daga gwiwar hannu zuwa gwiwar hannu ya sake komawa hannun hannu.
Bayan an gama wanke hannu, ana bushe hannaye da kayan da ba a kashe su ba kuma ana sanya rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu kafin da bayan kula da mara lafiya ko amfani da maganin kashe ƙwayoyin cuta.
Don sarrafa cututtukan staphylococcal a asibiti, an gano cewa mafi yawan fa'idodin wanke hannu sun kasance daga farkon 20% na wankewa, kuma an sami ƙarin fa'idodi kaɗan lokacin da aka ƙara maimaita wanke hannu sama da 35%.
Wankewa da sabulu na yau da kullun yana haifar da sau uku cikin adadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Duk da haka, sabulu da ruwa/ruwa sun fi tasiri fiye da rubs na hannu na barasa don rage yaduwar kwayar cutar H1N1 da kuma cutar ta Clostridium difficile daga hannu. Wannan na iya haɗawa da batutuwan wanke hannu, ilimantar da ma'aikata game da wadatar rubs na hannu na barasa, da kuma rubutaccen tunatarwa na magana ga ma'aikata don inganta tsabtace hannu a cikin yanayin kiwon lafiya.
Ana buƙatar ƙarin bincike kan waɗanne daga cikin waɗannan ayyukan haɓaka ne suka fi tasiri a cikin yanayin kiwon lafiya daban-daban.
A kasashe masu tasowa, wanke hannu da sabulu an gane shi a matsayin hanya mai sauki, hanya mai mahimmanci don samun lafiya, har ma da abinci mai gina jiki.
Koyaya, rashin wadatar ruwa mai inganci, sabulu ko kayan wanke hannu a gidajen mutane, makarantu da wuraren aiki yana haifar da ƙalubale ga samun al'adar wanke hannu a duniya.
Misali, ko da yake akwai wasu hanyoyin da ba su da tsada don samar da wuraren wanke hannu a yawancin yankunan karkara na Afirka, babu ruwan wanke hannu kusa da kowane gidan wanka na masu zaman kansu ko na jama'a.
Amma ƙananan yawan wanke hannu na iya zama saboda ƙarancin sabulu ko ruwa / ruwa maimakon saboda al'ada mai zurfi.
Gangamin wanke hannu da sabulu da shawarwari na iya tasiri kan yanke shawara na manufofi, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da haifar da sauye-sauyen al'adun mutane na dogon lokaci.
Don yin aiki yadda ya kamata, dole ne a lura da kimantawa.
"Binciken da aka yi na nazari 70 ya nuna cewa hanyoyin da al'umma ke amfani da su wajen wanke hannu a cikin LMIC suna da tasiri, yayin da kamfen din tallatawa na zamantakewa ba shi da tasiri. Misali na yaƙin neman zaɓe game da wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, masu araha don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran buƙatun kiwon lafiya".
Idan aka cimma mafi ƙarancin maki, makarantu na iya kaiwa taurari uku daga ɗaya zuwa ƙarshe.
Kafa tashoshin wanke hannu na iya zama wani bangare na tallafawa kamfen din wanke hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke kokarin canza halaye. A sakamakon cutar coronavirus ta 2019-20, UNICEF ta inganta karɓar emojis na wanke hannu.
DALYs sun yi la'akari da nazarin da aka yi game da rage farashin wanke hannu a ƙasashe masu tasowa.
Duk da haka, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin samar da ruwa da tsaftacewa.
"Mahimmancin wanke hannu don lafiyar ɗan adam  Musamman ga mutanen da ke cikin mawuyacin hali, kamar iyaye mata a asibiti waɗanda suka haifi jarirai ko sojoji da aka ji rauni - majagaba biyu na tsabtace hannu sun fara gane wannan a tsakiyar karni na 19: Likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ingilishi ""mai kafa aikin jinya na zamani""".
Har zuwa wannan lokacin, yawancin mutane sun yi imanin cewa cutar ta samo asali ne daga ƙanshin da ake kira miasma.
A cikin shekarun 1980, barkewar cututtukan da ke tattare da abinci da cututtukan kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su inganta tsabtace hannu a matsayin muhimmiyar hanyar hana yaduwar kamuwa da cuta.
Cutar mura ta alade a cikin 2009 da cutar COVID-19 a cikin 2020, sun ba da ƙarin haske game da mahimmancin wanke hannu da sabulu don kare kanku daga irin wannan cutar mai yaduwa a ƙasashe da yawa.
"A Jamus, alal misali, an rataye allon talla tare da "dabaru masu kyau na wanke hannu" a cikin dakunan wanka na jama'a da kuma kusa da wanke hannu a cikin gidajen wanka na ofis da filin jirgin sama".
"Wannan magana ""shan hannu"" tana nufin cewa mutum yana son ya dauki alhakin ko kuma ya zama mai haɗin gwiwa a cikin aikata laifi".
An samo asali ne daga nassi na Littafi Mai-Tsarki na Matta inda Pontius Pilate ya kawar da shawarar da ya yanke na gicciye Yesu Almasihu, amma ya zama wani nau'i na harshe ta hanyar amfani da shi a cikin wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a ƙoƙarin share ta da halayen da aka yi da ita ta hanyar nuna laifinta game da laifin da ta aikata da kuma sa mijinta ya aikata laifin.
An kuma gano cewa mutane, idan sun yi tunani ko tunani game da ayyukan lalata, suna yawan wanke hannayensu fiye da sauran mutane kuma suna da ƙimar kayan wanke hannu.
"Bugu da kari, wadanda aka basu damar wanke hannayensu bayan irin wannan niyyar ba su da saukin shiga wasu ayyukan biyan diyya kamar aikin sa kai".
Addinai suna ba da umarnin wanke hannu don dalilai masu tsabta da alama. Yin wanke hannu na alama, amfani da ruwa/ruwa don wanke hannu amma ba amfani da sabulu ba, wanke hannu yana da alama a cikin addinai da yawa, gami da Baha'i, Hindu, Tevilah da Netilat Yadiyim a Yahudanci, Lavo of Christianity da Ozu a Musulunci. Addinai musamman suna ba da umarnin wanke hannu bayan wasu ayyuka.
Yin wanka bayan amfani da bayan gida wajibi ne a addinan Hindu, Yahudanci da Musulunci.
Kuma, wanke hannu kafin da bayan cin abinci a cikin addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci.
Kula da haɗarin wurin aiki don COVID-19
Kula da haɗarin aiki don COVID-19 shine aiwatar da ayyukan lafiya da kiwon lafiya na sana'a don sarrafa haɗarin don hana cutar coronavirus 2019 (COVID-19).
Ingantattun matakan haɗarin aiki sun dogara da wurin aiki da aikin da ake yi, kimanta haɗarin hanyoyin haɗuwa, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikata na mutum waɗanda ke da haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aiki ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗuwa suna ƙarancin hulɗa da jama'a da sauran abokan aiki, wanda ke ba da shawarar matakan hana kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ladabi na numfashi, da tsaftacewa da kuma tsabtace yanayin aiki a kai a kai.
Ayyukan haɗarin haɗari sun haɗa da ayyukan da ba a san ko ake zargin cewa suna da COVID-19 ba, amma suna buƙatar haɗuwa ko kusanci da mutane da ke iya kamuwa da cutar saboda cutar da ke yaduwa a cikin al'umma a wuraren aiki ko ta hanyar balaguron ƙasa da ƙasa.
Wannan ya hada da ma'aikatan da ke hulɗa da jama'a, kamar a makarantu, wuraren aiki masu yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu cunkoso.
Baya ga matakan rigakafin kamuwa da cuta na farko, matakan kula da haɗari ga wannan rukunin sun haɗa da samun iska ta hanyar amfani da matattarar iska mai ƙarfi, masu tsaron kankara da kayan kariya na mutum idan sun haɗu da mutumin da ke da cutar COVID-19.
OSHA ta yi imanin cewa ma'aikatan kiwon lafiya da masu aiki a dakin gawa suna da haɗarin haɗuwa da mutanen da ke da tabbacin ko kuma waɗanda ake zargi da cutar COVID-19.
Kula da haɗarin da ya dace ga waɗannan ma'aikatan ya haɗa da sarrafa injiniyoyi kamar ɗakunan iska mai matsin lamba, da kayan kariya na sirri da suka dace da aikin.
Cutar COVID-19 na iya haifar da tasiri da yawa a wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, kula da wasu, ko tsoron yiwuwar kamuwa da cutar.
Kasuwanci na iya canzawa ta hanyoyi biyu, wanda shine abin da ake buƙata da kuma yadda ake sayen waɗannan kayayyaki (kamar yin sayayya a lokacin da ba aiki ko ta hanyar bayarwa ko sabis na tuki).
A ƙarshe, jigilar kaya daga yankunan da COVID-19 ya shafa sosai na iya zama cikas. Za a iya amfani da shirye-shiryen cututtukan cututtuka da shirin amsawa don ba da umarnin matakan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wurare daban-daban da ayyukan da ake yi, gami da tushen haɗari, abubuwan haɗari da ke fitowa daga gida da zamantakewar jama'a, da abubuwan haɗari na mutum ga ma'aikata kamar tsufa ko yanayin rashin lafiya mai tsawo.
Sun kuma bayyana matakan da ake bukata don magance wadannan kasada da kuma shirin da za a yi na shirya wa yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen shirye-shiryen cututtuka da shirye-shiryen amsawa na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin mayar da martani ga barkewar cutar sun hada da rage kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke cikin hadarin kamuwa da cututtukan kiwon lafiya, ci gaba da ayyukan kasuwanci da rage tasirin tasirin tasirin su ga sauran kamfanoni a cikin sarkar samar da su.
Matsayin cutar a cikin al'ummomin da kasuwancin yake yana shafar yadda ake amsawa.
Tsarin tsari na kula da haɗari shine tsarin da aka yi amfani dashi don sarrafa ayyukan lafiya da lafiya.
Inda ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun matakan sarrafawa sune sarrafa injiniya, sannan sarrafawa, kuma a ƙarshe kayan kariya na mutum.
Injiniyan sarrafawa ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba, kuma yana iya zama mafita mafi arha don aiwatarwa.
Gudanarwa na gudanarwa shine canji a cikin manufofi ko hanyoyin aiki wanda ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan aikin kare kai (PPE) ana ɗaukarsu marasa tasiri fiye da na injiniya da ƙa'idodin gudanarwa, amma suna iya taimakawa hana wasu fallasa.
Dole ne ma'aikaci ya zaɓi duk nau'ikan PPE bisa haɗarin, ya dace da dacewa kamar yadda ya dace (kamar masu numfashi), ya kasance mai daidaituwa da dacewa, bincika, kulawa da maye gurbin su akai-akai, kuma ya buɗe, tsabtace, kuma adana ko zubar da su yadda ya kamata don kauce wa gurɓataccen abu.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aiki ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗuwa suna da iyakantaccen hulɗa da jama'a da sauran abokan aiki.
Matakan farko na rigakafin kamuwa da cuta da aka ba da shawarar ga dukkan wuraren aiki sun haɗa da wanke hannu da kyau da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ba da ladabi na numfashi, gami da rufe fuska yayin hancin da tari, samar da kayan shafawa da kayan shara, shirya don sadarwa idan ya cancanta ko sauye sauye a rana, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da kuma kiyaye al'ada don tsabtace da kuma tsabtace yanayin aiki.
Ganowa da kuma ware mutanen da ke da cutar da wuri yana da mahimmanci don kiyaye ma'aikata, abokan ciniki, masu neman aiki da sauransu cikin aminci a wuraren aiki.
Ma'aikata da ke da alamun rashin lafiya mai tsanani na numfashi sun ba da shawarar cewa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar su zauna a gida, har sai sun sami ƙarancin zazzabi, alamun zazzabi, da sauran alamun cutar na aƙalla awanni 24 ba tare da amfani da maganin rage zazzabi ko wasu magungunan da ke canza alamun cutar ba, kuma ya kamata a sassauta manufofin hutu na rashin lafiya, wanda zai ba ma'aikaci damar zama a gida don kula da dangin da ke rashin lafiya, kuma ya kamata ma'aikata su san waɗannan manufofin.
A cewar OSHA, ayyukan haɗarin haɗari sun haɗa da ayyukan da ba a san ko ake zargin cewa suna da COVID-19 ba, amma suna buƙatar haɗuwa ko kusanci da mutane sau da yawa tsakanin ƙafa shida (1.8 m) waɗanda ƙila sun kamu da SARS-CoV-2 saboda cutar da ke gudana a cikin jama'a a wurin aiki ko kuma kwanan nan tafiya ta ƙasa da ƙasa zuwa wani wuri inda mutumin ya sami yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke da hulɗa da jama'a, kamar a makarantu, a cikin yanayin aiki mai haɗari, da kuma a cikin wasu shaguna masu yawan jama'a. Don haka, da kuma don ƙungiyoyin haɗari masu haɗari, sarrafawa na injiniya sun haɗa da sanya matattarar iska mai ƙarfi, haɓaka ƙimar iska, sanya shinge na jiki kamar masu tsabtace filastik, da kuma kafa taga mai ƙarfi don sabis na abokin ciniki. Don haka, da kuma don ƙungiyoyin haɗari masu haɗari, ana buƙatar kula da gudanarwa don ƙarfafa ma'aikata su kasance a gida ko a wuraren aiki marasa lafiya, samar da damar haɗuwa ta hanyar haɗuwa ta hanyar haɗuwa ta hanyar haɗuwa ta hanyar haɗuwa ta hanyar haɗuwa ta hanyar haɗuwa, gabatar da horo game da yadda za a iya daidaitawa da ma'aikata (staggered), amfani da kayan aikin da keɓaɓɓun kayan aiki a cikin gidajen da ba su da haɗari ga COVID-19 don hana abokan ciniki yin tafiya da hannu da hannu, samar da takamaiman bayanai game da yanayin aiki, samar da takamaiman hanyoyin kula da lafiya, da kuma yin amfani da kayan aikin da keɓaɓɓu, da kuma samar da hanyoyin sadarwa masu dacewa da ke nuna haɗari ga COVID-19, da kuma samar da takamaiman bayanai game da yanayin aiki, da kuma yadda za a kiyaye lafiyar jiki da kuma kiyaye kariya, da kuma kiyaye wasu abubuwan da suka shafi haɗari.
Ma'aikata a cikin wannan rukunin haɗarin suna buƙatar yin amfani da injin numfashi a cikin ƙananan lokuta.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da nisantar da mara lafiya daga wasu a tazarar ƙafa 6, sanya wani ma'aikaci don kula da mara lafiya, da samar da abin rufe fuska ga mara lafiya ko tambayar mara lafiya ya rufe baki da hanci da nama yayin yin fitsari ko tari.
Ya kamata ma'aikatan jirgin su sanya safar hannu ta likita mai yarwa yayin amsa kiran matafiyi mara lafiya ko taɓa ruwa na jiki ko yiwuwar gurɓataccen farfajiyoyi, kuma wataƙila su yi amfani da ƙarin kayan kariya na sirri idan matafiyin mara lafiya yana da zazzabi, tari mai ɗorewa ko numfashi.
Ya kamata a zubar da safofin hannu da sauran abubuwan da za a iya zubar da su a cikin jakar haɗarin haɗari, kuma a tsabtace da kuma kashe ƙwayoyin cuta a bayan haka. Ga jiragen ruwa na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa masu fasinja, kulawar haɗari sun haɗa da jinkirta tafiya idan suna rashin lafiya, ware kansu, da sanar da cibiyar kiwon lafiya ta jirgin nan da nan idan wani ya kamu da zazzabi ko wasu alamomi yayin da suke cikin jirgin.
A cikin yanayin da ya dace, ya kamata a bi diddigin likita a cikin ɗakin da aka keɓe. A cikin makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsaftacewa ko kashe ƙwayoyin cuta idan wani mai cutar ya shiga ginin makaranta, ba tare da la'akari da yaduwar cutar a cikin jama'a ba.
Lokacin da cutar ta kasance a cikin ƙananan matsakaici a cikin al'umma, ana iya aiwatar da dabarun nisantar da jama'a, kamar soke tafiye-tafiye, tarurruka da sauran manyan tarurruka, kamar karatun jiki ko cin abinci a cikin azuzuwan kiɗa ko cafeterias; ƙara nesa tsakanin tebur, raba lokutan zuwa ofis da hutu, iyakance ganawa da ba dole ba, da amfani da sararin ofis na kiwon lafiya daban don yara masu alamun mura.
Idan akwai cutar a cikin al'ummomin gida, ana iya yin la'akari da ƙara yawan lokacin hutu na makaranta don ƙarin dabarun nisantar da jama'a.
Jami'an tilasta yin doka da ke da alaƙa da mutanen da ke da tabbacin ko ana zargin suna da COVID-19 an shawarce su da su bi ƙa'idodin da masu aikin gaggawa ke bi, gami da kayan kariya na sirri.
Idan ma'aikata sun kusanci a lokacin haɗari, dole ne a tsabtace da kuma kashe ƙwayoyin cuta tare da amfani da fesa tsabtace gida ko gogewa kafin sake amfani da belin aiki da kayan aiki, kuma a bi hanyoyin gudanar da hujja don sarrafawa da kuma kawar da PPE da aka yi amfani da su.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da na mutuwa a matsayin masu haɗarin haɗari ko haɗari.
Ayyukan haɗari masu haɗari sun haɗa da masu ba da kiwon lafiya, masu ba da taimako, ma'aikatan dakin gwaje-gwaje, da ma'aikatan jigilar kayayyaki waɗanda ke haɗuwa da marasa lafiya da aka sani ko ake zargi da COVID-19.
Idan ma'aikata suna yin hanyoyin samar da aerosol, ko tattara ko motsa samfura daga marasa lafiya da aka sani ko ake zargi da COVID-19, waɗannan suna da haɗarin haɗuwa.
Hanyoyin samar da aerosol sun hada da shigar da bututu, hanyoyin fara tari, bronchoscopy, wasu hanyoyin hakori da kuma tattara samfuran ta hanyar shigar da gwaji ko kayan aiki.
Ayyukan haɗari masu haɗari, da ke da alaƙa da mutuwa sun haɗa da ma'aikatan da ke cikin aikin shirya gawawwakin duk mutanen da aka sani ko ake zargin suna da COVID-19 a lokacin mutuwar; wannan ya zama haɗari mai haɗari sosai idan sun yi bincike. Ƙarin ƙwarewar injiniya ga mutanen da ke cikin wannan rukunin haɗari sun haɗa da ɗakunan keɓewa don marasa lafiya da aka sani ko ake zargin suna da COVID-19, gami da lokacin da ake aiwatar da hanyoyin samar da aerosol.
Hanyoyin iska masu ƙarancin ƙarfi na musamman na iya zama masu dacewa da wasu wuraren kiwon lafiya da kuma yanayin gidan gawa.
Ya kamata a sarrafa samfurori bisa ga matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa masu zuwa marasa lafiya su keɓe su zuwa wuraren jira daban-daban dangane da ko ana zargin suna da COVID-19. OSHA ta ba da shawarar masu numfashi ban da sauran PPE ga mutanen da ke aiki a cikin ƙafa 6 na waɗanda aka sani ko ake zargin suna da SARS-CoV-2 da kuma mutanen da ke yin hanyoyin samar da aerosol.
A cikin Amurka, dole ne a yi amfani da N95 ko mafi kyawun tacewar fuska a cikin mahallin cikakken, rubutaccen shirin kariya na numfashi, gami da gwajin lafiya, horo da gwaji na likita.
Sauran nau'ikan na'urorin numfashi na iya samar da ƙarin kariya da haɓaka jin daɗin ma'aikaci. WHO ba ta ba da shawarar rufewa ba, saboda COVID-19 ba ya yaduwa ta hanyar abubuwan ruwa na jiki, amma cutar numfashi ce.
WHO ta ba da shawarar rufe fuska na tiyata ga ma'aikatan da ke yin gwajin a ƙofar shiga kawai.
WHO ta ba da shawarar yin amfani da abin rufe fuska, tabarau, ko garkuwar fuska, riguna da safar hannu ga waɗanda ke tattara, kula da, ko jigilar samfurori na numfashi daga marasa lafiya na COVID-19 ba tare da wata hanyar samar da aerosol ba.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Ganin rashin isasshen kayan PPE a duniya, WHO ta ba da shawarar yin amfani da telemedicine, amfani da tazara ta jiki kamar windows mai haske don rage buƙatun PPE, da barin waɗanda ke da alaƙa da kulawa kai tsaye su shiga ɗakunan da ke da mai cutar COVID-19 ɗaya, amfani da PPE kawai don takamaiman aiki, ci gaba da amfani da shi ba tare da cire na'urar numfashi ba yayin kula da marasa lafiya da yawa da cutar iri ɗaya, ba da izinin saka idanu da daidaita sarkar samar da PPE, da kuma hana masu rashin alamun sanya abin rufe fuska.
An aiko da shi daga: Katherine Maher, Wikimedia Foundation CEO
Daga: Dukan ma'aikatan Wikimedia Foundation
Maganar: [Covid-19] Sauƙaƙa nauyi da shirya don nan gaba
An aika kwanan wata: 14 ga Maris, 2020, 00:24 UTC
An ba da lasisi: CC0: Babu haƙƙin mallaka
Mun sami kanmu cikin yanayi mai ban mamaki a wannan watan.
Cutar ta COVID-19 ta duniya wani lamari ne wanda ya bayyana alakar ɗan adam da duniya da kuma nauyinmu ga juna.
Ba mu da wata alama game da kalubalen da muke fuskanta, amma mun san cewa mafi kyawun amsarmu ta dogara ne da jinƙai, haɗin kai da haɗin kai a duniya wanda shine ainihin zuciyar wannan ƙungiyar.
Abokan hulɗa, amincewa da kulawa da muka gani tsakanin abokan aikinmu ta hanyar imel, kira da hira da juna suna da kyau a matsayin shaida ga mutane masu ban mamaki waɗanda muke da sa'a muyi aiki tare.
Ina matukar godiya da kuma alfahari da samun ku duka a matsayin abokan aiki.
A makon da ya gabata, wani mutum ya yaba min kan aikin da muke yi.
Sun tunatar da ni yadda yake da muhimmanci ga duniya a wannan lokacin ta iya ganin Wikipedia da kuma yadda wannan muhimmin kayan aiki yake da iko a kan layi kuma yana samuwa ga kowa.
Aikinku ya sa hakan ya yiwu, ko kuna ci gaba da shafukan yanar gizo ko kuna biyan abokan aikinmu ko kuna kiyaye al'ummominmu lafiya ko kuma duk abin da kuke yi.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri sosai a duniya.
Saboda mahimmancin wannan aikin da kuma rawar da kuke takawa, za mu yi wasu canje-canje masu mahimmanci a cikin yadda muke aiki tare a cikin makonni masu zuwa.
Ka daidaita ayyukanka da tsarinka
Kamar yadda Robin ya ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da tsara jadawalin kwanaki da watanni masu zuwa.
Mun yi tunani a kan abin da ya dace da yanayin da muke fuskanta, kuma mun yi la'akari da mafi kyawun hanyar da za mu ci gaba da kasancewa a cikin wannan tattaunawar.
Yawancinmu muna son mu kawar da matsin lamba kuma mu tallafa wa manufofinmu na dogon lokaci.
Idan kana bukatar ka sake yin kira, ba matsala.
Ga dukkan ma'aikata, masu kwangila, da ma'aikatan kwangila:
Har sai da aka sanar da mu, muna sa ran yin aiki na tsawon sa'o'i 4 a rana, ko kuma awa 20 a mako.
Ba mu sanar da hutu ba - idan za ku iya aiki a lokuta na al'ada, aikin na iya amfani da ku.
Amma a wannan lokacin duniya ba ta da tabbas, kuma ko kuna buƙatar kula da ƙaunataccenku ko ku kawo kayan masarufi ko ku je wurin likita, lafiyar ku ita ce fifiko.
Ba ma kula da lokacinku.
Kada ku yi aiki idan kuna rashin lafiya.
Ba lallai ba ne a faɗi haka, amma muna faɗin haka.
Babu bukatar hutu na rashin lafiya ko PTO - kawai ka gaya wa manajanka kuma ka taimaka wa ƙungiyarka ta gyara kalandarku da jadawalin ku, don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan kun kasance masu kyau ga COVID-19, da fatan za a sanar da Brian na T&C Ops don T&C ta iya taimakawa da tabbatar da cewa hukumomi sun kula da yanayinku yadda ya kamata).
Za a biya ma'aikata cikakken albashi a cikin sa'a.
Mun riga mun fada, kuma muna sake tabbatar da cewa za mu cika alkawarinmu ga masu aikin kwangila da abokan aikinmu na sa'o'i.
Za a biya su bisa ga yawan sa'o'in da suka yi a cikin al'amuran yau da kullun.
Wannan ya hada da idan kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana son aiki, za mu taimaka maka.
Mutane da yawa suna amfani da aiki don su kawar da damuwarsu daga duniyar da ke kewaye da su.
Abin da muke yi na iya zama mai albarka musamman a irin wannan lokaci.
Bugu da ƙari, yana da game da kula da kanka.
Muna son ka ci gaba da tuntuɓar manajanka don mu san abin da za ka yi tsammani kuma mu daidaita yadda za ka yi hakan.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu yi.
SRE, HR Ops, Trust & Safety, da kuma kungiyoyin tara kudade (da sauransu) suna yin ayyuka masu mahimmanci waɗanda zasu iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofinmu na yanzu da kuma canza hankalinmu don yin aiki tare kan abin da ake buƙata don aikinmu.
Muna da ayyuka da yawa da za mu yi, amma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan ka yi aiki a hankali yanzu, ba za ka ji rauni ba.
Ba mu da niyyar yin aiki sau biyu don biyan bukatunmu bayan annobar ta ƙare.
Ba za a bukaci ka yi aiki na tsawon lokaci ba don ka kammala aikin a kan lokaci, wanda ba gaskiya ba ne.
Mun yarda cewa yanayi ya canza, kuma a inda ya dace, za mu yi aiki don saita sabbin manufofi da wa'adi.
Menene game da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin lokutan aiki na yau da kullun, muna kuma son daidaita lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Muna da niyyar ba da shawarar tsawaita shirinmu na 2019-2020, wanda zai ba ma'aikata ƙarin lokaci don tsara kasafin kuɗi don ba da fifiko ga ayyukan da suka dace, kula da kansu da kula da ƙaunatattun su, yayin da kuma biyan buƙatun waɗanda suke so ko buƙatar yin aiki a cikin saiti da aka rage a cikin makonni masu zuwa.
Wannan tsawaitawa na lokaci yana rage nauyi a kan aikin da ake yi yanzu da kuma a kan dukkan kungiyar.
Za mu gabatar da shawarwarinmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilai da kungiyoyi game da matakai na gaba da wuri-wuri da zarar mun sami tabbaci.
Ina godiya ga APP Team don jagorancinku a wannan batun.
Yanayin ofishi, tuntuɓar da tsaftacewa
A makon da ya gabata mun sami labarin cewa ɗaya daga cikin abokan aikinmu na SF na iya fuskantar cutar COVID-19.
Amma saboda taka tsantsan, mun tura ƙungiyar masu tsabtace mu don kashe ƙwayoyin cuta a duk wuraren da muke aiki a ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafin kwayar cutar da ta dace da asibiti don kashe ƙwayoyin cuta a kowane farfajiyar da kuma harabar da kuma bankunan lif da ke shiga bene.
Ginin yana amfani da kayan aikinsa na sabis na sabis na sabis wanda ke taimakawa amincin masu haya.
Muna jin dadi cewa ofishin zai kasance a shirye lokacin da muka yanke shawarar dawowa.
Ofishinmu na DC yana cikin WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da kuma duk ma'aikatan DC.
A makon da ya gabata ne ofishinmu na DC ya koma cikakken tsari na nesa, daidai da umarnin da aka ba San Francisco.
Wasu daga cikin abokan aikinmu da ke birnin New York sun san cewa muna tattaunawa game da hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma ana iya jinkirta ta.
Wasu daga cikin abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa wannan na iya zama daidaitawa, kuma suna so su ba ku wasu shawarwari:
Idan taron ya yi tsawo sosai, ka rage zuwa awa ɗaya ko biyu.
Idan ana bukatar zaman da ya fi haka tsawo, ka yi la'akari da yadda za ka raba su zuwa ga ƙananan zaman a cikin kwanaki da yawa.
Ka bayyana taron a fili, ka tsara jadawalin taro, kuma ka aika da littattafan da za ka karanta a gaba.
Don sauƙaƙe haɗin kai da haɗin kai, tare da kayan aiki kamar Google Docs da Zoom, sa bidiyo ya zama tsoho.
Ka sa wani ya yi ja-gora don sauƙaƙe kowane taro, ka sa wani ya lura da tambayoyin da ke cikin hira kuma ya lura da jerin masu magana, kuma ka sa wani ya rubuta (ko kuma ya rubuta tare).
Idan kana buƙatar wata lasifika mai dacewa, aika imel zuwa goyon bayan fasaha.
Yi amfani da kayan jin daɗin ku don abincin dare.
Shiga cikin tashar #remoties akan Slack don tattaunawa da abokan aikinku game da ayyukan da aka raba.
HR Team Management suna neman jagororin ergonomics na yanar gizo don taimakawa haɓaka aikin da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu ba da gudummawa a cikin al'umma da su soke duk wani taron jama'a kamar Editathon da Wikimedia ke tallafawa, har sai WHO ta ayyana cewa annobar ta ƙare.
Muna sanar da su cewa mun fahimci cewa buƙatarmu don sokewa da sauran ƙuntatawa na iya sa ba zai yiwu su kammala ayyukan ba da gudummawar da aka yarda da su ba, kuma ba za a hukunta kowa ba saboda jinkiri ko gyara waɗannan manufofin.
A cikin makonni masu zuwa za mu ba da ƙarin jagora ga Wikimania da sauran taron yanki da na al'umma.
A cikin dukan al'ummomin duniya, akwai damuwa game da rashin jin daɗi, amma a lokaci guda Wikimedia da sauran wurare, suna da ikon yin la'akari da al'ummomin su da kuma samun haske.
A nan gaba CRT tana aiki don ƙirƙirar shafi a cikin Meta-Wiki, don samar da wuri ga jama'a don lura da tasirin da kuma bin hanyoyinmu tare da su.
Kasancewa cikin hulɗa da ke mai da hankali kan al'amuran da suka shafi COVID-19
Za mu aika da gayyatar zuwa kalandarku don taron ma'aikata na musamman a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa da amsa tambayoyinku da kuma ɗan lokaci don haɗawa da juna.
A wannan halin da muke ciki, dukkanmu muna tare kuma za mu taimaka a duk hanyar da za mu iya.
A halin yanzu, zaku iya ci gaba da bincika bayanan daga wannan imel ɗin, da kuma samun sauran mahimman bayanai game da COVID-19 akan Wiki na Office.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma ta sanya duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da kasancewa cikin hulɗa tare da ma'aikatan da ke zaune a ƙasashen da ke fama da cutar.
Idan kuna da tambayoyi game da tafiya, abubuwan da suka faru, babban aiki ko ƙalubalen ɗaukar hoto, ko kuna buƙatar taimako a kan wani abu, don Allah kada ku yi jinkirin sanar da aiki tare da CRT.
Muna nan don taimakawa da daidaitawa idan ya cancanta.
Idan kuna da wasu batutuwa masu sirri ko masu mahimmanci, da fatan za a aika da imel zuwa Bryan Judan, Daraktan Ayyukan Duniya na HR International.
Babu wani daga cikin wadannan canje-canjen da za a yi la'akari da shi a matsayin watsi da aikinmu da alhakinmu.
Maimakon haka, yana nuna cewa a yanzu muna iya yin aiki da kuma ɗaukar nauyinmu a hanyoyi da ba mu taɓa yi ba a baya.
Mun yi imanin cewa waɗannan matakan suna da mahimmanci don tallafawa juna, don mu ci gaba da aiki, don ba da tallafin da ayyukanmu ke buƙata, da kuma samar da ayyukan da duniya ta dogara da su.
A lokacin da lokaci ya yi, ayyukan da muka tsara za su jira mu.
Yanzu lokaci ya yi da za mu taimaki juna da kuma samar da sarari don muhimman ayyukan da za su zo a makonni masu zuwa da watakila ma watanni.
Don yin hakan, muna bukatar hadin gwiwar ku duka, kuma muna so ku kula da kanku da danginku don ku kasance cikin koshin lafiya a lokacin da ya dace.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, ƙungiyar CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Haim V, Joel L, Lynette L, Ryan M, da Tony S) da sauran ƙungiyar jagoranci (Grant I, Heather W, Haim V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
BAngiotensin-converting enzyme 2 (ACE2) wani mai haɓaka ne wanda ke haɗuwa da ƙwayoyin ƙwayoyin cuta na huhu, jijiyoyi, zuciya, koda da ƙwayoyin cuta (ƙwayoyin ƙwayoyin cuta).
ACE2 yana hana aikin aikin enzymes masu canzawa na angiotensin (ACE) ta hanyar rage adadin angiotensin-II da kuma kara Ang ((1-7) wanda ya sa ya zama kyakkyawan maƙasudin magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin wuri don shiga cikin sel don wasu coronaviruses.
An kira kwayar halitta ta mutum na enzyme hACE2.
Angiotensin-converting enzyme 2 wani zinc-mai karɓar metallolenzymes ne wanda ke zaune a kan endothelial da sauran ƙwayoyin halitta.
ACE2 yana da wani nau'i na N-terminal peptidase M2 da kuma wani nau'i na C-terminal colectin na renal amino acid transporter.
ACE2 shine nau'in membrane mai nau'in nau'i na I wanda yake da ƙwayar cuta wanda ke nuna alamar ƙwayar cuta a cikin huhu da sauran kwayoyin halitta.
Ana rarraba yankin waje na ACE2 daga yankin transmembrane ta wani enzyme da ake kira shades kuma sakamakon furotin mai narkewa yana sakin jini kuma a ƙarshe ya fita ta fitsari.
ACE2 yana cikin mafi yawan gabobin jiki: ACE2 yana haɗuwa da ƙwayoyin ƙwayoyin cuta na alveoli na nau'in II na huhu, da ƙananan ƙwayoyin hanji, da ƙwayoyin arterial da endothelial na yawancin gabobin jiki, da ƙwayoyin ƙwayoyin tsoka na arteries.
Ana kuma samun bayanin mRNA na ACE2 a cikin ƙwayar kwakwalwa, stratum, hypothalamus, da kuma kwakwalwa.
Babban aikin ACE2 shine aiki a matsayin mai daidaitawa na ACE.
ACE yana raba hormone na angiotensin I zuwa vasokonstricting angiotensin II.
ACE2 ya ware carboxyl-terminal amino acid phenylalanine (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) daga angiotensin II kuma ya hada shi da hydrolyzed zuwa vasodilator angiotensin (1-7) (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya rarrabe wasu peptides, ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dinorphine A da ghrelin.
ACE2 yana sarrafa musayar membrane na SLC6A19, mai jigilar amino acid mai tsaka tsaki kuma yana da alaƙa da cututtukan zuciya.
ACE2 a matsayin furotin mai canzawa yana aiki a matsayin babban hanyar shiga cikin kwayar halitta don wasu coronaviruses, gami da HCoV-NL63; SARS-CoV (wanda ke da alhakin SARS); da SARS-CoV-2 (wanda ke da alhakin COVID-19).
Musamman, SARS-CoV da kuma spike S1 sun haɗa da sunadarai a cikin ƙwayar enzymatic na ACE2 zuwa farfajiyar tantanin halitta wanda ke haifar da endocytosis da kuma maye gurbin ƙwayoyin cuta da enzymes zuwa cikin ƙwayoyin halitta.
Wannan tsarin shigarwa yana buƙatar maida hankali kan furotin S ta hanyar mai karɓar serine protease TMPRSS2, wanda hana shi a halin yanzu ana bincika shi azaman mai warkarwa. Wannan ya taimaka wa wasu suyi tunanin cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, yawancin ƙungiyoyin ƙwararru da hukumomin kulawa sun ba da shawarar ci gaba da maganin ACE inhibitor da ARB.
"A cikin wani bita na tsarin da aka buga a ranar 11 ga Yuli 2012 da kuma meta-bincike ya nuna cewa ""hadarin cutar nimoniya ya ragu da kashi 34% idan aka kwatanta da na sarrafawa, tare da amfani da masu hana ACE"."
"Bugu da kari, ""Masu fama da cutar bugun jini da kuma cututtukan zuciya da ke da haɗarin kamuwa da cutar huhu sun rage haɗarin kamuwa da cutar huhu a cikin marasa lafiya da ke shan maganin ACE inhibitors, musamman marasa lafiya da ke da haɗarin kamuwa da cutar huhu".
"An kuma danganta amfani da masu hana ACE tare da rage yawan mutuwar da ke da alaƙa da cutar huhu, kodayake sakamakon bai yi tasiri sosai ba a cikin haɗarin cutar huhu gaba ɗaya"."
Ana ɗaukar sake haɗuwa da ɗan adam ACE2 (rhACE2) a matsayin sabon magani don lalacewar huhu mai tsanani kuma ya bayyana don inganta haemodynamics na huhu da kuma oxygen saturation na jarirai aladu tare da alamun cutar ta lipolipolysaccharide-induced acute respiratory syndrome.
A cikin mutane, rabin rayuwar rhACE2 kusan awanni 10 ne kuma farawa aiki a cikin mintuna 30, kuma tsawon lokacin tasiri (tsayawa) shine awanni 24.
Abubuwan da aka gano sun nuna cewa rhACE2 na iya zama mai kyau ga mutanen da ba za su iya jure wa masu hana tsarin renin-angiotensin na farko ba (RAS inhibitors) ko kuma waɗanda ke da cututtuka inda haɓakar angiotensin II ta karu. An kimanta rhACE2 a cikin gwajin gwaji don bayyanar cututtuka na cututtukan numfashi mai tsanani (acute respiratory distress syndrome).
"B'COVID-19 Apps aikace-aikacen software ne na wayar hannu waɗanda aka tsara don gano lamba a cikin martani ga cutar coronavirus ta 2019-20, watau tsarin gano mutumin da ya taɓa saduwa da mai kamuwa da cutar (""Lamantakewa"") ".
An samar da aikace-aikace da yawa ko kuma aka ba da shawarar tare da tallafin gwamnati a wasu yankuna da yankuna.
An samar da wasu kayayyakin more rayuwa don samar da aikace-aikacen gano lamba.
An bayyana damuwar sirri, musamman game da tsarin da ke aiki bisa ga gano wurin masu amfani da manhajar.
Zaɓuɓɓukan shiga ba tare da izini ba sun haɗa da amfani da siginar Bluetooth don kama-karya mai amfani a wasu wayoyin salula.
A ranar 10 ga Afrilu 2020, Google da Apple sun ba da sanarwar cewa za su haɗa aikin don tallafawa irin waɗannan ƙa'idodin tushen Bluetooth kai tsaye tsakanin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin ta kaddamar da wata manhaja tare da Alipay da ke baiwa 'yan kasa damar duba ko sun taba saduwa da wani da ke dauke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin.
An kirkiro manhajar ne ta hanyar kungiyar fasahar kere kere ta cikin gida, an fitar da ita a matsayin tushen budewa kuma za a mika ta ga gwamnati. Arewacin Macedonia ta ƙaddamar da Tsaya Corona!, aikace-aikacen da ke da tushen Bluetooth wanda ke da niyyar gano bayyanar cututtuka na mai yuwuwar kamuwa da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
Ma'aikatar sadarwa da fasaha da ma'aikatar lafiya ne suka kirkiro manhajar.
Tun daga ranar 14 ga Afrilu, 2020, app ɗin yana jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta sanar da cewa aikace-aikacen neman haɗin kai yana cikin ci gaba kuma zai kasance a cikin 'yan makonni. Ana shirin yin irin wannan aikace-aikacen ("StopCovid") a Ireland da Faransa".
Australia da New Zealand suna la'akari da aikace-aikacen da ke kan aikace-aikacen TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na shirin ƙaddamar da aikace-aikacen geofencing don marasa lafiya da ke da cutar COVID-19 da ke zaune a Moscow, don tabbatar da cewa ba su bar gidajensu ba.
Ross Anderson, farfesa a sashen injiniyan tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin tushen aikace-aikace, gami da rashin inganci idan karɓar aikace-aikacen ya iyakance ga ƙananan ɓangarorin jama'a.
"A cikin magance damuwa game da yaduwar ɓatarwa ko cutarwa ""coronavirus"" apps, Apple ya sanya iyaka kan irin kamfanonin da za su iya ƙara aikace-aikacen da suka shafi coronavirus a cikin Shagon App ɗin ta ta hanyar iyakance su ga "masu hukuma" ko kuma sanannun kamfanoni".
Google da Amazon sun sanya irin wannan takunkumin.
Masu fafutukar kare sirrin sun nuna damuwarsu game da tasirin sa ido kan mutane ta amfani da aikace-aikacen coronavirus, musamman, ko za a kawo karshen tsarin sa ido da aka tsara don magance cutar coronavirus a duniya bayan barazanar ta tafi.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
Kamfanin ya sanar da sharudda takwas game da shirin gwamnati:
"Shirye-shiryen dole ne su kasance "daidai, dole, kuma daidai".
Za a sami sassan rana don haɓaka sa ido da tsaro;
Amfani da bayanai don dalilai na COVID-19 dole ne a iyakance;
Za a kare tsaro da rashin sani da kuma tabbatar da tsaro;
Dole ne a sanya sa ido ta hanyar dijital don dakatar da ɓarna da nuna bambanci;
Dole ne a bayyana a cikin doka game da raba wani bayanan tare da ɓangare na uku;
Dole ne 'yan ƙasa su sami kariya daga cin zarafi da kuma haƙƙin yin zanga-zanga game da cin zarafi.
"Dukkanin "'yan wasa masu dacewa" da suka hada da masana kiwon lafiya da kungiyoyin da ba su da wata ma'ana za su buƙaci muhimmiyar shiga.
Manufar da aka gabatar ta Google/Apple ita ce magance matsalar sa ido a kai a kai ta hanyar cire ayyukan ganowa daga tsarin aiki na na'urorin su idan ba a buƙatar su.
Wasu ƙasashe sun yi amfani da sa ido kan wurin da ke kan hanyar sadarwa maimakon aikace-aikace, wanda ke kawar da buƙatar saukar da aikace-aikacen da ikon kauce wa sa ido.
A Isra'ila, an ba da izinin gano hanyar sadarwa.
Hanyoyin sadarwa da ke da damar samun damar bayanan wuri na asali suna da matsala mai mahimmanci game da sirrin sirri.
Koyaya, ba duk tsarin da ke da sabar cibiyar sadarwa ke buƙatar samun damar bayanan wurin zama na mutum ba; an ƙirƙiri tsarin tsare sirri da yawa waɗanda ke amfani da sabar cibiyar sadarwa kawai don sadarwa (duba sashin da ke ƙasa).
An yi amfani da tsarin da ba tare da aikace-aikace ba a Koriya ta Kudu don lura da hulɗa.
Maimakon amfani da aikace-aikacen da aka tura, tsarin ya tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na na'urar hannu da bayanan ma'amala akan katin, kuma ya haɗa su don aika sanarwar saƙon rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da yiwuwar haɗuwa, gwamnati ta ba da bayanan wuri ga jama'a, saboda canje-canje masu yawa a cikin dokar sirri na bayanan bayan barkewar MERS a ƙasar.
Wasu ƙasashe, ciki har da Jamus, sun yi la'akari da amfani da tsarin da aka tsara da kuma tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Gano sadarwa mai kariya ta sirri yana da kyakkyawan ra'ayi, tare da wani ɓangare na ilimin ilimi wanda ya fara aƙalla tun daga 2013. Har zuwa 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun masana suna aiki akan hanyoyin magance sirrin sirri, kamar rubuta kusanci da wani mai amfani da wayar hannu ta amfani da Bluetooth Low Energy (BLE).
Koyaya, PEPP-PT ƙoƙari ne na daidaituwa wanda ke da hanyoyi biyu da aka rarraba kuma ba ƙa'idar ɗabi'a guda ɗaya ba. Ka'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'
A cikin waɗannan ladabi, bayanan da za a iya ganowa ba su taɓa barin na'urar ba kuma duk abin da ke faruwa a cikin na'urar da ta dace.
Kungiyar sirri a MIT Media Lab tana haɓaka SafePaths, wani dandamali don amfani da dabarun kiyaye sirri yayin tattarawa da amfani da bayanan wuri ko hanyar tsakiya don saka idanu kan yaduwar COVID-19.
Wannan ya dogara ne akan takardar farin takarda mai suna Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic, wanda aka buga a watan Maris na 2020. Wani irin wannan yunƙurin shine Enigma MPC ta SafeTrace dandamali, wani kamfanin kera fasahar sirri wanda aka kafa a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki mai aminci don ba masu amfani damar musayar bayanan wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da yin sulhu kan sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyar TCN ta duniya ta kafa ta ta hanyar ƙungiyoyi da suka haɗu kan ainihin hanyoyin da ake buƙata, gami da hanyoyin da suka dace da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idididididididididididididididididididididididididididididididididididididididididid
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa tana da yarjejeniyar BlueTrace mai buɗe ido wanda ake amfani da ita ta hanyar aikace-aikacen gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun ba da sanarwar wani shiri don gano mutanen da suka yi hulɗa da su, wanda suka ce zai kare sirrin su, wanda ke aiki ne bisa haɗuwa da fasahar Bluetooth mai ƙarancin makamashi da kuma ɓoye ɓoye ɓoye.
Sun kuma bayyana cikakken bayani game da fasahar da aka yi amfani da ita a cikin tsarin.
A cewar Apple da Google, an shirya samar da tsarin a matakai uku:
Aikace-aikacen kayan aiki don ba gwamnatoci damar ƙirƙirar ƙa'idodin hukuma masu kiyaye sirrin gano coronavirus.
Haɗa wannan aikin kai tsaye zuwa iOS da Android: Google da Apple suna shirin magance matsalolin ɗaukar hoto da sa ido na yau da kullun ta hanyar ƙaddamar da tsarin ta hanyar sabunta tsarin aiki da kuma cire shi daga baya idan bala'i ya ƙare ta hanyar da ta dace.
Sake sanya magunguna (wanda aka fi sani da sake amfani da shi, sake fasalinsa, sabon magani ko maye gurbin magani) magani ne da aka yarda da shi don magance cututtuka ko yanayin da ya bambanta da wanda aka tsara don.
Wannan hanya ce ta binciken kimiyya da ake bi a halin yanzu don haɓaka lafiya da ingantaccen maganin COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma kamuwa da kwayar cuta ta jini. SARS-CoV-2 yana da kusan furotin 66 da aka yi niyya da magunguna, kowannensu yana da shafuka masu ɗaure ligand da yawa.
Nazarin waɗannan wuraren ɗaurewa yana ba da kyakkyawan shiri don ƙirƙirar magungunan rigakafin cutar da ke da tasiri akan furotin na COVID-19.
Muhimman sunadaran da SARS-CoV-2 ke niyya sune papine-like proteases, RNA-dependent RNA polymerases, helicases, S proteins da ADP ribophosphate.
Hussain A. A., da sauransu sun yi nazarin mahaɗan ɗan takara daban-daban waɗanda aka inganta da kuma bincika a cikin binciken sa na farko don kamannin kwarangwal na ɗan takarar ta hanyar magungunan da aka yarda da su don hanzarta haɓaka ingantaccen maganin anti-SARS-CoV-2 don ba da shawarar ƙirar binciken asibiti.
Chloroquine magani ne na rigakafin zazzabin cizon sauro wanda kuma ake amfani dashi akan wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da kuma hydroxychloroquine na da alaƙa da shi suna cikin magunguna huɗu da za a yi nazari a matsayin ɓangare na gwajin gwaji na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin chloroquine da hydroxychloroquine a jihar New York zai fara daga ranar 24 ga Maris. A ranar 28 ga Maris FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin Amfani da Gaggawa (EUA).
Ba a amince da maganin ta hanyar tsarin gwajin asibiti na FDA ba kuma an ba da izinin gwaji ne kawai don amfani da gaggawa ga marasa lafiya da ke asibiti amma ba za su iya shiga gwajin asibiti ba a ƙarƙashin EU.
"CDC ta ce ""amfani, sashi, ko kwanciyar hankali na hydroxychloroquine don rigakafi da maganin kamuwa da cutar SARS-CoV-2"" ba a tabbatar da su ba tukuna".
"Jikina ya ce ba su da wani zabi sai shan maganin".
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana gudanar da ƙaramin bincike kan amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Akwai bincike mai zurfi a jami'ar Duke da Oxford.
Makarantar Likita ta NYU Langone tana gudanar da gwaji game da aminci da ingancin amfani da rigakafin hydroxychloroquine.
"Binciken asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin nuna favipiravir yana da ""ainihin tasiri"".
A tsakanin kwanaki 4, marasa lafiya 35 a Shenzhen sun yi ba daidai ba, yayin da marasa lafiya 45 da ba su samu ba sun yi rashin lafiya na kwanaki 11.
A cikin binciken da aka gudanar a Wuhan na marasa lafiya 240 da ke fama da cutar huhu, an ba rabin su favipiravir da rabi umyfenovir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke tallafawa maganin ba ta da isasshen kuma ba ta da tushe.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don adanawa kuma za a yi amfani da sojoji don samar da magunguna ga asibitocin jami'a, inda za a yi amfani da magungunan don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya ba da shawarar ga gwamnatin Trump game da sayan magunguna. Magungunan na iya zama da ƙarancin tasiri a yanayin tsananin rashin lafiya inda cutar ta riga ta ninka.
Ba zai zama mai lafiya ba ga mata masu ciki ko waɗanda ke ƙoƙarin yin ciki.
"Binciken da aka yi akan maganin anti-viral na Lopinavir da Ritonavir Lopinavir/Ritonavir (Kaletra) ya kammala cewa ""Ba a lura da fa'ida ba""".
An tsara magungunan don hana HIV yin kwafi ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza magunguna don gano wani fili wanda zai ɗaure kwayoyin SARS-CoV-2. Akwai suka a tsakanin al'ummomin kimiyya game da amfani da albarkatu don canza manufar magunguna da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa Lopinavir/Ritonavir a cikin gwajin tallafi na duniya.
Gilead Sciences ta kirkiro da kuma bunkasa Remdesivir a matsayin magani don cutar Ebola da kuma kamuwa da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafi a cikin in-vitro akan yawancin filalo-, pneumo-, paramyco- da coronaviruses.
Wata matsala da maganin rigakafin cutar ita ce, yana haifar da rigakafi ta hanyar maye gurbi wanda zai iya haifar da cututtuka da kamuwa da cuta.
Wasu nazarin farko na gwaji sun nuna cewa remdesivir na iya samun babban shinge na asali don rigakafi. Yawancin gwaji na asibiti suna gudana, gami da gwaji biyu da Asibitin Jami'ar Cleveland ke gudanarwa; daya ga mutane masu matsakaiciyar rashin lafiya, ɗayan kuma ga masu rashin lafiya mai tsanani.
Akwai gwaji uku na asibiti na Vitamin C don samar da jijiyoyi ga marasa lafiya da ke cikin asibiti da masu fama da cutar COVID-19; biyu masu sarrafa wuribo (China, Kanada) da ɗaya mara sarrafawa (Italiya).
Jihar New York ta fara gwaji don maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin gudanar da gwajin gwaji don alvesco (cyclosonide) na Taizhen, corticosteroid da aka ɗauka ta hanyar numfashi don cutar asma don kula da marasa lafiya masu alamun cutar coronavirus.
Wani nau'in gwaji na enzyme mai canza angiotensin-2 yana gudana a cikin marasa lafiya 200 masu fama da cutar, waɗanda aka kwantar da su a cikin asibitoci a Denmark, Jamus da Austria don ƙayyade tasirin maganin.
Masu bincike a Cibiyar Zuciya ta Montreal, Kanada a halin yanzu suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun COVID-19 mai laushi.
Binciken da ake kira COLCORONA ya kunshi manya 6,000 masu shekaru 40 zuwa sama wadanda suka kamu da COVID-19 kuma suka sami alamun rashin lafiya wadanda ba sa bukatar asibiti.
Mata masu ciki ko masu shayarwa, ko kuma waɗanda ba su da ingantaccen maganin hana ɗaukar ciki ba su cancanci.
Ana gwada wasu magungunan hana jini a Italiya.
Ana amfani da ƙananan nauyin kwayar halitta don magance marasa lafiya, yana ƙarfafa Hukumar Magunguna ta Italiya ta buga jagororin game da amfani da shi.
An sanar a Italiya a ranar 14 ga Afrilu game da nazarin cibiyar bincike da yawa da ke nazarin amfani da anoxaparin sodium a cikin allurai masu hanawa da warkarwa a kan marasa lafiya 300.
Tun da SARS-CoV-2 kwayar cuta ce, an mayar da hankali kan ilimin kimiyya kan sake yin maganin antitoxin da aka amince da shi wanda aka yi don barkewar cutar da ta gabata kamar MERS, SARS da West Nile virus.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 a cikin jagororin 7th na China.
Umyfenovir: An ba da shawarar umyfenovir don maganin COVID-19 a cikin jagororin 7 na kasar Sin.
Wasu magungunan rigakafi da aka gano da yiwuwar amfani da su don sababbin dalilai a matsayin maganin COVID-19 sune:
Tosalizumab (Anti-IL-6 Receptor): China ta amince da shi.
Ana kuma gudanar da gwaji a Italiya da China.
b'A allurar rigakafin COVID-19 allurar rigakafi ce da aka tsara don cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu wani allurar rigakafi da ya kammala gwajin gwaji, akwai ƙoƙari da yawa da ke ci gaba don samar da irin wannan allurar.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 mai aiki a cikin ƙasa da watanni 18.
A watan Afrilu, akwai 'yan takarar allurar rigakafi biyar a cikin gwajin aminci na farko.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020 wani babban barkewar cutar ya barke a duniya, wanda hakan ya haifar da zuba jari da kuma gudanar da bincike mai yawa don samar da allurar rigakafi.
Yawancin kamfanoni suna amfani da kwayoyin halittar da aka saki don haɓaka alluran rigakafi masu yuwuwa akan SARS-CoV-2.
A watan Afrilu, an ce, abubuwan da ke buƙatar CEPI don samar da allurar rigakafi sune saurin, ƙarfin samarwa, aikace-aikace da yawa da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa a farkon 2020 akwai dandamali daban-daban na fasaha 10 da ke aiki don Bincike da Ci gaban don ƙirƙirar allurar rigakafi mai tasiri akan COVID-19.
Babban manufofin dandamali da suka ci gaba a cikin karatun tsaro na Phase I sun hada da:
Kwayoyin nucleic (DNA da RNA) (Mataki na I mai haɓakawa da mai neman allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto mai ɗaukar hoto (Mataki na I mai haɓakawa da mai neman allurar rigakafi: Cancino Biologics, adenovirus type 5 vector)
Kamar yadda masana kimiyya na CEPI suka bayyana a watan Afrilu, jimillar mutane 115 da aka yi wa allurar rigakafi suna cikin matakan farko na ci gaba, daga cikinsu 78 an tabbatar da su a matsayin ayyukan aiki (79 a cewar Cibiyar Milken) da kuma 37 da aka ruwaito a matsayin wasu, amma duk sun fito ne daga bayanan da ba a bayyana su ga jama'a ba (wanda ake tsammani ana shirin).
Gwajin Phase I-II yana gudanar da gwajin farko na aminci da rigakafi kuma ana yin sa ne a wurare da yawa, ana sarrafa su da wuribo, yayin da ake ƙaddamar da takamaiman, ingantattun allurai.
Gwaje-gwaje na kashi na uku, tare da gwajin ingancin allurar rigakafi don hana cututtuka da rukunin kulawa, yawanci suna ɗaukar mahalarta da yawa, yayin da ake lura da tasirin sakamako mara kyau a cikin mafi kyawun sashi.
"Daga cikin 'yan takarar allurar rigakafi 79 da ke cikin ci gaba (kamar yadda aka tabbatar a farkon Afrilu 2020), 74 ba a tantance su a cikin ɗan adam ba tukuna (har yanzu suna ƙarƙashin binciken ""preclinical"")".
A ranar 24 ga Janairun 2020, Jami'ar Queensland a Ostiraliya ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayar halitta wacce za ta canza kwayoyin halittar kwayar cutar don haifar da martani na rigakafi.
A Kanada a ranar 24 ga Janairun 2020, Cibiyar allurar rigakafin ƙasa da ƙasa ta Jami'ar Saskatchewan (VIDO-Intervac) ta sanar da cewa za ta fara aiki kan allurar rigakafin da nufin fara gwajin mutum a cikin 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020 da kuma Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairun 2020, Kamfanonin Magunguna na Janssen karkashin jagorancin Hanneke Schuitemaker sun sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen tana haɓaka allurar riga-kafi ta Seva tare da abokin aikinta na fasahar kere-kere Vaxart.
A ranar 18 ga Maris, 2020, Emergent Bio Solutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar rigakafin.
A ranar 8 ga Fabrairun 2020, Oncogen Laboratory a Romania ya buga wani ɗan gajeren aiki kan ƙirar allurar rigakafi na irin wannan fasaha da ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar binciken ya sanar da cewa sun kammala hada magungunan rigakafi kuma suna fara gwaji.
A ranar 27 ga Fabrairun 2020, kamfanin Newgenerex Immuno-Oncology, wani reshen kamfanin Genevex, ya sanar da cewa suna fara aikin allurar rigakafi don samar da allurar peptide ta LI-K don yaƙi da COVID-19.
Sun so su samar da allurar rigakafin da za a iya gwadawa a cikin mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Sojojin Amurka na Bincike da Kayan Aiki a Fort Detrick da Walter Reed Army Institute of Research a Silver Spring, duka biyu a yammacin Maryland, sun ba da sanarwar cewa suna aiki kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
A cikin ci gaba da samar da allurar rigakafi.
Abokan hulɗa sun kuma sanar da shirin gudanar da gwajin gwaji da gwaji na farko a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta ba da sanarwar cewa suna aiki a kan keɓaɓɓu 11 kuma zai ɗauki aƙalla shekaru 1.5 zuwa 2 don samar da allurar rigakafi, koda kuwa yana tafiya cikin sauri.
A ranar 12 ga Maris, 2020, kamfanin kera kayayyakin zamani na kasar Quebec, Quebec, ya ba da rahoton ci gaban kwayoyin halittar coronavirus wanda aka samu daga cibiyar nazarin halittu ta Kanada.
An fara gwajin gwajin rigakafin a cikin mutane a watan Yuli ko Agusta na 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba da shawarar ba da 'ƙarancin kuɗi' ga Kurivac don samun ikon mallakar allurar rigakafin Covid-19, wanda gwamnatin Jamus ta yi hamayya da shi.
A ranar 17 ga Maris, 2020, kamfanin Pharmaceutical na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
BNT162, dan takarar allurar rigakafin mRNA, wanda a halin yanzu yana cikin gwaji na farko, kuma ana sa ran fara gwajin gwaji a watan Afrilu 2020.
A ranar 17 ga Maris, 2020 a Italiya, wani kamfanin nazarin halittu na Italiya mai suna Takis Biotech ya ba da sanarwar cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020, kuma za a iya gwada ɗan takarar allurar rigakafin su na ƙarshe a cikin mutum a kaka.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) a Faransa ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike don allurar rigakafin COVID-19, wanda ya haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI a cikin ci gaban allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar saka hannun jari na CEPI don samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun ba da sanarwar cewa masana kimiyya sun fara gwajin takarar allurar rigakafi daban-daban shida a kan dabbobi.
Masu bincike a Kwalejin Imperial ta London sun ba da sanarwar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar RNA mai rarrabuwa don COVID-19.
An samar da takarar allurar rigakafin ne a cikin kwanaki 14 da karɓar umarni daga China.
A ƙarshen Maris, Gwamnatin Kanada ta ba da sanarwar C$275 miliyan don samar da tallafi ga ayyukan bincike 96 kan rigakafin likita akan COVID-19, tare da ƙungiyoyi da jami'o'in Kanada da yawa kamar Medicago da kuma yunivarsit na Saskatchewan.
"A lokaci guda, Gwamnatin Kanada ta sanar da dala miliyan 192 na C$192 musamman don samar da alluran rigakafin COVID-19 da kuma wasu sabbin alluran rigakafi da ke da shirin kafa wani "bankin allurar rigakafi" na ƙasa wanda za a iya amfani da shi idan wani sabon cutar coronavirus ya ɓarke".
"A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin yiwuwar allurar COVID-19 a kan beraye, PittCoVacc, suna cewa "" alluran rigakafin SARS-CoV-2 S1 da MNA ta cire sun haifar da ƙarfin antigen-takamaiman maganin rigakafi [a cikin beraye] wanda ya bayyana a farkon mako na 2 bayan allurar rigakafi. """
A Kanada a ranar 16 ga Afrilu, 2020, Makarantar Pharmacy ta Jami'ar Waterloo ta sanar da shirin don ɗan takarar allurar rigakafin DNA a matsayin yiwuwar fesa hanci.
Za a tsara DNA ta amfani da bacteriophage don yin kwafin cikin kwayoyin cuta na mutum don samar da kwayoyin cutar da ba su da lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta ga SARS-CoV-2.
A watan Maris na 2020, Hewlett Packard Enterprise, da kamfanonin girgije na Amazon, Microsoft da Google, sun haɗu da gwamnatin Amurka, masana'antu da jami'o'i uku don samar da hanyoyin haɗin kai don samun damar yin amfani da manyan kwamfutoci daga IBM.
Wasu masu ƙuntatawa suna da tasirin heterologous, wanda ake kira tasirin da ba a bayyana ba.
Wannan yana nufin cewa suna iya samun fa'idodi fiye da cututtukan da suke hanawa.
Ana ƙoƙarin yin rajistar ma'aikatan kiwon lafiya 4,170 don ƙarin gwaji na bazuwar a Ostiraliya.
Akwai yiwuwar cewa alluran rigakafin da ke ƙarƙashin ci gaba ba za su kasance masu aminci ko tasiri ba.
Binciken farko don kimanta ingancin allurar rigakafi a cikin samfuran dabbobi na COVID-19-takamaiman kamar ACE2-transgenic mice, sauran dabbobin gwaji, da kuma dabbobi masu shayarwa waɗanda ba mutane ba sun nuna buƙatar matakan kiyayewa na Biosafety-Level 3 da haɗin gwiwar ƙasa da ƙasa don sarrafa ƙwayoyin cuta masu rai don tabbatar da ingantattun hanyoyin kariya.
An gwada alluran rigakafi kan SARS da MERS a kan samfuran dabbobi marasa mutum.
A shekarar 2020, babu magani ko rigakafin kariya ga SARS wanda aka nuna yana da aminci da tasiri ga mutane.
Bisa ga takardun bincike da aka buga a 2005 da 2006, ganowa da kuma ci gaba da sababbin alluran rigakafi da magunguna don maganin SARS sun kasance fifiko ga gwamnatoci da kungiyoyin kiwon lafiya na duniya.
Lokacin da barkewar MERS, an yi imanin cewa binciken SARS na yanzu zai iya samar da samfuri mai amfani don samar da allurar rigakafi da rigakafi kan kamuwa da cutar MERS-CoV.
A watan Maris na 2020, akwai allurar MERS (wanda aka kafa ta DNA) wacce ta kammala gwajin farko a cikin mutane kuma akwai wasu uku da ke gudana, dukansu alluran rigakafin kwayar cuta ne, adenoviral-vector biyu (ChAdOx1-MERS, BVRS-GamVac) da MVA-vectored (MVA-MERS-S).
Rubutun kafofin sada zumunta sun yada ka'idar makirci da ke ikirarin cewa an san kwayar cutar da ke bayan COVID-19 kuma an riga an samu allurar rigakafi.
Takaddun shaida da aka ambata a cikin sakonnin kafofin watsa labarun daban-daban suna da alaƙa da takaddun shaida na yau da kullun don jerin kwayoyin halitta da alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
Cutar B'coronavirus cuta 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta ta hanyar cutar sankarar barbashi mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma numfashi.
Sauran alamun zasu iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rasa ƙanshi, da ciwon ciki.
Lokaci daga lokacin kamuwa da cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma zai iya zama daga kwana biyu zuwa 14.
Ko da yake mafi yawan lokuta ana nuna alamun rashin lafiya, a wasu lokuta ci gaban zai iya haifar da cutar nimoniya da rashin aiki da gabobin jiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu rahotannin sama da mutane miliyan 2.24 a kasashe da yankuna 210 wanda ya kai ga mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar ga mutane da farko ta hanyar ƙananan ƙwayoyin ƙura da ke haifar da tari, hancinsa ko magana yayin kusanci.
Lokacin da aka fitar da ƙwayoyin ƙura yayin numfashi, yawanci suna faɗuwa ƙasa ko saman ƙasa maimakon yin yawo a cikin nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓa idanunsu, hanci ko bakinsu bayan sun taɓa gurbataccen abu.
Kwayar cutar na iya rayuwa har zuwa awanni 72 a saman ƙasa.
Yana da mafi kamuwa da cuta a cikin kwanaki uku na farkon bayyanar cututtuka, kodayake akwai yiwuwar yaduwa kafin bayyanar cututtuka da kuma a cikin ci gaba da cutar. Hanyar da ta dace ta ganewa ita ce ta hanyar hakikanin lokaci na sake juyawa ta hanyar polymerase chain reaction (rRT-PCR) daga nasopharyngeal swabs.
Ana ba da shawarar cewa duk wanda ake zargi da kamuwa da cutar da kuma masu kula da su su sanya takunkumin rufe fuska.
Shawarwarin amfani da abin rufe fuska ga jama'a sun bambanta, wasu hukumomi suna ba da shawarar a kan amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna buƙatar su.
A halin yanzu babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu karuwar kamuwa da cutar a cikin kasashe da dama a duk yankuna shida na WHO.
Wadanda ke dauke da kwayar cutar na iya zama marasa alamun cutar ko kuma suna iya nuna alamun mura kamar zazzabi, tari, gajiya da numfashi.
Alamomin gaggawa sun haɗa da numfashi, ciwon kirji ko damuwa, rikicewa, wahalar farkawa, da kuma fuska ko lebe mai launin shuɗi; ana ba da shawarar neman kulawar likita nan da nan idan waɗannan alamun sun bayyana.
A cikin ƙananan ƙananan, za a iya samun alamun cututtuka na sama kamar yin fitsari, ruwa daga hanci ko ciwon makogwaro.
An lura da alamun cututtukan ciki kamar amai, tashin zuciya, da zawo tare da bambancin kashi.
Wasu daga cikin masu cutar a kasar Sin da farko an gano su ne kawai da bugun kirji da kuma bugun kirji.
A wasu lokuta cutar na iya zuwa cutar huhu, nakasa ga wasu gabobin jiki da kuma mutuwa.
Wannan shine ake kira lokacin haifuwa na kwayoyin.
Lokacin haifuwa na kwayar cutar COVID-19 yawanci kwanaki biyar zuwa shida ne amma zai iya wucewa daga kwana biyu zuwa 14.
97.5% na mutanen da ke nuna alamun cutar za su nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa duk waɗanda ke kamuwa da cutar ba su nuna alamun cutar ba.
Ba a san cikakken rawar da waɗannan masu ɗaukar hoto marasa alamomi ke takawa ba a cikin kamuwa da cuta; duk da haka, shaidar farko ta nuna cewa suna iya taka rawa wajen yada cutar.
A halin yanzu ba a san adadin mutanen da ke dauke da cutar ba kuma ana nazarin su, cibiyoyin kula da cututtuka da rigakafi na KCDC sun ba da rahoton cewa kashi 20% na dukkan wadanda aka tabbatar da cutar ba su da alamun cutar yayin da suke asibiti.
A ranar 1 ga watan Afrilu, Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada marasa alamun cutar a cikin adadin masu kamuwa da cutar a kullum; daga cikin mutane 166 da suka kamu da cutar a ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Dukansu yau da kuma bargo na iya ɗaukar ƙwayoyin cuta da yawa.
Idan ka yi magana da ƙarfi, za ka iya yin magana da ƙura fiye da yadda kake yi.
Wani bincike da aka yi a Singapore ya nuna cewa tari ba tare da rufe baki ba zai iya yada ƙananan ɗigon ruwa har zuwa mita 4.5 (ƙafa 15).
Kodayake kwayar cutar ba ta yawan yin iska ba, amma Cibiyar Nazarin Kimiyya ta Kasa ta nuna cewa yaduwar bioaerosol na iya yiwuwa kuma masu tattara iska da aka sanya a cikin baranda na waje na gidajen mutane sun ba da samfurin tabbataccen RNA na kwayar cutar.
Wasu hanyoyin magani kamar intubation da CPR na iya haifar da ƙarancin iska a cikin iska kuma ya haifar da yaduwar iska.
Ko da yake akwai damuwa cewa ana iya yada shi ta hanyar stool, ana ganin wannan haɗarin yana da ƙananan. Kwayar cutar tana da saukin kamuwa da cutar idan akwai alamun bayyanar a cikin mutane; yana yiwuwa a yada kafin bayyanar cututtuka, amma ba shi da haɗari.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba amma mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a farfajiya na awanni zuwa kwanaki.
Musamman, an gano kwayar cutar a cikin kwali har zuwa kwana ɗaya, filastik (polypropylene) da bakin karfe (AISI 304) har zuwa kwana uku, da kuma jan ƙarfe 99% har zuwa awanni huɗu.
Wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kayan wanki ma suna iya zama masu tasiri idan aka yi amfani da su yadda ya kamata; kayan sabulu suna lalata layin mai na kwayar cutar, suna kashe shi kuma suna kawar da su daga fata da sauran farfajiya.
Sauran mafita, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe kwayoyin cuta na tiyata) ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an ɗauki samfurori na haushi tsakanin kwanaki biyu bayan an fara asibiti.
Na farko daga cikin biyar daga cikin marasa lafiya shida sun nuna mafi yawan kwayar cutar, kuma na shida ya nuna mafi yawan kwayar cutar a rana ta biyu.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 ana iya ganin su a cikin kwayar cutar corona da ke da alaƙa da yanayi.
A waje da jikin mutum, kwayar cutar tana mutuwa a cikin sabulu na gida, wanda ke fashe da kumfa mai kariya.
Fuka-fuka sune gabobin da COVID-19 ya fi shafa saboda kwayar cutar tana shiga cikin ƙwayoyin cuta ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda aka samo a cikin ƙwayoyin alveolar nau'in II na huhu.
"Cutar ta yi amfani da glycoproteins na musamman da ake kira ""spikes"" (peplomeres) don haɗawa da ACE2 don shiga cikin ƙwayoyin mahaifa".
An samu mummunan rauni na zuciya a cikin kashi 12% na mutanen da ke fama da cutar da aka kwantar a asibiti a Wuhan, China, kuma yana da yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya yana da yawa saboda halayen kumburi na tsarin kumburi da kuma cututtukan tsarin rigakafi yayin ci gaban cutar, amma mummunan rauni na myocardial na iya kasancewa da alaƙa da masu karɓar ACE2 na zuciya.
Masu karɓar ACE2 suna tafiya cikin sauri zuwa zuciya kuma suna da hannu cikin aikin zuciya.
An gano thrombosis (31%) da venous thromboembolism (25%) a cikin marasa lafiyar ICU da ke fama da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da mummunan ci gaban. Binciken gawa na mutanen da suka mutu daga COVID-19 ya nuna lalacewar lalacewar alveolar (DAD), da kuma ƙwayoyin cuta masu haɗuwa da ƙwayoyin cuta masu kumburi.
Kodayake SARS-COV-2 yana da saurin zuwa ƙwayoyin epithelial -ACE2 waɗanda ke haɗa hanyoyin numfashi, marasa lafiya masu fama da COVID-19 suna da alamun cutar hawan jini.
Musamman, an gano cewa kwayoyin halittar GM-CSF-sake ɓoye T-cell a cikin marasa lafiya na COVID-19 suna da alaƙa da ƙwayoyin IL-6-sake ɓoye ƙwayoyin cuta da sake dawowa (ƙaddamarwa) na cututtukan huhu masu tsanani.
An gano cewa an samu cutar lymphocytic infiltrate a jikin gawa.
WHO ta fitar da wasu ka'idojin gwaji don cutar.
Hanyar da ta dace ta gwadawa ta amfani da ainihin lokacin juyawa na juyawa polymerase chain reaction (rRT-PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samo ta hanyar nasopharyngeal swab; duk da haka, ana iya amfani da samfurori na nasal swab ko saliva.
Sakamakon yana samuwa a cikin sa'o'i biyu zuwa kwana biyu.
Ana iya yin gwajin jini, amma suna buƙatar ɗaukar samfuran jini biyu a tsakanin makonni biyu kuma sakamakon yana da ƙarancin darajar nan take.
Masana kimiyya na kasar Sin sun sami damar ware kwayar cutar coronavirus da kuma sakin jerin kwayoyin halitta don dakunan gwaje-gwaje a duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, gwaje-gwajen rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma gano ko mutum ya kamu da cutar a baya) suna kan ci gaba, amma har yanzu ba a yi amfani da su sosai ba.
Kwarewar kasar Sin a gwajin ta nuna daidaito tsakanin kashi 60 zuwa 70 cikin dari.
A ranar 21 ga Maris, 2020, FDA ta amince da gwajin farko na maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Bi-lateral, multilobar ƙasa-gilashin opacity tare da iyaka, rashin daidaituwa da kuma rarraba baya-bayan nan yana da mahimmanci ga kamuwa da cuta na farko.
Ana iya ganin rinjaye na subplural, ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
Akwai bayanai kaɗan game da ilimin halittu da lalacewar microscopic na COVID-19.
Babban mahimman bayanai na cututtukan cututtuka a cikin binciken bincike shine:
Maganin hoto: Pleritis, pericarditis, haɗuwa da huhu da kuma kumburi na huhu
Akwai nau'ikan cutar nimoniya guda hudu:
Ƙarfin cutar huhu: edema na huhu, hyperplasia na pneumocyte, manyan ƙwayoyin atypical pneumocytes, ƙwayoyin cuta tare da infiltration na lymphocytic da kuma samar da kwayoyin halitta masu yawa.
Cutar huhu mai tsanani: Cutar cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar.
DAD yana haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ciwon huhu: Ƙungiyar abubuwan da ke cikin alveolar cavity da kuma ciwon huhu na ciwon huhu
jini: yaduwar jini na jini (DIC); amsawar leukoarythroblastic
Matakan kariya don rage yiwuwar kamuwa da cutar sun hada da kasancewa a gida, guje wa wuraren da jama'a ke taruwa, wanke hannuwanku da sabulu da ruwa akai-akai na aƙalla dakika 20, da yin tsabtace jiki mai kyau da kuma numfashi, da kuma guje wa taɓa idanu, hanci ko baki da hannayen hannu.
CDC ta ba da shawarar yin amfani da hanci da hanci a lokacin tari ko hancin, kuma idan babu wani nama, to, amfani da ciki na gwiwoyi.
Ana ƙarfafa tsabtace hannu bayan tari ko hancin.
CDC ta ba da shawarar yin amfani da suturar rufe fuska a cikin jama'a don iyakance kamuwa da cuta ta hanyar mutanen da ba su da alamun cutar. An tsara dabarun nisantar da jama'a don rage hulɗar mutane masu kamuwa da cuta da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata balaguro da soke manyan tarurruka.
Umarnin nisantarwa ya hada da cewa mutane su kasance aƙalla ƙafa 6 (1.8 m).
"Babu wani magani da aka sani da zai iya hana COVID-19". Tun da ba a sa ran samun allurar rigakafi ba har zuwa kafin 2021, babban ɓangare na kula da COVID-19 shine ƙoƙarin rage ƙimar cutar, wanda aka sani da ""lanƙwasa lanƙwasa"".
CDC ta kuma ba da shawarar mutane su wanke hannayensu akai-akai da sabulu da ruwa na aƙalla dakika 20, musamman bayan sun je bayan gida ko idan hannayensu sun kasance masu datti, kafin cin abinci da bayan zubar hanci, tari ko hancin.
Ya kuma ba da shawarar yin amfani da tsabtace hannu na giya wanda ya ƙunshi aƙalla kashi 60% na giya idan sabulu da ruwa kawai ba su da shi. WHO ta ba da takamaiman tsari guda biyu don samarwa na gida a wuraren da ba a samun tsabtace hannu na kasuwanci.
A cikin waɗannan shirye-shiryen, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide a cikin barasa don kawar da ƙwayoyin cuta; ba shi da "wani abu mai aiki don antiseptic na hannu".
Glycerol an kara shi a matsayin humicant.
Mutane suna motsawa ta hanyar kulawar tallafi, wanda zai iya haɗawa da maganin ruwa, taimakon oxygen da kuma taimakawa sauran gabobin da ke fama da cutar.
CDC ta ba da shawarar cewa duk wanda ake zargi da dauke da kwayar cutar ya sanya abin rufe fuska.
An yi amfani da Oxygenation na membrane na Extracorporeal (ECMO) don magance matsalar rashin ƙarfi, amma fa'idodin sa har yanzu ba a tantance su ba.
An ba da shawarar tsabtace jiki da rayuwa mai kyau da abinci don inganta rigakafi.
Kulawa da marasa lafiya da ke fama da cutar COVID-19 a farkon lokacin kamuwa da cutar na iya zama da amfani ga masu fama da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari don kula da mutanen da ke cikin asibiti da cutar COVID-19.
Masu ba da shawara kan jinya daga kungiyoyi daban-daban na masu ba da kulawa da ciwo mai tsanani da masu ilimin cututtukan huhu a Amurka sun shirya a cikin wata hanya ta kyauta, IBCC.
Babu takamaiman magani ga COVID-19 kamar na Afrilu 2020.
Don bayyanar cututtuka, wasu likitocin likitanci sun ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Dole ne a yi taka tsantsan don rage haɗarin kamuwa da cutar, musamman a cikin yanayin kiwon lafiya lokacin da ake aiwatar da hanyoyin kamar intubation ko iska mai iska wanda zai iya haifar da ƙwayoyin iska.
Ga masu aikin kiwon lafiya da ke kula da mutanen da ke fama da COVID-19, CDC ta ba da shawarar sanya mutum a cikin dakin keɓewa na kamuwa da cutar ta iska (AIIR), ban da amfani da gargaɗin shaida, gargadi game da taɓawa, da gargadi game da iska. CDC ta ba da umarnin don amfani da kayan kariya na mutum (PPE) yayin annobar a duk duniya.
Abubuwan da aka ba da shawarar sune: rigunan PPE, masu numfashi ko abin rufe fuska, masu kare ido da safar hannu ta likita. Idan akwai, ana ba da shawarar masu numfashi (maimakon abin rufe fuska).
An ba da izinin N95 respirator don yanayin masana'antu amma FDA ta ba da izinin masks don amfani a ƙarƙashin Izinin Amfani da Gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura, amma ba a ba da tabbacin inganci ga takamaiman abubuwan ƙwayoyin halitta ba don takamaiman amfani.
Idan ba a sami abin rufe fuska ba, CDC ta ba da shawarar yin amfani da abin rufe fuska ko abin rufe fuska na gida a matsayin mafita ta ƙarshe.
Yawancin masu kamuwa da cutar ba su da COVID-19 mai tsanani da zai buƙaci iska ta inji ko madadin, amma wasu ɗaruruwan masu kamuwa da cutar suna da tsanani.
Ana nazarin nau'ikan taimakon numfashi a cikin mutane da ke fama da rashin nasarar numfashi da ke da alaƙa da COVID-19 don mutanen da ke asibiti, tare da wasu shaidu cewa ana iya guje wa intubation tare da babban kwararar hanci ko kuma matsin lamba mai kyau na iska.
Ba a san ko ɗayan waɗannan zai haifar da fa'idodi iri ɗaya ga waɗanda ke da mummunan rashin lafiya ba.
Wasu likitoci sun zaɓi yin amfani da iska mai mahimmanci idan akwai saboda wannan fasaha ta iyakance yaduwar ƙwayoyin iska fiye da na'urar ƙwayoyin cuta mai zurfi. Abubuwan da suka faru a cikin tsofaffi sun fi yawa (waɗanda suka wuce shekaru 60 da musamman fiye da shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kan kowane mutum, wanda ke iyakance ikon gudanar da kiwon lafiya don magance ƙaruwar ƙaruwar adadin masu cutar COVID-19 waɗanda ke buƙatar asibiti.
Wani bincike a China ya nuna cewa kashi 5% an kwantar da su a cikin cibiyoyin kulawa, kashi 2.3% na bukatar taimakon injiniya na iska, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da ke kamuwa da COVID-19 a asibiti suna zuwa ICU.
COVID-19 yana haifar da ciwon cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana buƙatar yanayin sarrafa matsa lamba da masu ba da iska masu ƙarfi don haɓaka isar da iskar oxygen, yayin da masu ba da iska ke rage haɗarin rauni na huhu da cutar huhu.
Ba za a iya samun PEEP mai yawa a cikin tsofaffin na'urorin numfashi ba.
An fara binciken yiwuwar magani a cikin Janairu 2020 kuma ana gudanar da gwajin gwaji na magungunan antiviral da yawa.
Da alama maganin Remdesivir ne mafi kyawun magani.
Kodayake sabbin magunguna na iya ɗaukar har zuwa 2021, yawancin magungunan da ke cikin gwaji an riga an amince da su don wasu amfani ko kuma suna cikin gwaji na gaba.
Ana iya gwada magungunan rigakafin cutar a cikin mutanen da ke da mummunan cuta.
Hukumar ta WHO ta ba da izinin masu sa kai don shiga cikin gwaji kan inganci da amincin yiwuwar magani. FDA ta ba da izinin ɗan lokaci don maganin plasma mai haɗari a matsayin magani na gwaji inda rayuwar mutum ke cikin haɗari ko ta gaggawa.
Ba a gudanar da nazarin asibiti da ake buƙata don nuna cewa yana da lafiya da tasiri ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar hannu don magance barkewar cutar.
Ana tambayar masu amfani da su shigar da sunayensu da lambar ID.
Aikace-aikacen yana iya amfani da bayanan sa ido don gano 'kusanci' da yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Aikace-aikacen ba kawai yana ba da shawarar keɓe kai ba ne kawai idan an gano yiwuwar haɗari, har ma yana faɗakar da jami'an kiwon lafiya na gida.Babban nazarin bayanan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da ilimin kere kere ana amfani da su don sa ido kan mutane masu kamuwa da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar sa ido kan bayanan wayar salula na mutanen da ake zargi da cutar coronavirus.
An dauki matakin ne don kare mutanen da ke iya kasancewa a cikin hulɗa da mutanen da ke da cutar da kuma tilasta keɓewa.
Hakanan a cikin Maris 2020, Deutsche Telecom ta raba bayanan wurin wayar da aka haɗa tare da Robert Koch Institute, wata hukumar gwamnatin tarayya ta Jamus don hana yaduwar cutar da kuma bincike.
Rasha ta yi amfani da fasahar gano fuska don gano masu keta dokar killacewa.
"Kwamishinan kiwon lafiya na yankin Italiya Giulio Galera ya ce masu amfani da wayoyin salula sun gaya masa cewa "kashi 40 cikin dari na mutane suna tafiya a ko'ina".
Gwamnatin Jamus ta shirya taron Hackathon na tsawon sa'o'i 48 a karshen mako tare da masu halarta sama da 42,000.
Shugaba Kersti Kaljulaid na Estonia ya kuma yi kira ga duniya da ta samar da hanyoyin magance yaduwar cutar.
Mutane na iya jin rashin lafiya saboda keɓewa, ƙuntatawa na tafiya, tasirin tasirin magani ko tsoron kamuwa da cutar.
"BBC ta nakalto Rory O'Connor yana cewa, ""Ƙara yawan zamantakewar zamantakewa, kadaici, damuwa da lafiyar jiki, damuwa da kuma koma bayan tattalin arziki shine mummunar lalacewa ga lafiyar mutum da lafiyar mutum"."
Kamar sauran cututtukan numfashi na sama, kamar sanyi, cutar na iya ci gaba da sauƙi ba tare da alamomi ba.
Yawancin lokuta masu rauni suna murmurewa cikin makonni biyu, amma masu fama da cutar mai tsanani ko mai tsanani na iya ɗaukar makonni uku zuwa shida don murmurewa.
Bayanai game da wasu ƙwayoyin cuta irin su SARS da MERS sun nuna cewa mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19, amma babu bayanai game da COVID-19. A cikin wasu mutane, COVID-19 na iya haifar da cutar huhu ta hanyar cutar huhu.
A cikin yawancin masu fama da cutar, COVID-19 na iya haifar da saurin kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Matsaloli da ke tattare da COVID-19 sun haɗa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A cikin kashi 6% na waɗanda aka kwantar da su a asibiti tare da COVID-19, an bayyana rashin daidaiton jini, musamman lokacin da aka ba da prothrombin, yayin da aikin koda mara kyau ya bayyana a cikin kashi 4% na wannan rukunin.
An gano cewa an sami karuwar cutar hanta a cikin kusan kashi 20-30% na mutanen da ke da COVID-19.
A cewar wannan rahoton, tsawon lokacin da ya kasance tsakanin bayyanar cututtuka da mutuwa, tare da asibiti biyar, ya kai kwanaki goma.
Koyaya, akwai kwanaki bakwai tsakanin kwantar da marasa lafiya zuwa ICU da mutuwa.
A cikin binciken da aka yi na farkon masu cutar, lokacin da ya wuce daga bayyanar alamun farko zuwa mutuwa, tare da tsawon kwanaki shida zuwa 41, ya kasance kwanaki 14.
Wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar ya nuna cewa mace mace tana mutuwa ne da kashi 2.8 cikin dari, yayin da mace ke mutuwa da kashi 1.7 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An lura da canje-canjen kwayar cutar kwayar cuta a cikin ƙwayar cuta.
Hoton huhu yana kama da ciwon ciwon numfashi mai tsanani (ARDS).
An gano lalacewar zuciya ta hanyar bugun zuciya ko karuwar matakan troponin a cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito.
A cikin watan Maris, kashi 89% na waɗanda aka kwantar a asibiti a Amurka suna da cutar da ta riga ta kasance.
Adadin mutuwar da ke faruwa daga wannan cuta ya bambanta ba kawai saboda bambancin yanki ba amma kuma saboda matsalolin tsarin.
Idan aka rage yawan wadanda suka kamu da cutar, za a iya yin karin adadin mutuwar.
Amma gaskiyar ita ce, mutuwar ta kasance sakamakon kamuwa da cutar a baya, wanda ke nufin cewa ana rage yawan mutuwar yanzu.
Masu shan sigari sun fi sau 1.4 samun alamun bayyanar cututtuka na COVID-19 fiye da masu shan sigari kuma sun fi sau 2.4 buƙatar kulawa mai tsanani ko mutuwa. An nuna damuwa game da sakamakon cutar na dogon lokaci.
Hukumomin asibitin Hong Kong sun lura da raguwar karfin huhu da kashi 20% zuwa 30% a cikin wasu mutanen da suka warke daga cutar, kuma hotunan huhu sun nuna lalacewar gabobin.
Wannan zai iya haifar da ciwon bayan-matsanancin kulawa bayan warkewa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata tana ba da kariya mai inganci da na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Akwai yiwuwar rashin kariya daga sauran cututtukan coronavirus dangane da halayensu, amma an ba da rahoton warkewa daga COVID-19 bayan an gwada sakamako mai kyau na cutar coronavirus a baya.
Ana fargabar cewa waɗannan lamuran sun faru ne saboda mummunan lalacewar kamuwa da cuta fiye da sake kamuwa da cuta.
Ana tsammanin kwayar cutar ta kasance ta halitta kuma ta samo asali ne daga dabbobi, ta hanyar yaduwar kamuwa da cuta.
Ba a san ainihin asalin ba, amma har zuwa watan Disamba na 2019, yaduwar kamuwa da cuta kusan ana sarrafa ta ne ta hanyar kamuwa da mutum zuwa mutum.
Wani bincike na farko na mutane 41 da aka tabbatar da cutar COVID-19 da aka buga a cikin The Lancet a watan Janairun 2020, inda aka ba da farkon farkon bayyanar cututtuka a ranar 1 ga Disamba, 2019.
A ranar 8 ga Disamba, 2019, wallafe-wallafen hukuma daga WHO sun ce farkon bayyanar cututtuka.
Akwai wasu matakai da aka saba amfani dasu don tantance yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki, kuma ana rinjayar su da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya wuce tun farkon barkewar cutar, da kuma yanayin yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar ICD-10 ta gaggawa ta U07.1 ga mutuwar da ta faru saboda kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje, kuma lambar U07.2 ga mutuwar da ta faru saboda cutar SARS-CoV-2 da ba a tabbatar da ita a cikin dakin gwaje-gwaje ba ko kuma cutar ta kamu da cutar COVID-19.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mace-mace da cutar a duniya ya kai kashi 6.9% (153,822/2,240,191) har zuwa 17 ga Afrilu, 2020.
Yawan yana bambanta ta yanki. Sauran ma'aunin sun haɗa da yawan mutuwar mutane (Case Fatality Rate, CFR) wanda ke nuna yawan mutanen da aka gano da cutar da suka mutu daga cutar da kuma yawan mutuwar kamuwa da cuta (Infection Fatality Rate, IFR), wanda ke nuna yawan mutanen da ke da cutar (ba tare da ganewa ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da takamaiman lokaci kuma suna bin ƙididdigar yawan jama'a daga kamuwa da cuta zuwa ganewar asali.
Ko da yake ba duk mutanen da ke dauke da cutar ba ne ke samar da rigakafi, kasancewar rigakafin na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
Cibiyar barkewar cutar a Italiya, Casiglione Di Adda, wani karamin kauye mai yawan mutane 4,600, inda mutane 80 (1.7%) suka riga sun mutu.
A Gangelet, cutar ta bazu ta hanyar bikin Carnival kuma ta bazu tsakanin matasa, wanda ke haifar da ƙananan mutuwar, kuma duk mutuwar COVID-19 na iya zama ba a rarraba su a hukumance ba.
Bugu da ƙari, tsarin kiwon lafiyar Jamus bai lalace ba.
A cikin Netherlands, masu ba da jini suna da ƙwayoyin cuta kusan 3% bisa ga kimantawa.
An tabbatar da mutuwar mutane 69 (kashi 0.004 cikin ɗari na yawan jama'a) daga COVID-19.
Cutar da kuma tasirinta kan yawan mace-mace sun bambanta tsakanin maza da mata.
A cikin binciken da aka gudanar a China da Italiya, an sami karin mace-mace a cikin maza.
Maza suna da haɗari mafi girma a cikin shekarunsu na 50, kuma tsakanin maza da mata, wannan rata ta ƙare a cikin shekarun 90.
Yawan mace-macen a kasar Sin ya kai kashi 2.8 cikin dari a cikin maza da kashi 1.7 cikin dari a cikin mata.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma akwai yiwuwar wasu abubuwa na asali da na dabi'a.
Bambancin ilimin rigakafi na jinsi, yawan shan sigari tsakanin mata da ƙananan ƙananan, da kuma ci gaban cututtuka a cikin maza a cikin matashi fiye da mata, kamar hawan jini, na iya zama sanadiyar yawan mutuwar maza.
A Turai, maza sun kai kashi 57% na mutanen da suka kamu da cutar, kuma maza sun kai kashi 72% na mutanen da suka mutu sakamakon COVID-19.
Tun daga watan Afrilu 2020, gwamnatin Amurka ba ta kula da bayanan jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan cututtukan cututtuka kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya mata ne kuma suna iya fuskantar kamuwa da cutar.
"A ranar 11 ga Fabrairun 2020, Hukumar Lafiya ta Duniya ta sanar da cewa sunan hukuma na cutar zai zama ""COVID-19""".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana nufin coronavirus, VI yana nufin kwayar cuta, D shine cuta, kuma 19 shine lokacin da aka fara gano barkewar cutar: 31 ga Disamba 2019.
An zaɓi sunan don kauce wa ambaton takamaiman wuri na ƙasa (misali, China), nau'in dabba, ko rukunin mutane, daidai da shawarwarin ƙasashen duniya don sanya suna don hana kamuwa da cutar. An sanya wa kwayar cutar da ke haifar da COVID-19 sunan mai tsanani mai saurin numfashi mai saurin numfashi 2 (SARS-CoV-2).
"A cikin sadarwar jama'a, WHO tana amfani da ƙarin ""Covid-19 virus"" da ""Covid-19 virus""".
"Dukkan cututtuka da ƙwayoyin cuta ana kiransu da ""coronavirus""".
"A lokacin barkewar cutar a Wuhan, China, an fi kiran kwayar cutar da cutar da ""coronavirus"" da kuma ""Wuhan coronavirus""".
A cikin Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV a matsayin sunayen wucin gadi na ƙwayoyin cuta da cututtuka bisa ga jagororin 2015 dangane da amfani da wuri na ƙwayoyin cuta da cututtuka.
An ba da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Wasu masana'antun dijital suna buga kayan aikin kiwon lafiya kamar swabs na hanci da sassan masu ba da iska saboda iyakancewar iyawa a cikin sarkar samar da daidaito.
A wani misali, lokacin da aka bukaci bawul din iska a asibiti a Italiya kuma mai samar da shi bai iya samar da shi a lokacin da ake buƙata ba, wani sabon kamfani na gida ya gwada ƙirar samfurin masana'anta kuma ya samar da bawul 100 da ake buƙata cikin dare.
Bayan barkewar cutar COVID-19, ra'ayoyin rikice-rikice, rashin fahimta da jita-jita game da asalin cutar, girmanta, rigakafi, magani da sauran fannoni sun fito kuma sun bazu cikin sauri akan layi.
An yi imanin cewa mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken bai sami wata hujja ba game da kwayar cutar ta kwafi a cikin aladu, ducks da kaji.
Babu wani magani ko allurar rigakafi da aka amince da shi don magance cutar.
Ana gudanar da bincike na duniya kan allurar rigakafi da magunguna don COVID-19 ta hukumomin gwamnati, kungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin "goyon bayan juna" don tantance tasirin maganin maganin maganin cutar antiviral guda huɗu da ke da mafi yawan alkawuran aiki.
Babu riga-kafi, amma kamfanoni suna aiki sosai don samar da takarar rigakafi.
Ana amfani da aikin da aka yi a baya akan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ana binciken dabarun allurar rigakafi guda uku.
Da farko, masu bincike suna da niyyar samar da cikakken allurar rigakafin cutar.
Amfani da cutar, ko ta mutu ko ta kashe, yana nufin kawar da hanzarin rigakafin jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafin subunit, tana da nufin ƙirƙirar allurar rigakafin da ke sa tsarin garkuwar jiki ya zama mai saurin kamuwa da ƙwayoyin cuta.
A game da SARS-CoV-2, binciken ya gano furotin S-spike wanda ke taimakawa kwayar cutar shiga cikin mai karɓar enzyme ACE2.
Hanya ta uku ita ce allurar rigakafin nucleic acid (DNA ko RNA allurar rigakafi, fasaha ce ta zamani don samar da allurar rigakafi).
Don tabbatar da aminci da inganci, ana buƙatar gwada alluran rigakafi na gwaji daga ɗayan waɗannan dabarun.A ranar 16 ga Maris, 2020, gwajin farko na gwaji na allurar rigakafi tare da masu sa kai huɗu ya fara a Seattle.
Kwayar cutar tana da kwayar halitta wacce ba ta haifar da cutar ba. An nuna ci gaban da ke dogara da ƙwayoyin cuta a matsayin wata matsala ga ci gaban allurar rigakafin SARS-COV-2, amma ana iya jayayya.
Sama da gwaji 300 ne ke gudana tun daga watan Afrilu 2020.
An gudanar da gwaji bakwai don tantance magungunan da aka riga aka amince da su don magance zazzabin cizon sauro, gami da nazarin hudu akan hydroxychloroquine ko chloroquine.
Yawancin bincike a China ana yin su ne kan amfani da magungunan rigakafin cutar don dalilai daban-daban, kuma ana sa ran rahoto game da gwaji tara na III akan remdesivir a cikin ƙasashe daban-daban a ƙarshen Afrilu.
An shirya wani bita mai motsi game da ci gaban bincike na alluran rigakafi da magungunan rigakafi na COVID-19 a watan Afrilu 2020. Ana kimanta wasu magungunan rigakafin cutar antiviral da ake dasu don maganin COVID-19 ciki har da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir da interferon beta tare da lopinavir / ritonavir.
Akwai shaidar gwaji na tasiri ta hanyar Remdesivir a cikin Maris 2020.
An lura da ci gaban bincike a cikin marasa lafiya da ke shan maganin gwaji na Remdesivir.
Ana gudanar da gwaji na gwaji na Phase III a Amurka, China da Italiya.An yi nazarin chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, a China a watan Fabrairun 2020.
Duk da haka, akwai bukatar a sake nazarin binciken.
Hukumomin kiwon lafiya na Koriya da na China sun ba da shawarar amfani da chloroquine.
Duk da haka, Cibiyar Nazarin Kwayoyin Cutar Wuhan, yayin da ta ba da shawarar yin amfani da allurar a kowace rana, ta lura cewa sau biyu na wannan maganin na iya zama mai haɗari da kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine bisa ga shawarar likitocin da ke kula da mutanen da ke fama da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban maganin ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar yin ƙarin nazarin vivo na nitasoxanide bayan nuna ƙarancin ƙwayar cuta na SARS-CoV-2. Nazarin ya nuna cewa samar da furotin na farko ta hanyar serine 2 (TMPRSS2) ta hanyar samar da furotin na farko yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da iyakancewa mai tsanani wanda ya hana ƙungiyar likita ɗaukar waɗannan magungunan ba tare da ƙarin nazari ba. Oseltamivir ba ya hana SARS-CoV-2 a cikin vitro kuma ba shi da sanannen rawar a cikin maganin COVID-19.
Cytokine disruption na iya zama mawuyacin hali a cikin matakan COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kayan aikin hana fitowar cytokine da sauri. Hukumar Lafiya ta Kasa ta kasar Sin ta sanya tosalizumab a cikin umarnin likita bayan kammala karamin bincike.
Ana fuskantar gwaji na biyu a matakin ƙasa a Italiya bayan an sami sakamako mai kyau a cikin mutane masu fama da cutar.
Gwajin jini don gano cutar cytokine tare da maganin ferritin yana nufin hana ci gaban cutar, wanda ake tsammanin yana haifar da mutuwa a wasu mutane masu kamuwa da cutar.
A cikin 2017 an yarda da maganin CAR T cell don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Zuwa yau, babu wata hujja ta bazuwar, tabbatacciyar hujja cewa tosalizumab magani ne mai tasiri don CRS.
Ana bincika rigakafin rigakafi da aka sarrafa da kuma ƙarancin rigakafi da tsarin rigakafin waɗanda suka warke daga COVID-19 ke samarwa a matsayin hanyar ba da allurar rigakafi ba don ba da allurar rigakafi ga waɗanda suke buƙata.
An gwada wannan dabarar don SARS tare da sakamako mara kyau.
Rushewar kwayar cuta ita ce hanyar da aka tsara ta musamman ta hanyar da maganin rigakafi na iya taimakawa wajen kare rigakafi da SARS-CoV-2.
Duk da haka, wasu matakai kamar su antibody-dogara cellular cytotoxicity da / ko phagocytosis na iya zama mai yiwuwa.
Sauran nau'ikan maganin rigakafi na marasa aiki, misali, amfani da ƙwayoyin cuta na monoclonal, suna kan ci gaba.
Samun maganin warkewa, wanda ya ƙunshi ruwa na jini da aka karɓa daga marasa lafiya da suka warke kuma ana iya haɓaka shi don saurin samar da ƙwayoyin cuta na wannan ƙwayar cuta.
Cutar coronavirus, rukuni ne na cututtuka masu alaƙa da juna
Likita Li Wenliang na asibitin tsakiya na Wuhan, wanda ya kamu da COVID-19 ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
